Genome scale analysis of the role of superantigens in Staphylococcus aureus disease pathogenesis by Wilson, Gillian Jane C.
 
Genome scale analysis of the 
role of superantigens in 
Staphylococcus aureus 
disease pathogenesis  
 






Doctor of Philosophy 







I declare that I have composed this thesis, that the work described here is my own, 
and has not been submitted for any other degree or professional qualification. 




























First and foremost, I would like to thank my supervisor Dr Ross Fitzgerald for all his 
help, support and guidance throughout the course of my PhD. I’d also like to thank 
Professor Ivan Morrison for his help and advice.  
 
 I would like to say a big thanks to Dr Caitriona Guinane for sharing her cloning and 
qRT-PCR expertise, and for her support and encouragement both in and outside the 
lab. I would also like to thank Dr Timothy Connelley for helping me with the TCR 
work, and Robyn Cartwright for carrying out the PCR and sequencing of selx alleles 
described in this study.  
 
In addition, I am very grateful to Professor Greg Bohach for inviting me to visit the 
University of Idaho to carry out the experimental infections described in this study. 
Special thanks are due to Keun Seok, not only for helping me with protein 
purification and providing human Vβ data for SElX, but for looking after me 
throughout my stay. I’d also like to thank Claudia, Sun and Anna for their excellent 
hospitality.  
 
I would like to thank everyone who has helped and inspired me over the past 4 years. 
In particular, the original LBEPers, Caitriona, Nouri, Jeannette, Shruti and Bethan 
(the other half of “Gill ‘n’ Bethan”), their support from the very beginning was 
invaluable. Thanks also to newer group members, Mark, Paul, Laura, Helen, and 
Anne. Huge thanks are due to Robyn who never fails to cheer me up not least with 
her baking! Thanks to all my friends in the ZAP, Morrison and MPRL groups for all 
their advice and banter! 
 
Last but by no means least, I would like to say a massive thank you to Andrew for 
his love and support, and to my Mum and Dad and William who have been an 




  Page 
 Title page i 
 Declaration ii 
 Acknowledgements iii 
 Contents iv 
 List of figures ix 
 List of tables xii 







1.1 Staphylococcus aureus 2 
1.2  Bovine mastitis 3 
1.3 Population genetics of S. aureus 4 
1.4 Comparative Genomics 5 
1.5 Pathogenesis of S. aureus 6 
1.6 Superantigens 8 
     1.6.1 Bacterial SAgs 8 
     1.6.2 Endogenous SAgs 14 
1.7  Staphylococcal superantigen like toxins (SSLs) 14 
1.8 SAg activity 15 
1.9 SAg structure 16 
1.10 SAg interactions with the MHC and TCR 17 
1.11 The T-cell receptor (TCR) 18 
1.12 SAg stimulation of bovine T lymphocytes 21 
1.13 Distribution of staphylococcal SAgs     21 
1.14 Staphylococcal gene regulation 23 
1.15 Expression of SAg genes 24 
1.16 Toxic shock syndrome (TSS) 25 
1.17 Other SAg-associated diseases 26 
 v 
  Page 
1.18 Therapeutics 27 
1.19 Hypothesis 27 
1.20 Project aims 
 
28 
Chapter 2 General Materials and Methods 
 
29 
2.1 Bacterial culture conditions 30 
2.2 Genomic DNA extraction 30 
2.3 DNA isolation 30 
2.4 Restriction digestion 30 
2.5 Polymerase Chain Reaction (PCR) 31 
2.6 Agarose gel electrophoresis 31 
2.7 DNA quantification 32 
2.8 DNA sequencing 32 
2.9 Phylogenetic analysis 32 
2.10 Cloning of SAg genes 32 
2.11 Preparation of electro-competent cells and electro-
transformation 
33 
2.12 Sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) 
33 
2.13 Western immunoblot analysis 34 
2.14 Isolation of bovine peripheral blood lymphocytes (PBLs) 35 




Diversity, distribution and expression of bovine  




3.1 Introduction 38 
3.2 Materials and methods 39 
     3.2.1 Bacterial strains 39 
     3.2.2 Phylogenetic analysis of staphylococcal SAg genes 39 
 vi 
  Page 
     3.2.3 PCR amplification of putative SAg genes 46 
     3.2.4 Transcriptional analysis of SAg genes 46 
         3.2.4.1 RNA extraction from S. aureus 46 
         3.2.4.2 Reverse transcriptase - PCR (RT-PCR) 46 
         3.2.4.3 Quantitative reverse transcriptase – PCR (qRT-PCR) 46 
    3.2.5 Cloning and purification of recombinant SAg proteins 47 
    3.2.6 Western immunoblot analysis 48 
3.3 Results 49 
    3.3.1 Bovine S. aureus strain RF122 encodes an array of SAg 
genes 
49 
    3.3.2 Phylogenetic analysis of SAg genes 52 
    3.3.3 Distribution of putative SAg genes in S. aureus strains 
from humans and animals   
52 
    3.3.4 SAg genes are expressed at different levels in a growth 
phase dependent manner 
52 
    3.3.5 Transcription of egc genes 55 
    3.3.6 Recombinant expression of SAgs encoded by RF122 55 




Chapter 4 Functional evolutionary characterization of a 




4.1 Introduction 65 
4.2 Materials and methods 66 
    4.2.1 Bacterial strains and plasmids 66 
    4.2.2 DNA sequencing of selx 66 
     4.2.3 Phylogenetic analysis 66 
     4.2.4 Transcriptional analysis of selx. 70 
     4.2.5 Cloning and purification of recombinant SElX variants. 70 
 vii 
  Page 
     4.2.6 Concentration of secreted S. aureus proteins 71 
     4.2.7 Western immunoblot analysis 71 
     4.2.8 Bovine T-cell proliferation assays 71 
     4.2.9 Protein structural modelling 72 
4.3 Results 73 
     4.3.1 selx is encoded by the majority of S. aureus strains 73 
     4.3.2 selx exhibits species-wide allelic variation and evidence 
for assortive recombination 
75 
     4.3.3 SElX is expressed by clinical isolates in vitro and during 
human, bovine and ovine infection 
79 
     4.3.4 SElX demonstrates Vβ-dependent mitogenicity  81 
     4.3.5 SElX has a unique predicted SAg structure 81 





Comprehensive analysis of bovine T-cell reactivity 




5.1 Introduction 91 
5.2 Materials and methods 92 
     5.2.1 Bacterial strains and plasmids  92 
     5.2.2 Cloning of SAg genes into expression plasmid pALC2073 92 
     5.2.3 Expression of SAg proteins in RF122-8α 92 
     5.2.4 T-cell proliferation assays 98 
     5.2.5 Analysis of Vβ T-cell activation 98 
5.3 Results 101 
      5.3.1 Expression of individual RF122-encoded SAgs in the 
SAg-deficient strain RF122-8α 
101 
      5.3.2 RF122-encoded SAgs are mitogenic for bovine T-cells  104 
      5.3.3 RF122-encoded SAgs activate unique bovVβ profiles 108 
5.4 Discussion 116 
   
 viii 
   




Experimental intra-mammary infection of dairy cattle 




6.1 Introduction 121 
6.2 Materials and Methods 122 
      6.2.1 Bacterial strains and plasmids 122 
      6.2.2 Construction of allele replacement plasmids 122 
      6.2.3 Allelle replacement mutagenesis by temperature shifting 
with enrichment 
129 
      6.2.4 Southern Hybridisation 132 
      6.2.5 Extraction of S. aureus secreted and CWA proteins 132 
      6.2.6 Haemolytic activity of S. aureus 132 
      6.2.7 Growth curve of S. aureus strains 133 
      6.2.8 Experimental infection of dairy cattle 133 
6.3 Results 136 
       6.3.1 Construction of a SAg-deficient derivative of RF122 136 
       6.3.2 Phenotypic analysis of the RF122 and SAg-deficient 
derivative RF122-8  
142 
       6.3.3 SAg-deficient strain RF122-8 requires a higher infectious 
dose than wild type RF122 to establish experimental 
infection of dairy cattle 
147 
       6.3.4 Construction of α-toxin-deficient derivatives of RF122 
and RF122-8  
147 
       6.3.5 Phenotypic verification of α toxin deficient derivatives of 
RF122 and RF122-8 
148 










List of figures 
  Page 
Chapter 1   
Figure 1.1 Schematic diagram of SAg activity 9 
Figure 1.2 Phylogenetic analysis of SAgs produced by  
S. aureus and S. pyogenes and ssls. 
12 
Figure 1.3 Ribbon diagram of SEC2 structure. 19 
Chapter 3   
Figure 3.1 Relative positions of SAg genes in the S. aureus 
RF122 genome 
51 
Figure 3.2 Phylogenetic analysis of all characterised 
staphylococcal SAg genes, including allelic variants 
from all fully sequenced genomes of S. aureus. 
53 
Figure 3.3 Transcription levels of RF122-encoded SAg genes 
from exponential and stationary cultures, relative to 
16S rRNA 
54 
Figure 3.4 Transcriptional architecture of egc genes 56 
Figure 3.5 Recombinant expression and immunogenicity of 
SAgs encoded by RF122 with sera from bovine, 
ovine and human S. aureus infections. 
58 
Chapter 4   
Figure 4.1 Genomic location of selx in S. aureus 74 
Figure 4.2 Phylogenetic analysis of selx and its species-wide 
distribution. 
77 
Figure 4.3 Predicted recombination sites identified in selx 
alleles 
78 
Figure 4.4 SElX is expressed by clinical isolates in vitro and 
during infection. 
80 





  Page 
Figure 4.6 Schematic diagram of the solved structures of 
TSST-1, SSL7 and modelled structures of human, 
bovine and ovine variants of SElX 
84 
Chapter 5   
Figure 5.1 Schematic diagram of the procedure used to clone 
SAg genes encoded by RF122 into expression 
plasmid pALC2073 
97 
Figure 5.2 Verification of pALC2073 constructs containing 
RF122-encoded SAg genes by digestion with SacI 
and KpnI 
102 
Figure 5.3 Expression of SAg genes in RF122-8α 103 
Figure 5.4 Western blot analysis of SECbov, TSST-1bov, SElLbov 
and SElXbov expression in RF122-8α 
105 
Figure 5.5 Proliferation of bovine T-cell populations in 
response to stimulation with RF122-encoded SAgs 
106 
Figure 5.6 T-cell proliferation in response to stimulation with 
RF122-encoded SAgs assessed by CFSE staining 
107 
Figure 5.7 SElZbov has mitogenic activity for bovine T-cells 109 
Figure 5.8 Vβ-dependent activation of bovine T-cell 
populations in response to stimulation with RF122-
envoded SAgs 
113 
Figure 5.9 Phylogenetic analysis of bovine TCR Vβ gene 
sequences 
       115 
Chapter 6   
Figure 6.1 Schematic diagram of the procedure used to obtain 
gene replacement by recombination using the 
pMAD plasmid. 
       131 
Figure 6.2 Experimental infection of dairy cows        135 
Figure 6.3 Verification of pMAD deletion plasmids        137 
Figure 6.4 PCR verification of deleted SAg genes 
 
       139 
 xi
      Page 
Figure 6.5 Schematic of sequential allele replacement events in 
S. aureus RF122-1 resulting in the generation of 
RF122-8 
       140 
Figure 6.6 Southern blot analysis to confirm deletion of SAg 
genes 
       141 
Figure 6.7 Phenotypic analysis of the RF122 and SAg-deficient 
derivative RF122-8 
       144 
Figure 6.8 FACS analysis of CFSE stained bovine PBLs after 
stimulation 
       145 
Figure 6.9 Experimental IMI of dairy cattle        146 
Figure 6.10 Phenotypic verification of α toxin-deficient 
derivatives of RF122 and RF122-8. 
       151 
Figure 6.11 Bovine T-cell activation by RF122t, RF122t-α, 
RF122-8 and RF122-8α. 










List of Tables 
  Page 
Chapter 1   
Table 1.1 Properties of characterised staphylococcal SAgs 13 
Chapter 3   
Table 3.1 S. aureus strains investigated by PCR to determine 
distribution of selx, sely and selz 
40 
Table 3.2 S. aureus whole genome sequences examined 43 
Table 3.3 Primers used in this study 44 
Table 3.4 SAgs encoded by S. aureus strain RF122 50 
Table 3.5 Immunogenicity of recombinant SAg proteins with 
sera from bovine, ovine and human S. aureus 
infections 
59 
Chapter 4   
Table 4.1 S. aureus strains used in this study 67 
Table 4.2 Distribution and coordinates of selx in sequenced S. 
aureus genomes 
68 
Table 4.3 Activation of bovVβ subfamilies in response to 
rSElX variants 
83 
Table 4.4 Activation of human and bovine Vβ subfamilies in 
response to rSElX variants.  
87 
Chapter 5   
Table 5.1 Bacterial strains and plasmids used in this study 93 
Table 5.2 Primers used to clone SAg genes encoded by RF122 
into the SacI and KpnI sites of pALC2073 
96 
Table 5.3 Primers used to identify bovVβ activation  100 
Table 5.4 Activation of Vβ subfamilies in response to RF122-
encoded SAgs 
114 
Chapter 6   
Table 6.1 Bacterial strains and plasmids used in this study 123 
   
 xiii 
  Page 
Table 6.2 Primers used to obtain and verify pMAD gene 
deletion constructs.  
125 


























List of commonly used abbreviations 
Abbreviation Full description 
α alpha 
agr accessory gene regulator 
AIP auto inducing peptide 
APC antigen presenting cell 
APS ammonium persulphate 
β beta 
BLAST     basic local alignment search tool 
bovVβ bovine variable beta 
bp    base pair 
BSA    bovine serum albumin 
BHI brain heart infusion 
°C                                                      degrees Celsius 
CA-MRSA community-acquired methicillin resistant 
Staphylococcus aureus 
CC clonal complex 
CDC Centers for Disease Control  
cDNA   complementary deoxyribonucleic acid 
CFSE caboxyflourescein succinamidyl ester 
CFU colony forming units 
CO2 carbon dioxide 
ConA concanavalin A 
cpm     counts per minute 
CT threshold cycle 
CWA cell wall-associated 
d days 
dATP 2’-deoxyadenosine triphosphate 
dCTP 2’-deoxycytidine triphosphate 
ddH2O double distilled water 
dGTP 2’-deoxyguanosine triphosphate 
DMSO dimethyl sulphoxide 
 xv
Abbreviation Full description 
dTTP 2’-deoxythymidine triphosphate 
dNTP mixture of dATP, dCTP, dGTP and dTTP 
DNA deoxyribonucleic acid 
ECL enhanced chemiluminescence 
EDTA    ethylene-diamine-tetra-acetic acid 
egc enterotoxin gene cluster 
ET electrophoretic type 
FACS   fluorescence-activated cell sorting                                                         
FCS foetal calf serum 
x g force of gravity 
γ gamma 
g grams 
gDNA genomic DNA 
h   hours 
HBSS hanks buffered saline solution 
HCl   hydrochloric acid 
HGT horizontal gene transfer 
HLA     human leukocyte antigen 
3
H hydrogen radioactive isotope 3 (tritium) 
humVβ human variable beta 
IFN interferon 
Ig                                                           immunoglobulin 
IL   interleukin 
IMGT       Immunogenetics Database 





L     litre 
LB Luria-Bertani broth 
 xvi
Abbreviation Full description 
kb kilo-base 
MEGA   Molecular Evolutionary Genetics Analysis 
mM milli-molar 
MGE mobile genetic element 
MHC    Major histocompatability complex 
MHC class I Major histocompatability complex class I 
MHC class II Major histocompatability complex class II 
MLEE multi locus enzyme electrophoresis  
MLST multi locus sequence type  
min    minutes 
µg      micro-grams 
µF micro-Faraday 
ml     milli-litres 
µl   micro-litres 
µCi micro-curie 
mRNA                                                   messenger ribonucleic acid 
MRSA methicillin-resistant Staphylococcus aureus 
MSSA methicillin-susceptible Staphylococcus 
aureus 
MWCO molecular weight cut off 
NCBI        National Centre for Biotechnology 
Information 
ng nano-grams 
nm  nano-metre 
nM nano-molar 
ND not done 
NK not known 
NTC no template control 
OD optical density 
PBL peripheral blood lymphocyte 
 xvii
Abbreviation Full description 
PBMC peripheral blood mononuclear cell 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDB protein data bank 
pmol pico-molar 
PSG penicillin, streptomycin, L-glutamine 
PVL Panton-Valentin leukocidin 
qRT-PCR quantitative reverse transcriptase-
polymerase chain reaction 
RBC red blood cells 
RNA ribonucleic acid 
rpm revolutions per minute 
RT-PCR  reverse transcriptase-polymerase chain 
reaction 
RT  reverse transcriptase 
s  second 
SAg superantigen 
SaPIbov bovine staphylococcal pathogenicity island 
SCC somatic cell counts 
SDS sodium dodecyl sulphate 
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis 
SE staphylococcal enterotoxin 
SEl staphylococcal enterotoxin like 
ST sequence type 
TAE tris-acetate ethylene-diamine-tetra-acetic 
acid 
TBE Tris-borate/EDTA 
TCR  T-cell receptor 
TCS Two component system 
 xviii 
Abbreviation Full description 
TE Tris- ethylene-diamine-tetra-acetic acid 
TEMED tetramethylethylinediamine 
Th1 T helper 1 
TNF  Tumor necrosis factor 
TRBV T-cell receptor beta variable 
Tregs Regulatory T-cell 
TSA Tryptone soya agar 
TSB Tryptone soya broth 
TSS Toxic shock syndrome 




v/v volume for volume 
WT wild type 



























Staphylococcus aureus produces a family of at least 21 distinct superantigens (SAgs) 
which include staphylococcal enterotoxins (SEs), staphylococcal enterotoxin-like 
toxins (SEls), and toxic shock syndrome toxin-1 (TSST-1), and contribute to disease 
pathogenesis via modulation of the host immune response. Specific SAgs have been 
shown to cause toxinoses such as staphylococcal food poisoning and toxic shock 
syndrome, and have been implicated in immunological disorders such as rheumatoid 
arthritis, psoriasis, and Kawasaki syndrome. However the role of SAgs in disease 
pathogenesis, in general, is poorly understood. 
S. aureus is a common cause of bovine mastitis. Analysis of the genome 
sequence of the bovine strain RF122 revealed genes encoding bovine variants of 
characterized SAgs, TSST-1, SElL, SEC, SEG, SEI, SElU, SElO, SElN and a 
truncated form of SElM. In addition we identified 3 genes with sequence homology 
to characterized SAgs, which are predicted to encode novel SAgs, SElX, SElY and 
SElZ. Expression of all 11 predicted SAg genes was detected in vitro, including 
several with growth phase-dependent expression.  
Characterization of a novel SAg, SElX which is encoded in the core genome 
of 94% of phylogenetically diverse S. aureus strains from human and animal 
infections was carried out. In addition to its superantigenic properties, SElX has a 
unique predicted structure characterized by a truncated SAg B domain. At least 14 
different alleles of the selx gene were identified among the common human and 
animal pathogenic clones, and evidence for assortive recombination of selx alleles 
between distinct clonal lineages was discovered. SElX was expressed by 
representative human, bovine and ovine strains in vitro, in a growth phase dependent 
manner, and during human, bovine and ovine infections, consistent with a broad role 
in the pathogenesis of different S. aureus diseases in multiple hosts. SElX produced 
by bovine- and ovine-specialized S. aureus strains had 10-fold greater mitogenic 
activity and a distinct Vβ activation profile for bovine lymphocytes compared to 
SElX made by the human strain USA300 indicating functional diversification of selx 
alleles from different hosts. This is the first description of a core-genome encoded 
 xx
SAg of S. aureus.  The discovery that the great majority of S. aureus clinical isolates 
have superantigenic capacity has important implications for our understanding of 
staphylococcal disease pathogenesis. 
To investigate the role of SAgs in disease pathogenesis, a SAg-deficient 
strain of S. aureus, RF122-8 was constructed by sequential allele replacement. 
RF122-encoded SAg genes were cloned into the pALC2073 plasmid, which has an 
inducible promoter allowing controlled expression in the SAg-deficient strain 
RF122-8.  These constructs allowed us to determine that TSST-1bov, SElLbov, SECbov, 
SElNbov, SEIbov and novel SAgs, SElXbov and SElYbov were mitogenic for bovine T-
cells, and stimulated T-cell receptor β variable (TRBV) sub-family-specific 
activation. Preliminary experimental intra-mammary infections of dairy cows 
revealed that clinical symptoms were similar during infection with wild type RF122 
and SAg-deficient strains, including high somatic cell counts (6 Log
SCC
), and 
elevated body temperature (106 °F). However a higher infectious dose was required 
to establish infection with the SAg-deficient strain RF122-8 in comparison to the 
wild type, RF122 indicating an attenuation of virulence.  
Overall, these data provide broad new insights into the importance of SAgs in 




















1.1 Staphylococcus aureus 
Staphylococcus aureus is a Gram-positive bacterium which was first identified in 
association with a surgical wound infection by Alexander Ogston in 1882 (Ogston, 
1882). S. aureus is a facultative anaerobe, able to exist both in the environment and 
as an external commensal of humans and other animals (Lowy, 1998). The 
organism is frequently isolated in the anterior nares, female genital tract and skin 
surface of humans, and is found in the nostrils, rectum and teat skin of ruminants 
(Fitzgerald, 2008, Lowy, 1998). Studies have identified three nasal carriage patterns 
within adult human populations, of which 20% are persistent S. aureus carriers, 
60% are intermittent and 20% are persistent non-carriers (Peacock et al., 2001, 
Gould & Mc, 1954, Kluytmans et al., 1997). Clinical infections occur if skin or 
mucosal barriers are breached (Ferens & Bohach, 2000, Lowy, 1998), and in the 
hospital setting, carriers are at an increased risk of S. aureus infection, caused in 
80% of cases by the colonising strain (Wertheim et al., 2004). In addition, 
colonisation is known to be a risk factor in community-acquired infections (von Eiff 
et al., 2001).  
S. aureus is a major human pathogen, responsible for an array of different 
diseases including, septicaemia, endocarditis, osteomyelitis, localised abscesses and 
toxigenic illnesses such as toxic shock syndrome (TSS), scalded skin syndrome 
(SSS) and necrotising pneumonia (Lowy, 1998). S. aureus is a major cause of 
nosocomial infection, and the increased spread of the organism has been 
accompanied by an increase in antibiotic resistance. In Europe, Japan and the USA, 
it has been reported that between 40% to 60% of hospital acquired S. aureus 
infections are resistant to methicillin (Tiemersma 2004, Grundmann et al., 2006). 
Methicillin-resistant S. aureus (MRSA) strains were first identified in the 1960s, 
however it was not until the late 1980s that pandemic spread of MRSA occurred 
(Grundmann et al., 2006). Although MRSA infections can be successfully treated 
with vancomycin, the emergence of vancomycin resistance has been reported 
(Chang et al., 2003, Grundmann et al., 2006). In addition, increasingly virulent CA-
MRSA strains have emerged in the community causing severe skin and soft-tissue 
infections, which are characterised by carriage of type IV or V staphylococcal 
cassette chromosome (SCCmec), and are often associated with the production of 
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Panton-Valentin leukocidin (PVL) toxin (Morgan, 2007, Lina et al., 1999). 
However the role of PVL in CA-MRSA is controversial as not all strains express the 
toxin (Said-Salim et al., 2005), and contrasting results have been obtained in animal 
models (Wardenburg et al., 2008, Labandeira-Rey et al., 2007, Voyich et al., 2006). 
The emergence of highly-virulent and antibiotic-resistant strains highlights the need 
to understand the pathogenesis of this successful and rapidly-evolving bacterium. 
 
1.2 Bovine mastitis 
S. aureus can infect a diverse range of host species causing diseases such as 
staphylococcosis in rabbits, pyaemia in sheep, chondronecrosis, septicaemia and 
dermatitis in chickens, pneumonia and osteomyelitis in turkeys and mastitis in cattle 
(McNamee et al., 1999, Hermans et al., 2003, Takeuchi et al., 2002, Ferens & 
Bohach, 2000, Webster & Mitchell, 1989, Miles et al., 1992). S. aureus is one of the 
most common causes of bovine mastitis, an infection of the milk-secreting tissue of 
the udder, which represents a huge economic problem for the dairy industry 
worldwide (Miles et al., 1992, Barkema et al., 2006). Economic loss in the United 
States due to reduced quantity and quality of milk, and increased veterinary and 
labour costs associated with mastitis is estimated to be over $2 billion annually 
(Wells et al., 1998). Symptoms observed in dairy cows include inflammation of the 
udder, flakes or clots in milk, fever, loss of appetite, dehydration and death 
(Schroeder, 1997). Subclinical infection is the most common form of disease, where 
milk production is lowered by 10% to 25% (Sutra & Poutrel, 1994). Antibiotic 
treatment is often not curative, instead converting a clinical infection to a latent or 
subclinical infection, and has led to concern that milk containing antibiotic products 
may be contributing to the growing problem of antibiotic resistance (David, 1999). 
S. aureus is known to adhere to keratinized cells of the teat canal, and is internalised 
by mammary epithelial cells (Bayles et al., 1998). Bovine mastitis caused by S. 
aureus infection is typically chronic in nature and the host is often unable to 
completely eliminate the organism (Ferens & Bohach, 2000). The factors 




1.3   Population genetics of S. aureus 
The highly clonal population structure of S. aureus has been demonstrated by multi 
locus enzyme electrophoresis (MLEE) and multi locus sequence typing (MLST) 
studies (Feil et al., 2003, Musser et al., 1990). There are at least 10 major clonal 
complexes (CC) amongst human strains, of which CC5, CC8, CC22, CC30, CC45 
and hybrid lineage CC239 have acquired mecA and become widespread in the 
hospital environment. In addition, strains belonging to CC1, CC8, CC30, CC59 and 
CC80 which have acquired mecA have become prevalent in the community, causing 
CA-MRSA infections (McCarthy & Lindsay, 2010). Companion animals are 
usually colonised and infected by common human lineages (Loeffler et al., 2005). 
Unique phenotypes of animal strains were identified in the 1930s, which led to the 
identification of ecological variants (ecovars) specific for different host species 
(Devriese, 1984). A number of population genetic studies have revealed that strains 
belonging to specific CCs including, CC97, CC71 and CC151 are associated mainly 
with ruminants and rarely with humans, suggesting they are host specific (Jorgensen 
et al., 2005, Fitzgerald, 1997, Kapur et al., 1995, Smyth et al., 2009, Guinane et al., 
2010). In cattle it has been determined that a few specialised clones of S. aureus 
with broad geographic distribution are responsible for the majority of cases of 
bovine mastitis (Smyth et al., 2009, Fitzgerald et al., 1997, Guinane et al., 2010). In 
particular, CC151 is a bovine-specialised clone which has not been detected 
amongst humans (Guinane et al., 2008).  
Bacterial evolution occurs in part through horizontal gene transfer (HGT) 
mechanisms such as transformation, transduction and conjugation. Some Gram-
positive species such as the streptococci are naturally transformable and are able to 
take up free DNA from their environment, leading to freely recombining 
populations. In contrast, S. aureus is not naturally transformable and point 
mutations are known to exceed recombination events (Witte, 2006). Mobile genetic 
elements (MGE) such as pathogenicity islands, plasmids, phage, transposons and 
insertion sequences, are usually passed on to daughter cells by vertical transmission 
leading to a strong association with clonal lineage, or horizontally transferred which 
allows dissemination between lineages (Lindsay & Holden, 2006). Absence of 
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MGE from particular lineages can be due to restrictions on horizontal transfer 
(Kuroda et al., 2001). 
 
1.4 Comparative Genomics 
Substantial genomic heterogeneity exists between S. aureus strains. An 
understanding of which combinations of genes are responsible for the success of 
dominant clonal lineages of S. aureus is very important. DNA microarray analysis 
of diverse strains showed that about 78% of genes were common amongst all 
strains, forming a core genome (Fitzgerald et al., 2001b, Lindsay & Holden, 2006). 
The core genome is comprised of genes essential for growth and survival, including 
some genes encoding virulence factors such as cell wall-associated (CWA) proteins, 
certain toxins, and the polysaccharide capsule (Lindsay & Holden, 2006). The 
remaining 22% of the genome is composed of strain-specific accessory genetic 
material including genes involved in colonisation of specific host or environmental 
niches. The accessory genome includes 18 large chromosomal regions of difference 
(RDs) including MGEs, and core variable regions, comprising of lineage-specific 
genes (Fitzgerald et al., 2001b). The wide distribution of MGEs in strains of 
divergent clonal lineages which do not share a common ancestor indicates that HGT 
has been central to the evolution of pathogenic S. aureus strains (Fitzgerald et al., 
2001b). For example, the genome sequences of an MRSA isolate, MRSA252, and a 
methicillin sensitive S. aureus isolate, MSSA476 were compared, and the isolates 
differed considerably in their accessory elements (Holden et al., 2004). MRSA252 
was found to be particularly genetically diverse with 6% of the genome novel in 
comparison to other published genomes (Holden et al., 2004). Recently, the genome 
sequences of S. aureus isolates from bovine, ovine and avian hosts have been 
determined and comparative genomic analysis has revealed molecular evidence for 
staphylococcal adaptation to different host species, including gene decay and 
acquisition of genes encoding proteins
 
involved in host-pathogen interactions 





1.5  Pathogenesis of S. aureus 
S. aureus pathogenesis is multi-faceted, and mediated by a vast range of virulence 
factors including secreted and CWA proteins. The complement of virulence factors 
allows the organism to evade the host immune system, adhere to extracellular 
matrix molecules, enter host cells and spread within the tissues. Most S. aureus 
strains produce a polysaccharide capsule which interferes with phagocytosis and 
allows the bacteria to survive in the bloodstream (O'Riordan & Lee, 2004). There 
are 11 capsular serotypes of which type 5, 8 and 336 are most common among 
clinical isolates (Roghmann et al., 2005, O'Riordan & Lee, 2004).  
CWA proteins are particularly important as they allow the organism to 
adhere to host tissue components, bind proteins in blood, and resist phagocytosis 
(Joh et al., 1999, Skaar & Schneewind, 2004, Foster & Hook, 1998). In addition, 
several CWA proteins promote iron uptake and contribute to biofilm formation 
(Lowy, 1998, Otto, 2008). Well characterised CWA proteins include Protein A, Sdr 
(serine-aspartate repeat domain) proteins, fibronectin-binding proteins (Fnbp) A and 
B and clumping factors A and B (Joh et al., 1999). CWA proteins are covalently 
anchored to cell wall by sortase which cleaves sorting signals at the LPXTG motif 
(Mazmanian et al., 2001), and have been shown to be important in the pathogenesis 
of infections associated with indwelling medical devices and infective endocarditis 
(Lowy, 1998).  S. aureus can invade many different cell types, through a fibronectin 
bridge which is formed between FnbpA or B and host α5β1 integrin receptors which 
leads to internalisation (Schwarz-Linek et al., 2003, Peacock et al., 1999, Schwarz-
Linek et al., 2004). Small colony variants have been shown to survive within host 
cells in a semi dormant state (von Eiff et al., 2000).  
Secreted virulence determinants including tissue degrading enzymes, 
cytotoxins, SAgs and exfoliative toxins enable the organism to survive within the 
host, and contribute to S. aureus virulence (Bohach., 2006). A large number of 
extracellular enzymes such as coagulase, numerous proteases, nuclease and lipase 
are produced, which can degrade organic macromolecules to provide low molecular 
weight nutrients for the bacterium, or degrade tissue constituents to facilitate 
bacterial spread (Arvidson, 2006). Proteolytic activity varies between strains, 
however most human isolates harbour genes encoding one serine protease (V8), one 
 7 
metalloprotease (aureolysin) and two cysteine proteases (staphopain A and B) 
(Arvidson, 2006). In addition, S. aureus produces a number of immune evasion 
factors, including a chemotaxis inhibitory protein (CHIPS), which interferes with 
the complement system by binding formyl peptide receptor and C5a receptor, and 
staphylococcus complement inhibitor (SCIN) which binds C4bC2a and C3bBb 
inhibiting formation of C3b (Lee et al., 2004, de Haas et al., 2004). About 60% of 
human S. aureus strains harbour the chips and scin genes however there is a very 
low incidence in ruminant isolates (Sung et al., 2008), consistent with their human-
specific activity (van Wamel et al., 2006).  
Another group of virulence factors are the secretable expanded repertoire 
adhesive molecules (SERAMs), which include extracellular adherence protein 
(Eap), extracellular fibrinogen binding factor (Efb) and von Willebrand factor 
binding protein (vWbp) (Hauck & Ohlsen, 2006). Eap binds to ICAM-1 on 
endothelial cells and reduces neutrophil migration (Chavakis et al., 2002). Eap 
induces proliferation of human peripheral blood mononuclear cells (PBMC), with 
proinflammatory cytokine release (Scriba et al., 2008). The crystal structure of Eap 
is homologous to the C-terminal of SAgs (Geisbrecht et al., 2005). However Eap is 
not a SAg, but non-specifically cross-links MHC class II molecules (Massey et al., 
2007), and at high concentration has been shown to inhibit T-cell activation by 
TSST-1 (Haggar et al., 2005).  
Another important group of toxins are cytolytic and contribute to host cell 
damage by pore formation in the membrane, resulting in cell lysis and release of 
internalised bacteria (Foster, 2005). Cytolytic toxins include α-, β-, γ-, and δ- 
toxins, which lyse neutrophils allowing S. aureus to evade the innate immune 
response and form abscesses (Foster, 2005). α-toxin is secreted as a monomer and 
assembles into a heptamer forming a β-barrel pore in the membrane (Montoya & 
Gouaux, 2003) Most S. aureus strains harbour the hla gene encoding α-toxin, but 
expression is variable (Bohach., 2006). Animal infection studies have shown that 
strains expressing high levels of the toxin gene are more virulent than their isogenic 
derivatives (Bubeck Wardenburg et al., 2007). Bi-component leukotoxins are 
another class of toxin which are secreted as two separate subunits and assemble into 
oligomers in the cell membrane, and include γ-toxin and PVL, that can stimulate 
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and lyse neutrophils and macrophages (Bohach., 2006). γ-toxin gene is present in 
about 90% of strains whereas pvl was found in only 2% of strains in total, but in 
98% of  CA-MRSA isolates (Peacock et al., 2002, Moran et al., 2006). Exfoliative 
toxins (ET), A, B and D are associated with SSS and bullous impetigo. ETs bind 
desmoglein-1, a glycoprotein in the epidermis leading to disruption of the stratum 
granulosom (Plano, 2004, Ladhani, 2003). 
 
1.6 Superantigens 
The term ‘superantigen’ (SAg) was proposed in 1989 (White et al., 1989, Choi et 
al., 1989) to describe 2 previously known toxin families including staphylococcal 
enterotoxins (SEs), the causative agents of food poisoning (Jordan, 1931), and 
streptococcal pyrogenic exotoxins (SPEs) responsible for scarlet fever (Dick & 
Dick, 1924) and streptococcal toxic shock (Stevens et al., 1989). SAgs are proteins 
which bypass the conventional antigen processing pathway, by binding to MHC 
class II molecules of antigen-presenting cells and the variable region of the T-cell β 
chain (Vβ) outside of the antigen binding groove (Figure 1.1) (Peavy et al., 1970, 
Fraser, 1989, Kappler et al., 1989, Dellabona et al., 1990, Jardetzky et al., 1994) 
(Choi et al., 1989, Dellabona et al., 1990). In so doing, SAgs can react with all T-
cells expressing reactive Vβ regions (up to 20%), instead of the normal responding 
frequency to an antigen of approximately 0.01% (Figure 1.1), resulting in massive 
inflammatory cytokine release leading to toxic shock (Drake & Kotzin, 1992). SAgs 
also have the capacity to cause immune suppression through T-cell anergy or 
deletion (Kawabe & Ochi, 1990).  
 
1.6.1 Bacterial SAgs 
S. aureus is known to produce at least 21 distinct SAgs, including SEA - E, SEG - 
J, SER – T, SElK- Q, U, V, and toxic shock syndrome toxin, TSST-1 (Table 1.1) 
(Lina et al., 2004, Ono et al., 2008b, Thomas et al., 2007). Staphylococcus 
pseudintermedius produces a canine variant of SEC and SE-int (Edwards et al., 
1997, Futagawa-Saito et al., 2004). 11 SAgs have been identified in Streptococcus 
pyogenes including, SPEA, SPEC, SPEG to M, streptococcal superantigen A 

































Figure 1.1 Schematic diagram of SAg activity. a) The interaction between 
conventional antigen presented by the MHC class II presentation pathway and the 
TCR which leads to the oligoclonal activation of approximately 1:10000 T-cells. b) 
The interaction of SAg with MHC class II molecule and the TCR, which leads to 
polyclonal activation of approximately 20% of all T-cells. 
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S. dysgalactiae produces a variant of SPE-G, and S. dysgalactiae mitogen (SDM) 
(Fraser & Proft, 2008). In addition Streptococcus equi produces SePE-H, I, Lse, and 
Mse (Paillot et al., Fraser & Proft, 2008).  
Staphylococcal and streptococcal SAgs are short secreted proteins of 21 to 
28 kDa, (Thomas., 2007, Petersson et al., 2004), which share similar biochemical 
and structural properties (Dinges et al., 2000, Thomas et al., 2007). With the 
exception of TSST-1, SAgs are resistant to most proteolytic enzymes and can 
function in the digestive tract after ingestion (Thomas., 2007). In addition, they are 
highly resistant to heat, and prolonged autoclaving is required to eliminate function 
(Schantz et al., 1965).  SAgs can be differentiated into 5 distinct subgroups 
according to their phylogenetic relatedness (Figure 1.2). Surprisingly, some 
staphylococcal SAgs such as SEH are more phylogenetically similar to 
streptococcal SAgs, which is likely to be due to HGT between the species. 
Staphylococcal and streptococcal SAgs have many biological features in common, 
but one feature which appears to be distinct to staphylococcal SAgs is their ability 
to transcytose across the epithelium (Hamad et al., 1997). This could explain why 
TSS but not STSS has been observed in non-invasive disease (Sriskandan et al., 
2007).  
A further 2 bacterial SAgs, Mycoplasma arthriditis mitogen (MAM) and 
Yersinia pseudotuberculosis mitogen (YPM), are phylogenetically and structurally 
unrelated to this group (Thomas et al., 2007, Orwin et al., 2002, Thomas et al., 
2009). MAM is responsible for a shock-like disease in rats, mice and rabbits, and 
has also been shown to be associated with arthritis in rats (Cole et al., 1981, Cole et 
al., 1971). There is evidence to suggest that a soluble form of the M1 protein of 
Group A streptococcus (GAS) has superantigenic activity (Cunningham, 2000). M 
protein is a surface protein which can be released via host- or bacterium-derived 
protease activity. M1 strains have been epidemiologically associated with invasive 





















































Figure 1.2: Phylogenetic analysis of SAgs produced by S. aureus and S. 
pyogenes and SSLs. Sequences were obtained from the NCBI Genbank database. 
Phylogenetic tree was constructed using MEGA (Molecular Evolutionary Genetics 
Analysis) software, from a ClustalW multiple amino acid alignment of the 
nucleotide sequences. Evolutionary distances were determined by constructing 
Neighbour Joining trees using the Maximum Composite Likelihood method. At 
least 500 bootstrap trees were generated to examine the stability of the phylogenetic 
relationship. Green circles indicate S. aureus SAgs, red squares, streptococcal 


























Table 1.1: Properties of characterised staphylococcal SAgs 
a
 known or predicted. 
b
 NK, not known. 
c
 data compiled from the references (Seo et al., 2010 Thomas et al., 2009, Ono et    








Human VB specificity 
c
 Genomic  Location 
SEA 27.1 + 1, 5, 6, 7, 9, 15, 16, 18, 21, 
22, 24 
ΦSa3n 
SEB 28.3 + 3, 12, 13, 14, 15, 17, 20 SaPI 
SEC 27.5 + 3, 12, 13, 14, 15, 17, 20 SaPI 
SED 26.4 + 1, 3, 5, 8, 9, 12, 14 Plasmid (pF5) 
SEE 26.4 + 5, 6, 8, 9, 13, 16, 18, 21 Integrated plasmid 
SEG 27 + 3, 12, 13, 14, 15 vSAβ 
SEH 25.2 + 6, Vα8 transposon 
SEI 24.9 + 1, 5, 6, 23 vSAβ 
SEJ 28.5 + 8, 21 Plasmid (pF5) 
SElK 26 - 1, 5, 6 SaPI/ ΦSa3n 
SElL 26 - 1, 5, 7, 16, 22, 23 SaPI 
SElM 24.8 NK 8, 9, 18, 21 vSAβ 
SElN 26.1 NK 7, 8, 9, 17 vSAβ 
SElO 26.7 NK 5, 7 vSAβ 
SElP 27 - 5, 8, 16, 18, 21 ΦSa3n 
SElQ 28 - 6, 21 SaPI/ ΦSa3n 
SER 27 + 3, 12, 14 Plasmid (pF5) 
SES 26.2 + 9, 16 Plasmid (pF5) 
SET 22.6 + - Plasmid (pF5) 
SElU 27.1 NK 13, 14 vSAβ 
SElU2/W 26.7 NK NK vSAβ 
SElV 25 NK 6, 18, 21 vSAβ 
TSST-1 22 - 2 SaPI 
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1.6.2 Endogenous SAgs  
Superantigenic activity was recognised as similar to minor lymphocyte-stimulating 
antigens (Mls) (Buxser & Vroegop, 1988). Mls are endogenous SAgs, such as the 
mouse mammary tumour virus (MMTV) products which were incorporated into the 
mouse genome, and facilitated the deletion of T-cells as they matured in the thymus, 
thereby preventing the host from mounting an appropriate T-cell response against 
gut B cells infected with MMTV (Choi et al., 1991, Marrack et al., 1991, Acha-
Orbea & Palmer, 1991, Woodland et al., 1991). MMTV-related retroviral 
endogenous SAgs in humans have been implicated in type II diabetes (Conrad et al., 
1997).   
 
1.7 Staphylococcal superantigen like toxins (SSLs) 
SSLs are toxins produced by S. aureus which display significant sequence and 
structural homology with SAgs. However they are not mitogenic for T-cells and do 
not bind MHC class II (Langley et al., 2005, Williams et al., 2000, Fitzgerald et al., 
2003). Instead they have been shown to target the innate immune system in various 
ways (Fraser & Proft, 2008). ssl genes 1 to 11 are located on the highly variable 
chromosomal region vSaα, with ssl 12 to 14 located 0.7 MB downstream of the 
main cluster (Fraser & Proft, 2008). vSaα corresponds with RD13, one of 18 large 
chromosomal regions of difference identified by comparative genomic hybridisation 
(Fitzgerald et al., 2001b). This region was identified in all strains and varied in size 
from 12 to 17 kb, encoding at least 7 SSLs (Fitzgerald et al., 2003). It has been 
shown that SSL7 enhances survival at mucosal surfaces due to an ability to block 
binding to the FcαR1 portion of IgA (Langley et al., 2005). In addition the β-grasp 
domain of SSL7 binds complement factor C5 and inhibits complement-mediated 
haemolytic activity (Langley et al., 2005). SSL5 and SSL11 target neutrophils, 
through a glycan-binding site in the C-terminal domain, which is specific for tri-
saccharide sialyl-lactosamine (sLacNac), a ligand that regulates neutrophil 
adherence to endothelial cells, and is expressed on cell surface glycoproteins such 
as P-selectin glycoprotein (PSGL-1) (Baker et al., 2007, Chung et al., 2007). 
Recombinant SSL5 and SSL11 have been shown to inhibit neutrophil adherence 
and become internalised by neutrophils (Bestebroer et al., 2007, Chung et al., 
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2007). The sLacNac binding site is also present on SSL2, 3, 4, 5, 6 and 11 (Baker et 
al., 2007).  
 
1.8 SAg activity 
The consequences of SAg activity during S. aureus infection are not fully 
understood. SAgs are potent toxins which are responsible for massive polyclonal 
activation of T-cells, rather than the typical focussed T-cell response to foreign 
antigens. Rapid expansion of T-cells leads to systemic release of pro-inflammatory 
cytokines, including interleukin-1 (IL-1), tumour necrosis factor- α (TNF-α), TNF-
β, and interferon-γ (IFN-γ) (Langford et al., 1978, White et al., 1989). The release 
of TNF-α and IL-1 is responsible for symptoms associated with TSS such as 
hypotension, shock and fever (Petersson et al., 2004). SAg interference with the 
immune response to infection can lead to a number of detrimental effects within the 
host including, pyrogenicity (Clark & Borison, 1963), lethal shock (Crawley et al., 
1966) and increased susceptibility of the host to endotoxin (Sugiyama et al., 1964, 
Dinges et al., 2000). The mechanism of endotoxin and SAg synergy established in 
vitro involves SAg-MHC II interaction followed by IFN-γ release by T-cells which 
activates TLR4 (Hopkins et al., 2008, Dalpke & Heeg, 2003). In turn TLR4 
recognition of LPS leads to LPS-enhanced MHC class II expression on APC 
(Jephthah-Ochola et al., 1988). SAgs have been shown to suppress the immune 
system through T-cell anergy or deletion (MacDonald et al., 1991, Wang et al., 
1998, Kawabe & Ochi, 1990), modulation of apoptosis (Boshell et al., 1996, 
Alderson et al., 1995), and the induction of regulatory T cells (Tregs) (Sundstedt et 
al., 1997, Zheng et al., 2002, Seo et al., 2009). Additionally they have been 
proposed to play a role in autoimmunity, due to the stimulation of T-cells reactive to 
self-antigens (Thomas et al., 2007).  
Staphylococcal SAgs which have the capacity to induce an emetic response 
are classified as staphylococcal enterotoxins (SEs), and those which lack emetic 
properties or have not been tested are designated as staphylococcal enterotoxin-like 
toxins (SEls) (Lina et al., 2004, Ono et al., 2008, Thomas et al., 2007). Despite 
intensive research efforts, the mechanism by which SEs induce emesis is still 
unclear. A disulphide loop located in the N-terminus was thought to be associated 
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with emetic activity, but recent studies using site directed mutagenesis have 
observed only a reduction in emesis rather than elimination (Wang et al., 2009) 
(Hovde et al., 1994). More recently it has been proposed that SEs and not SEls are 
able to penetrate the gut lining, activating a local and systemic immune response 
with the release of inflammatory mediators including histamine which could be 
responsible for GI tract damage and emesis (Shupp et al., 2002, Thomas et al., 
2007).  
 
1.9 SAg structure 
Crystallography has revealed the structure of a number of SAgs including  
staphylococcal SAgs, SEA, B, C2, C3, D, G, H, I, K, and TSST-1, streptococcal 
SAgs SPEA, C, H, I, J, SMEZ-2 and SDM, MAM and YPM (Brouillard et al., 
2007, Papageorgiou et al., 1999, Roussel et al., 1997, Arcus et al., 2000, Baker et 
al., 2004, Saarinen et al., 2007, Swaminathan et al., 1992, Schad et al., 1995, 
Papageorgiou et al., 1995, Fields et al., 1996, Sundstrom et al., 1996, Fernandez et 
al., 2006b, Marisa M. Fernández, 2007, Hakansson et al., 2000, Gunther et al., 
2007, Acharya et al., 1994). Staphylococcal and streptococcal SAgs share a 
compact 2-domain globular protein structure including domain A which contains a 
long central α-helix, and a C-terminal β-grasp motif. Domain B is smaller and 
contains a mixed β-barrel or oligonucleotide-oligosaccharide binding-fold (OB) 
(Murzin, 1993) (Figure 1.3). The OB fold is a common domain in heat labile 
enterotoxins such as verotoxin, pertussis and cholera toxins, members of the AB5 
toxin family (Mitchell et al., 2000). Close packing of the domains and extension of 
the N-terminus over the top of the C-domain underlies the impressive stability of 
SAg proteins. The disulfide bond which has been implicated in emetic activity is 
located at the top of domain B (Krakauer, 2005). YPM and MAM are structurally 
unrelated to staphylococcal and streptococcal SAgs. YPM is a single domain 
structure with a jelly roll fold of 2 β-sheets, and MAM consists of 10 α-helices 
which form an L-shaped protein fold (Donadini et al., 2004, Zhao et al., 2004). The 
MAM protein binds to the top of  MHC class II α-1-helix and β-1 helix, via 2 α-
helical bundles (Zhao et al., 2004). Crystal structures of SSL5, SSL7, and SSL11 
have also been solved and each display a 2-domain structure analogous to SAgs, 
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and in particular TSST-1 (Al-Shangiti et al., 2004, Arcus et al., 2002, Chung et al., 
2007). However there are notable differences in regions involved in SAg activity 
such as MHC class II and TCR binding (Fraser & Proft, 2008). The SSLs are 
characterised by an elongated β6 to β7 loop in the C-terminal domain, through 
which they crystallise as a homodimer. However the functional significance of this 
is currently unknown (Fraser & Proft, 2008). 
 
1.10 SAg interactions with the MHC and TCR 
SAgs co-ligate MHC class II molecules on the surface of antigen-presenting cells 
(APC) and TCR molecules, but simultaneous binding is considered unlikely 
(Sriskandan et al., 2007). The SAg must first bind to the MHC class II, in order to 
utilise the adhesion and accessory molecules required to bind to the TCR. SAgs 
bind to common conserved elements of MHC class II molecules, but preferential 
binding to certain MHC HLA (human leukocyte antigen) types is exhibited. SEC 
preferentially binds to HLA-DQ, a cell surface protein found on antigen presenting 
cells, whereas SEA, SEB, SED, SEE, SEH and TSST-1 preferentially bind HLA-
DR (Herrmann et al., 1989). The strength of binding between SAg and HLA class 
II is variable depending on the HLA allele, which may impact on the level of T-cell 
stimulation (Llewelyn et al., 2004). HLA haplotypes are also implicated in 
susceptibility to severe shock caused by GAS (Kotb et al., 2002). Information on 
the HLA-binding affinity of many recently identified SAgs has not yet been 
determined. SAgs have a higher affinity to MHC class II molecules than towards 
TCR (Pless et al., 2005).   
When the surface concentration of bound SAg on the APC is sufficient to 
cross-link multiple TCR molecules, a TCR signalling cascade is activated leading to 
rapid cytokine production (Pless et al., 2005). The affinity and binding rates of 
SAg/TCR/MHC complexes are comparable to those measured for 
TCR/peptide/MHC complexes (Sundberg et al., 2007, Petersson et al., 2004). SAgs 
can be divided into 3 distinct groups based on their MHC class II binding 
mechanism; binding to the MHC class II α-chain (e.g SEB and TSST-1), zinc-
mediated binding to MHC class II β-chain (e.g SEH and SEI) or the ability to bind 
to both α- and β-MHC class II chains (e.g SEA) (Tiedemann & Fraser, 1996, 
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Jardetzky et al., 1994, Fernandez et al., 2006a, Petersson et al., 2001, Petersson et 
al., 2004, Kim et al., 1994, Tiedemann et al., 1995). SEB and TSST-1 bind to MHC 
class II α-chain via their OB fold (Jardetzky et al., 1994, Kim et al., 1994). SPEC 
binds to the MHC class II β-chain via a C terminal Zinc binding site (Li et al., 
2001). It has been shown that a strong MHC class II/SAg interaction is required for 
the extreme potency of SAgs, as murine PBMC require a 5-fold higher dose of    
SAg than human PBMC for mitogenicity (Fraser & Proft, 2008). Mice transgenic 
for human MHC class II are significantly more sensitive in their T-cell proliferation 
responses, confirming that SAgs have a higher affinity for human than murine MHC 
class II (Nooh et al., 2007, Sriskandan et al., 2001). SAgs primarily interact with the 
TCR by binding to the variable region of the T-cell β chain (Vβ) region, with the 
exception of SEH which recognises the variable region of the TCR α-chain 
(Pumphrey et al., 2007). The TCRVα region is thought to indirectly influence the 
specificity for SAg by interaction with the β-chain of MHC (Petersson et al., 2004). 
Crystallography studies have revealed that SAgs bind to the complementary 
determining region (CDR) loop 2 domain of the TCR (Sundberg et al., 2007). The 
SAg TCR binding site is a cleft between the N-terminal and C-terminal domains 
(Figure 1.3). The interface between domains is the only highly conserved sequence 
amongst all staphylococcal and streptococcal SAgs and SSLs characterised to date 
(Fraser & Proft, 2008). SEB, SEC, SPEA binding to the TCR is CDR2 and hyper-
variable region (HVR) 4 restricted and is independent of specific Vβ amino acids 
(Sundberg et al., 2002b).  Specificity is achieved through binding Vβ hypervariable 
loops CDR1, CDR2, CDR3 and HVR4 (Li et al., 1998). It has been suggested that 
SAgs can be divided into either promiscuous TCR binders or highly specific T-cell 
activators with a narrow Vβ profile (Sundberg et al., 2002a). However further 
experiments will be required to investigate this hypothesis properly. The SAg/TCR 
binding mechanism is generally thought to be similar for distinct SAgs (Petersson et 
al., 2004).  
 
1.11 The T-cell receptor (TCR) 
The TCR is a heterodimer consisting of α- and β- or γ- and δ-chains. The αβ TCR 














Figure 1.3: Ribbon diagram of SEC2 structure. α-helices are shown in red and β-








the large number of MHC ligands presented to T-cells (Nikolich-Zugich et al., 
2004). Diversity can be generated by somatic recombination, whereby individual 
variable (V), diversity (D), and joining (J) segments are combined to form the single 
exons encoding the variable regions of α- and β-chains. Combinatorial joining of V-
J and V-D-J region gene segments generates diversity within TCR β chain CDR 
loop region 3 (Davis & Bjorkman, 1988, Rowen et al., 1996). Imprecise joining 
during VDJ recombination and insertion of palindromic nucleotides within the VD, 
DJ, and VJ region leads to further diversification (Behlke et al., 1985, Marrack & 
Kappler, 1997). CDR1 and CDR2 sequences within the TCR interact with the α-
helix of the MHC class II molecule (Garcia et al., 1996), and the CDR3 region 
interacts with the antigenic peptide associated with MHC leading to clonal T-cell 
proliferation (Garcia et al., 1996).  
T-cell receptor β variable (TRBV) genes encode the variable region of the β 
chain, and the full repertoire of human and murine TRBV genes has been 
established (Rowen et al., 1996). In cattle, TRBV genes are designated as 
orthologues of their most similar human genes, on the basis of over 75% sequence 
homology to each other and human TRBV genes and are assigned to subgroups 
accordingly. Vβ sequence homology between orthologous subfamilies from 
different species is higher than between different subfamilies in the same species 
which indicates that TRBV gene subfamilies were established before mammalian 
radiation 60 to 80 million years ago (Clark et al., 1995). The recent bovine genome 
sequencing project added to the TRBV information obtained from cDNA analyses 
and revealed that the bovine TRBV locus is around 730 kb in size, containing 134 
genes of which 79 are predicted to be functional (Houston & Morrison, 1999, Elsik 
et al., 2009). These genes can be assigned to 24 subgroups of which 18 contain 
functional genes (Connelley et al., 2009). Organisation of the bovine TRBV locus is 
broadly similar in humans and mice. However the bovine repertoire is much larger, 
with human and murine TRBV loci encoding 65 genes belonging to 30 subgroups, 
and 35 genes belonging to 31 subgroups, respectively (Rowen et al., 1996, Folch & 
Lefranc, 2000, Bosc & Lefranc, 2000). Therefore it appears that the cattle TRBV 
gene repertoire is distinct from other species and indicates that there has been 
extensive gene duplication in the TRBV locus during evolution (Houston et al., 
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2005). It is thought that expansion of genomic TRBV evolved by extensive gene 
duplication involving tandem duplication of DNA blocks containing multiple genes 
(Su & Nei, 2001). In particular, there has been massive expansion of bovVβ 
subfamilies 1, 10 and 13 containing 35, 16 and 40 genes respectively, comprising 
68% of all bovine TRBV genes (Connelley et al., 2009).  
 
1.12 SAg stimulation of bovine T lymphocytes 
Of the SAgs produced by S. aureus, SEA, SEB, SEC and TSST-1 have been shown 
to be mitogenic for bovine T lymphocytes (Deringer et al., 1997, Seo et al., 2007, 
Fitzgerald et al., 2001a, Yokomizo et al., 1995), but their contribution to disease 
pathogenesis has not been investigated in detail. Interestingly, TSS has not been 
described in cattle, despite the high incidence of infection with SAg-producing S. 
aureus strains, which suggests that the bovine immune system may be distinct in its 
response to SAg stimulation (Park Y.H, 2006). Bovine T-cell proliferation on 
exposure to SAgs has been shown to be Vβ-dependent. Deringer et al, examined the 
response of 5 bovine Vβ subfamilies in response to stimulation with SECbov and 
found Vβ 28 T-cells were selectively expanded (Deringer et al., 1997). The Vβ 
specific expansion of bovine lymphocytes in response to stimulation with culture 
supernatants of a bovine strain of S. aureus and tst- and secbov-deficient isogenic 
mutants, was also investigated by Fitzgerald et al. TSST-1 was shown to activate 
bovVβ 2, consistent with the effect of the toxin on human T-cells (Fitzgerald et al., 
2001a). Vβ 1 and Vβ 7 levels were elevated in the absence of tst and secbov, which 
suggested expression of other SAgs by strain RF122 (Fitzgerald et al., 2001a).  
 
1.13 Distribution of staphylococcal SAgs  
All SAgs identified to date are encoded MGEs such as plasmids, phages, 
transposons and staphylococcal pathogenicity islands (SaPIs), or the highly variable 
genomic region vSaβ (Table 1.1) (Fitzgerald et al., 2001a, Jarraud et al., 2001, 
Johns & Khan, 1988, Ono et al., 2008, Ben Zakour et al., 2008). For example, sea 
and selp are encoded by phage ΦSa3n, and sed, sej, ser, ses, and set are carried by a 
plasmid (Ono et al., 2008, Zhang et al., 1998). The enterotoxin gene cluster (egc) is 
located at a highly variable region of the chromosome vSaβ and consists of five 
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genes, seg, sei, selo, selm, seln and either two pseudogenes φent1 and φent2 or selu 
(Letertre et al., 2003, Jarraud et al., 2001). vSaβ is found in all strains however the 
presence of the egc is strain-dependent. The S. aureus pathogenicity islands (SaPIs) 
encode a number of genes associated with virulence, including, seb, sec, selk, sel 
selq and tst (Novick et al., 2010). SaPIs range in size from 14 kb to 17 kb, contain a 
site-specific integrase, are capable of autonomous replication, and can be transferred 
horizontally between strains (Novick et al., 2010). Transfer relies on induction by 
bacteriophages to initiate an excision-replication-packaging mechanism resulting in 
incorporation of the genomic island into infective phage-like particles (Ubeda et al., 
2007). Accordingly, the distribution of SAg genes among S. aureus strains is highly 
variable. For example, Omoe et al, showed that 80% of human nasal isolates 
contain at least one SAg gene, including 50% which contain the egc locus, and 
Smyth et al demonstrated that 57% of animal-associated strains examined contained 
at least one SAg gene with the egc found in 30% of isolates (Smyth et al., 2005, 
Omoe et al., 2005a). These data imply that no single SAg is encoded by more than 
50% of strains and that about a fifth of all strains may not have superantigenic 
capacity at all. Staphylococcal SAgs have also been described in coagulase negative 
staphylococci (CNS) including; S. chromogenes, S. xylosis, S. hyicus, S. simulans, S. 
epidermidis, and S. haemolyticus. Park et al demonstrated that 31% of CNS isolates 
tested harboured at least one SAg gene (Park et al., 2010). In addition a high 
proportion of S. pseudintermedius strains harbour the SAg gene seint and a small 
number of S. pseudintermedius strains produce a canine variant of SEC (Edwards et 
al., 1997, Futagawa-Saito et al., 2004).  
  There are a number of studies which suggest that specific combinations of 
SAg genes are linked to different clinical outcomes. For example, sea and sej have 
been associated with invasive disease, sea, seb, and tst are more frequently observed 
in sepsis isolates and the egc genes are thought to predominate in commensal strains 
(Peacock et al., 2002, Ferry et al., 2005). However it has been reported that specific 
gene combinations often occur as a result of the clonal origin of the strains 
(Holtfreter et al., 2007). Holtfreter et al investigated the distribution of SAg 
encoding MGEs in a wide range of human MSSA and MRSA isolates, and observed 
SAg gene complement was tightly linked to specific clonal complexes. The egc was 
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present in all CC5, CC22 and CC45 isolates, and tst was strongly linked to the 
CC30 lineage. However, broader distribution was observed for the sea carrying 
phage, ΦSa3n implying wide horizontal transfer (Holtfreter et al., 2007).  
 
1.14 Staphylococcal gene regulation 
The survival of S. aureus in the environment and within various niches in a variety 
of animal hosts relies on a number of adaptive gene regulatory systems. In 
particular, the accessory genes of S. aureus are controlled by an intricate regulatory 
network comprised of two component signal transduction systems (TCS) and 
transcription factors including alternative sigma factors and the Sar (Staphylococcal 
accessory regulator) protein family of homologous DNA binding proteins. This 
network allows the bacterium to produce the appropriate accessory or virulence 
factors it needs in response to environmental or population density stimuli. Analysis 
of the S. aureus genome revealed at least 16 TCSs in S. aureus (Cheung et al., 
2004, Novick, 2003). The accessory gene regulator (agr) is a well characterised 
staphylococcal TCS consisting of 4 genes which encode components of a quorum-
sensing system activated at high cell density (Novick, 2003). AgrA and AgrC form 
the TCS, and AgrB and AgrD produce an autoinducing peptide (AIP) for activation 
(Novick, 2003). AIP is post-translationally modified from AgrD which is a 
propeptide, and binds to the agr signal receptor AgrC (Ji et al., 1995, Lina et al., 
1998). The agr locus contains two separate transcripts, RNAII and RNAIII driven 
by promoters P2 and P3 repectively. RNAII encodes agrDBCA, the TCS and its 
autoinducing ligand, RNAIII transcript encodes a regulatory molecule (RNAIII) 
and hld (δ-toxin). When the response regulator, AgrA is activated by 
phosphorylation, P2 and P3 promoters are upregulated. Intracellular accumulation 
of RNAIII leads to increased transcription of exotoxins (Novick, 2003). Four major 
agr groups have been described based on sequence divergence within the locus 
(Wright et al., 2005, Novick, 2003). The virulence of agr mutants is attenuated in a 
number of animal models, therefore agr has been well established as a global 
regulator of virulence (Novick, 2003, Abdelnour et al., 1993, Gillaspy et al., 1995)  
The sarA locus is controlled by 3 upstream promoters, and can produce 3 
distinct transcripts encoding the SarA protein (Cheung et al., 2004). SarA is a 
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transcriptional factor which upregulates expression of RNAIII through interaction 
with, or independent of the agr (Chien & Cheung, 1998, Dunman et al., 2001). The 
rot (repressor of toxin) locus is a member of the Sar family which interacts with the 
agr (McNamara et al., 2000). Inactivation of rot restored α-toxin and protease 
expression in an agr null mutant (McNamara et al., 2000). Rot is a global regulator 
of virulence factors including protease, alpha haemolysin, protein A and clumping 
factor (Said-Salim et al., 2003). Overall, this complex gene regulatory network 
allows differential expression of proteins in different phases of bacterial growth. 
During exponential phase, expression of many adhesive CWA proteins occurs 
(Cheung et al., 2004, Xiong et al., 2004). During post-exponential phase 
extracellular toxins such as SAgs, α-toxin and proteolytic enzymes are upregulated, 
which are likely to facilitate nutrient acquisition and dissemination (Cheung et al., 
2004). Inactivation of either sarA or agr loci leads to reduced virulence in animal 
infection models (Cheung et al., 2004, Xiong et al., 2004).  
 
1.15 Expression of SAg genes 
Gaskill et al demonstrated that seb was under the control of the agr, as SEB 
production was lower in an agr null mutant (Gaskill & Khan, 1988). In vitro 
experiments have shown that in addition to seb, agr upregulates the expression of 
genes encoding SEC, SED and TSST-1 in stationary phase (Tseng et al., 2004, 
Regassa et al., 1991, Novick, 2003). However this does not appear to be the case for 
all SAg genes, as SEA is known to be constitutively expressed and SEG and SEI are 
produced maximally in exponential phase (Lina., 2004, Munson et al., 1998b, 
Tremaine et al., 1993). TSST-1 and SEB have themselves been reported to function 
as transcription factors, acting as global repressors of exoprotein genes at the level 
of transcription (Vojtov et al., 2002b). Expression of TSST-1 has also been 
confirmed in vivo, and TSST-1 toxin levels of up to 5 ng/ml have been detected in 
sera from TSS patients (Miwa et al., 1994). In addition, expansion of Vβ 2 
lymphocytes by TSST-1 was observed in TSS patients (Takahashi et al., 2000). 
Some SAgs encoded by S. pyogenes such as SPEA, are produced at greater 
levels in BALB/c mice compared to liquid culture in vitro, indicating that optimal 
expression relies on unknown host factors (Kazmi et al., 2001). In addition, SPEC 
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expression was significantly increased in co-culture with human pharyngeal cells 
(Broudy et al., 2001). Another important study which monitored cynomolgus 
macaques throughout the course of S. pyogenes infection, revealed maximal spej 
and smez transcription during colonisation, and spej expression during early 
infection stages (Virtaneva et al., 2005). The closely related SSLs are also produced 
at low levels in vitro (Fraser & Proft, 2008), but are dramatically upregulated under 
stress conditions, in a hemin-fed strain of S. aureus  which is deficient in hrtAB, 
required for iron efflux (Torres et al., 2007). 
 
1.16 Toxic shock syndrome (TSS) 
TSS is an acute disorder which was first identified in children in 1978, and is 
characterised by high fever, vomiting, diarrhoea, and an erythrematous rash, which 
progresses to more severe disease with hypotension, shock and renal failure (Todd 
et al., 1978). In 1980, 400 cases were reported to the Centers for Disease Control 
(CDC) (Bergdoll et al., 1981). Almost all of the cases during the initial US outbreak 
were associated with menstruating females infected with a phage group I strain of S. 
aureus (Bergdoll et al., 1981). 88% of all subsequent menstrual cases examined 
from 5 countries were attributed to a single clone of S. aureus (Musser et al., 1990). 
Bergdoll et al showed that 94% of menstrual TSS isolates produced high levels of 
TSST-1 compared with only 4% of non-TSS strains (Bergdoll et al., 1981).  TSST-1 
is thought to be the only SAg able to penetrate the vaginal mucosa, by binding 
directly to vaginal epithelial cells and activating innate chemokines to allow 
penetration into the bloodstream (Peterson et al., 2005). Therefore TSST-1 is 
generally considered to be the only SAg responsible for menstrual toxic shock 
(Thomas et al., 2007).  
A further link to the use of a particular brand of highly absorbent tampons 
(Rely) amongst TSS patients was discovered (Kehrberg et al., 1981, Schlech et al., 
1982). The removal of that brand of tampons from the market and changes in 
tampon manufacture led to a significant reduction in the incidence of menstrual TSS 
(Schuchat & Broome, 1991). Since then, non-menstrual TSS which affects a 
heterogenous patient group has been more commonly observed, and in addition to 
TSST-1, is associated with strains producing SEA, SEB, and SEC (Ferry et al., 
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2005, Dauwalder et al., 2006). While menstrual TSS rates have fallen, non-
menstrual TSS rates have remained stable (Schlievert et al., 2004, Hajjeh et al., 
1999). Recurring TSS is thought to be associated with a failure to generate 
neutralizing antibodies due to immuno-depression caused by SAgs (Andrews et al., 
2001).  
 
1.17 Other SAg-associated diseases 
Leydon et al first proposed that S. aureus may be involved in atopic dermatitis 
(AD), as it was observed that the skin of almost all patients were colonised with S. 
aureus compared with only 5% of healthy volunteers (Leyden et al., 1974). A 
number of studies subsequently reported that AD isolates produced SAgs and a 
possible role in the progression of AD disease was speculated (Hoeger et al., 1992, 
Michie & Davis, 1996, Leung & Bieber, 2003). Strickland et al later demonstrated 
that SAgs upregulate the expression of the skin homing receptor, cutaneous 
lymphocyte associated antigen (CLA), and AD patients showed significant SAg-
specific Vβ skewing within the CLA
+
 T-cell subsets (Strickland et al., 1999).   
A similar association with SAg activity was proposed for allergic rhinitis, as 
nasal carriage levels in patients (44%) was much higher than in healthy subjects 
(20%) (Shiomori et al., 2000). Rossi et al determined the prevalence of serum-
specific IgE towards SEA, SEB, SEC, SED and TSST-1 in patients suffering from 
rhinitis, and observed an increase in serum eosinophil cationic protein (ECP), which 
is a marker for the severity of allergic disease, in patients with anti-SAg IgE 
compared to IgE negative patients (Rossi & Monasterolo, 2004). SAgs have been 
shown to stimulate immunoglobulin class switching to SAg specific IgE or 
“superallergens” in mucosal B cells. Superallergens then promote chronic 
inflammation and persistent sensitisation of mast cells and dendritic cells to 
conventional allergens, in mucosal tissues of atopic dermatitis, rhinitis, and asthma 
patients and in nasal polyposis (Bachert et al., 2001, Barnes, 2009).  
Another disease which has been linked to SAg activity is Kawasaki disease 
(KD). KD is an acute disease in children with symptoms similar to TSS (Falcini, 
2006), but the etiology of this disease is unknown. Leung et al observed Vβ 2-
specific T-cell expansion associated with TSST-1 production in a number of 
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patients (Leung et al., 1993, Leung et al., 1995). Matsabura et al described an 
increase in SAg-specific serum IgM antibodies in patients in the weeks following 
diagnosis with KD (Matsubara et al., 2006). However further investigations are 
required to confirm the role of SAgs in KD.  
 
1.18 Therapeutics  
The growing problem of antibiotic resistance amongst S .aureus isolates has led to 
increased need to develop alternative therapeutic agents. Currently, there is no 
vaccine available for S. aureus, but a number of clinical trials are ongoing (Garcia-
Lara & Foster, 2009). Potential targets include CP5 and CP8 capsular 
polysaccharides, α-toxin, CWA proteins and SAgs. SAg vaccines which are in pre-
clinical development include a toxoid mutant of TSST-1 which has shown 
protection in rabbits and an SEB toxoid which is protective in monkeys (Garcia-
Lara & Foster, 2009). Another therapy in development are peptide agonists, which 
target regions of SAg which interact with the host to inhibit activity (Arad et al., 
2000). Yang et al have described a broad spectrum antagonist which consists of 
multiple Vβ domains expessed in tandem as a single-chain protein which can 




SAgs are produced by a large number of S. aureus strains and contribute to 
pathogenesis through modulation of the host immune response. However the exact 
role SAgs play in the pathogenesis of disease is unclear. Studies have revealed that 
SAg genes are commonly found in bovine mastitis isolates (Smyth et al., 2005). 
SEC and TSST-1 have been shown to activate bovVβ specific T-cell activation 
(Fitzgerald et al., 2001a), but the effect of other staphylococcal SAgs on bovine 
immune response has not been investigated. We propose that a number of bovine-
specific SAg genes encoded by the bovine S. aureus strain RF122 will have a role in 
activation of the bovine immune response. Chronic, persisting, subclinical infection 
is the most common form of disease and we believe persistence may be due in part 
to SAg activity.  
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1.20 Project aims 
The aim of this project was to elucidate the role of staphylococcal SAgs in the 
pathogenesis of S. aureus by:  
 
• Employing a genome scale approach to identify the full complement of SAg 
            genes encoded by bovine strain RF122, and investigate levels of gene 
            expression 
 
• Investigating bovine T-cell activation in  response to staphylococcal 
            SAgs 
 
• Examining the role of SAgs in pathogenesis during experimental 















































2.1 Bacterial culture conditions 
S. aureus strains were grown in tryptone soya broth (TSB) or brain heart infusion 
broth (BHI) (Oxoid, UK) shaken at 200 rpm, or on tryptone soya agar (TSA) 
(Oxoid, UK) at 37 °C for 16 h unless otherwise stated. E. coli strains were grown in 
Luria-Bertani Broth (LB) (Melford Laboratories, UK) shaken at 200rpm, or on LB-
agar (Melford Laboratories, UK) at 37 °C for 16 h unless otherwise stated. Media 
were supplemented where appropriate with antibiotics as stated in each chapter. 
Strains were stored in appropriate liquid culture medium containing 40% (v/v) 
glycerol (Sigma-Aldrich, UK) in cryovials (Nunc, Thermo Scientific, UK) at -80 
°C.  
 
2.2 Genomic DNA extraction 
Genomic DNA (gDNA) was extracted from 1ml of an overnight culture of S. 
aureus strains using the PurElute™ Bacterial Genomic Kit (Edge Biosystems, MD, 
USA) as described in the manufacturer’s protocol, except for the addition of 100 
µg/ml lysostaphin to Spheroplast lysis buffer and incubation at 37 °C for 20 min 
(AMBI products LLC, NY, USA). gDNA pellets were resuspended in 100 µl 1 x 
Tris-EDTA (TE) buffer (10mM Tris, 1mM EDTA, adjusted to pH 8) (Sigma-
Aldrich, UK).  
 
2.3 DNA isolation 
DNA plasmids were isolated from 5 ml overnight cultures of E. coli using the 
QIAprep Spin Miniprep kit (QIAgen) as described in the manufacturers 
instructions, and from S. aureus with the addition of lysostaphin (AMBI products 
LLC) to Buffer P1 at 100 µg/ml and incubation at 37 °C for 1 h. DNA fragments 
were purified using QIAquick gel extraction or PCR purification kits from QIAgen 
as outlined in the supplied protocol.  
 
2.4 Restriction digestion 
gDNA and plasmid DNA were digested with appropriate restriction enzymes and 
buffers as outlined in the manufacturer’s instructions (New England Biolabs, Herts, 
UK). Digestion of 2 µg gDNA was carried out in a 50 µl reaction containing 1 x 
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reaction buffer, 2 U restriction endonuclease and dH20 for 16 h. 50 ng plasmid 
DNA was digested in a 20 µl reaction containing 1 x reaction buffer, 1 U restriction 
endonuclease and dH20 for 2 h at 37 °C unless otherwise stated. 
 
 2.5 Polymerase Chain Reaction (PCR) 
Oligonucleotides were designed using Primer 3 v. 0.4.0 (Rozen, 2000), and 
synthesised by Sigma-Genosys, UK or Invitrogen, UK. PCR reactions were carried 
out in a BioRad thermal cycler and contained 100 nM forward and reverse primers 
as stated in each chapter, 0.25 mM dNTP (Promega, Hampshire, UK), 10 x reaction 
buffer, and either 1 U of Taq DNA polymerase (Promega, Hampshire, UK), 1 unit 
of PfuUltra II Fusion DNA Polymerase (Agilent, UK), or 1 U Vent polymerase 
(New England Biolabs, Herts, UK), 10 ng of template DNA and ddH2O to a final 
volume of 50 µl. Colony PCR was carried out by boiling single colonies in 10 µl 
ddH2O. Unless otherwise stated, the thermal programme was; 1 cycle at 95 °C for 3 
min, 30 cycles at 95 °C for 1 min, 50 °C for 1 min, 72 °C for 30 s per kb (Taq), 15 s 
per kb (Pfu), or 1 min per kb (Vent), followed by a final extension at 72°C for 10 
min  
 
2.6 Agarose gel electrophoresis  
Agarose gel electrophoresis of DNA fragments was carried out in 1% (w/v) agarose 
gels (Melford Laboratories, UK), with 1 x Tris borate EDTA (TBE) buffer (Sigma-
Aldrich Co., Dorset, UK) containing either 0.5 µg/ml ethidium bromide (Sigma-
Aldrich Co., Dorset, UK) 1 x SYBR Safe DNA gel strain (Invitrogen, UK) or 1 x 
Gel Red (Biotium Limited, Cambridge Bioscience, UK). 1 x Bluejuice (Invitrogen, 
UK) or Promega loading dye (Promega, UK)  was added to DNA samples before 
being loaded onto to the gel alongside a molecular weight marker, 100 bp or 1 kb 
DNA ladder (Promega, UK). Electrophoresis was carried out at 100 V for 60 to 90 
min. Gels were visualised using a UV transilluminator (MultiImage
TM
 Light 





2.7 DNA quantification 
DNA concentration (ng/µl) was determined using a nanodrop ND-1000 
spectrophotometer (Thermo Scientific, USA) by measuring the absorbance of the 
sample at a wavelength of 260 nm.  
  
2.8 DNA Sequencing 
Sequencing reactions were carried out by Genepool Sequencing Service (King’s 
Buildings, University of Edinburgh, UK). Reactions contained 5 µl (approximately 
50 ng) purified DNA with 100 nM sequencing primer and the BigDye
TM
 
Terminator v3.0 Ready Reaction Cycle sequencing kit as described in the 
manufacturer’s instrucions (Applied Biosystems, UK) and loaded onto an ABI3730 
capillary DNA analyzer. DNA sequences were assembled using ContigExpress 
(Vector NTI Advance 10, Invitrogen, UK) or DNAbaser v.2.80.0 
(www.dnabaser.com).  
 
2.9 Phylogenetic analysis 
Sequences were aligned by ClustalW using MEGA 4.0.1 software (Tamura et al., 
2007). Evolutionary distances were determined by constructing Neighbour Joining 
trees using the Maximum Composite Likelihood method. At least 500 bootstrap 
trees were generated to examine the stability of the phylogenetic relationship. 
 
2.10 Cloning of SAg genes 
Inserts were amplified by PCR using primers and enzymes as stated in each chapter. 
PCR products were then purified by either gel extraction or PCR purification, and 
cloned into the Strataclone pSC-B plasmid as described in the manufacturer’s 
instructions (Stratagene). pSC-B plasmids containing inserts were then restriction 
digested with appropriate restriction enzymes, purified and ligated into digested 
plasmid, with T4 DNA ligase (NEB) for 16 h at 4 °C. The ligations were dialysed 
on 0.025 µm filter discs (Millipore) and transformed into E. coli strain DH5α. The 
constructs were subsequently isolated from E. coli and transformed by 
electroporation into S. aureus or E. coli expression strain, BL21. 
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2.11 Preparation of electro-competent cells and electro-transformation 
E. coli electro-competent cells were prepared by inoculating 250 µl of an overnight 
culture into 25 ml of LB shaken at 200 rpm, 37 °C until an OD600 of between 0.4 
and 0.6 was reached. Cells were washed once in an equal volume of ddH2O, 
centrifuged at 4000 x g, 4 °C, washed twice in a 1/2 volume of 10% (v/v) glycerol, 
and once in 1/4 volume of 10% (v/v) glycerol. Cells were pelleted and resuspended 
in 10% (v/v) glycerol at a final volume of 400 µl. S. aureus cells were made 
competent by inoculating 1 ml of overnight culture into 25 ml of TSB, followed by 
shaking at 200 rpm, 37 °C until mid-exponential phase (OD600 value of between 0.8 
and 1.0). Cells were washed three times in an equal volume of distilled water, 
washed once in a 1/5 volume of 10% (v/v) glycerol, resuspended in 1/10 volume of 
10% (v/v)  glycerol and incubated at 20 
◦
C for 15 min. Cells were pelleted and 
resuspended in a final volume of 800 µl 10% (v/v) glycerol. Electro-transformation 
was carried out with 1 µg plasmid or ligated DNA added to 70 µl competent cells in 
a 0.1 cm gap cuvette (Sigma-Aldrich, UK), and electroporated with the following 
settings; 100 Ω, 25 µF and 2.5 kV. 300 µl TSB or LB was immediately added and 
cells were shaken at 37 °C for 1 h unless otherwise stated. Cells were plated onto 
TSA or LB-agar supplemented where appropriate with antibiotics, and incubated 
for 18 h at 37 °C. 
 
2.12 Sodium Dodecyl Sulphate – Polyacrylamide gel electrophoresis 
(SDS-PAGE) 
Proteins were resolved by SDS-PAGE. 10% (w/v) polyacrylamide resolving protein 
gels were prepared using a mini-protean gel casting apparatus (Biorad) with 4.05 ml 
of distilled water, 2.5 ml of 1.5 M TrisHCl, pH 8.8 (ForMedium, UK), 100 µl 10% 
(w/v) Sodium-dodecylsulphate (SDS) (Melford, UK), 3.3 ml 40% (w/v) 
Acrylamide/Bis-acrylamide (Sigma-Aldrich, UK), 50 µl 10% (w/v) Ammonium 
persulphate (APS) (Sigma-Aldrich, UK) and 5 µl Tetramethylethylenediamine 
(TEMED) (Sigma-Aldrich, UK), and sealed using 1 ml of isopropanol (Sigma-
Aldrich, UK). 4% (w/v) polyacrylamide stacking gels were prepared with 6.3 ml of 
distilled water, 2.5 ml 0.5 M TrisHCl, pH 6.8, 100 µl of 10% SDS (w/v), 1 ml 40% 
(w/v) acrylamide/bis-acrylamide, 100 µl of 10% (w/v) APS and 10µl TEMED. This 
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was added to the polymerized resolving gel and a comb was inserted. Once 
polymerized the protein gel was assembled in running apparatus, placed into a gel 
tank and covered with 1x running buffer. 5 x running buffer was prepared using: 
124 mM Tris hydroxymethyl (methylamine) base (Tris) (ForMedium, UK), 960 
mM Glycine (Melford, UK) and 17 mM SDS. Protein samples were boiled in 1 x 
Protein Sample buffer (Laemmli, Sigma-Aldrich, UK) for 5 min, loaded into wells 
and electrophoresed at 100V for 1 h 30 min.  
Large protein gels were prepared using a vertical dual gel caster (Hoefer). 
Resolving gels contained 17.31 ml of distilled water, 10 ml of 1.5 M TrisHCl, 400 
µl 10% SDS, 12 ml 40% Acrylamide/Bis-acrylamide (Sigma), 250 µl 10% APS and 
40 µl TEMED, and sealed with isopropanol. Stacking gels were prepared with 
12.78 ml of distilled water, 5 ml 0.5 M TrisHCl, 200 µl of 10% SDS, 2 ml of 40% 
acrylamide/bis-acrylamide, 200 µl of 10% APS and 20µl TEMED. This was added 
to the polymerized resolving gel and a comb was inserted. Once polymerized the 
protein gel was assembled in a standard dual cooled vertical unit running apparatus 
(Hoefer), placed into a gel tank and covered with 1 x running buffer. Protein 
samples were boiled in 1 x Protein Sample buffer for 5 min, loaded into wells and 
electrophoresed at 50 mA for 4 to 6 h. SDS-PAGE gels were either stained 
overnight at room temperature with Coomassie Blue (Severn Biotech), and de-
stained for 1 d in ddH20 or transferred to nitrocellulose membranes (Amersham 
Hybond™ ECL™, GE Healthcare, Slough, UK) for Western analysis. 
 
2.13 Western immunoblot analysis 
SDS-PAGE gels were transferred to nitrocellulose membranes (Amersham 
Hybond™ ECL™, GE Healthcare, Slough, UK) for Western analysis in Towbin 
transfer buffer (20 mM Tris, 154 mM Glycine and 20% (v/v) Methanol (Fisher 
Scientific, UK), with a Mini Trans-Blot cell (Bio Rad, Hertfordshire, UK) at 60 V 
for 1 h 30 min. The membrane was incubated in PBS (Oxoid, Cambridge, UK) 
containing 8% (w/v) powdered milk (Fluka, Sigma-Aldrich, Dorset, UK), at 4 °C 
overnight. Membrane was washed 3 times with washing buffer; PBS containing 1% 
(w/v) powdered milk and 0.05% (v/v) Tween 20 (Sigma-Aldrich, Dorset, UK). The 
membrane was then incubated for 1 h with primary antibody at the dilutions stated 
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in each chapter. Membrane was washed 3 times with washing buffer (PBS with 
0.05% (v/v) Tween 20 and 1% (w/v) powdered milk), and incubated with secondary 
antibody for 1 h at the dilutions stated in each section. Membrane was washed as 
before and visualised by enhanced chemiluminescene (ECL), in equal volumes of 
ECL solutions 1 and 2. ECL solution 1 contained 1 ml Luminol, (Fluka, UK), 250 
mM dimethyl sulfoxide (DMSO) (Sigma-Aldrich, UK), 0.44 ml p-coumaric acid 
(Sigma-Aldrich, UK) 100 mM TrisHCl, with dH2O to a final volume of 100 ml. 
ECL solution 2 contained 64 µl 30% H2O2 (Sigma-Aldrich, UK), 100 mM TrisHCl, 
and ddH2O to a final volume of 100 ml.  
 
2.14 Isolation of bovine peripheral blood lymphocytes (PBLs) 
Blood was obtained from Holstein-Friesian cattle aged 18–36 months via jugular 
vein puncture. Animals were reared indoors and maintained on a ration of hay and 
concentrates. PBMC were isolated by density gradient centrifugation using Ficoll 
Paque PLUS, GE Healthcare, Slough, UK ) as described previously (Goddeeris & 
Morrison, 1988).  
 
2.15 T-cell proliferation assays  
Bovine PBLs were adjusted to a concentration of 1 × 106 cells/ml in complete cell 
culture medium, RPMI 1640 medium (Gibco, Invitrogen, Paisley, UK) 
supplemented with 10% heat-inactivated FCS (Gibco, Paisley, UK), 100 U/ml 
penicillin, 100 µg/ml streptomycin, 292 µg/ml L-glutamine (PSG) (Gibco, Paisley, 
UK) and 50 µM 2-mercaptoethanol (Sigma-Aldrich, UK), and cultured in 96 well 
tissue culture plates (Nunc) for 96 h at 37 °C in humidified air with 5% CO2. Cells 
were stimulated at least in triplicate with protein samples as described in each 
section. Cells in culture medium alone and stimulated with 50 µg/ml Concanavalin 
A, were used as negative and positive controls respectively. Proliferation of bovine 
PBMC was assessed by a [
3
H]-thymidine incorporation assay. Cells were pulsed 
with 1 µCi/well [3H]-thymidine (GE Healthcare, Slough, UK) after 72 h, and 
harvested 18 h later using a Tomtec Mach III M Harvester 96 (Hamden, 
Connecticut, USA) onto Wallac A filters (Perkin Elmer, MA, USA), using a 96-
well plate harvester. A Meltilex A wax scintillant strip (Perkin Elmer, MA, USA) 
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was melted onto the dried filter and [
3
H] thymidine incorporation into cellular DNA 
was determined by scintillation counting using a β radiation counter (Wallac 1450 
Microbeta PLUS, PerkinElmer, Beaconsfield, Bucks, UK) and recorded as counts 
per minute (cpm). 
 Proliferation of bovine PBMC was also assessed by carboxyfluorescein 
succinimidyl ester (CFSE) staining. Prior to stimulation, PBMC at 2 x 10
7
 cells/ml 
in Hanks buffered saline solution (HBSS) (Gibco, Invitrogen, Paisley, UK) were 
incubated with 2 µM CFSE for 10 min at 37 °C (Molecular probes, Invitrogen, 
Paisley, UK). An equal volume of ice cold FCS was added, cells were centrifuged 
at 250 x g for 20 min and washed 3 times in culture media. Stained cells were 
cultured and fluorescence associated cell sorting (FACS) analyses were performed 
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S. aureus is known to produce at least 21 distinct SAgs, including SEA to E, SEG 
to J, SER to T, SElK to Q, U, V, and TSST- 1. In recent years, a multitude of S. 
aureus genomes have been sequenced which has led to the identification of genes 
encoding novel SAgs (Omoe et al., 2005b). S. aureus strain RF122 which belongs 
to the bovine specific lineage ST151, was the first animal associated isolate to be 
fully sequenced (Herron-Olson et al., 2007). A comprehensive, genome-wide 
analysis of the complement of SAgs encoded by a bovine strain of S. aureus has not 
been carried out to date. 
 
The aim of this component of the study was to investigate the diversity, distribution 
and expression of SAgs among bovine S. aureus strains by: 
 
• Identifying the full complement of SAg genes in the genome of bovine 
isolate, RF122  

















3.2 Materials and Methods 
 
3.2.1 Bacterial strains  
S. aureus strains investigated in this study were selected to represent a broad variety 
of clonal genotypes, with diverse host range and geographical origins (Table 3.1). 
Media was supplemented where appropriate with 50 µg/ml ampicillin (Sigma-
Aldrich, UK).  
 
3.2.2 Phylogenetic analysis of staphylococcal SAg genes 
The sequences of characterised staphylococcal SAg genes were obtained from the 
NCBI Genbank database. SAg allelic variants were identified in the fully sequenced 
S. aureus genomes listed in Table 3.2 by Basic Local Alignment Search Tool 
(BLASTn) analysis. Nucleotide and translated amino acid sequences of all allelic 
variants of staphylococcal SAg genes were aligned by ClustalW using MEGA 4.0.1 
software (Tamura et al., 2007). Evolutionary distances were determined by the 
Maximum Composite Likelihood method, and Neighbour Joining trees were 
constructed and a bootstrap test of phylogeny performed.  
 
3.2.3 PCR amplification of putative SAg genes 
PCR reactions were carried out as described in General Methods using Taq DNA 
polymerase (Promega, UK), primers to amplify within the coding sequence of 
putative SAg genes selx, sely and selz (Table 3.3), and 1 µl gDNA isolated from 
strains listed in Table 3.1. Amplification of Multi Locus Sequence Type (MLST) 
gene glpF was used as a control for the integrity of each gDNA sample (Enright et 
al., 2000).  
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Strain Host ST/ET Geographic origin Reference/ Source selx sely selz 
434 (C434) Human 8 UK, 1997 (Enright et al., 2000) + + + 
LAC Human CA-MRSA 8 USA (Kennedy et al., 2008) + - - 
88006 Human CA-MRSA 8 USA (Kennedy et al., 2008) + - - 
88007 Human CA-MRSA 8 USA (Kennedy et al., 2008) + - - 
88008 Human CA-MRSA 8 USA (Kennedy et al., 2008) + - - 
88009 Human CA-MRSA 8 USA (Kennedy et al., 2008) + - - 
88010 Human CA-MRSA 8 USA (Kennedy et al., 2008) + - - 
126 (C126P) Human 12 UK, 1997 (Enright et al., 2000) + + - 
383 (H383) Human 22 UK, 1997 (Enright et al., 2000) + - - 
03-2372.2 #4 Human MRSA 22 UK Scottish MRSA reference 
laboratory (SMRSAL) 
+ - - 
07-8898.11 #10 Human MRSA 22 UK SMRSAL + - - 
02-2008.L #23 Human MRSA 36 UK SMRSAL - - - 
MSA1832 Human 30 USA, 1968 (Musser & Selander, 1990) - - - 
MSA2389 Human furunculosis 45 (ET39) Sweden (Musser & Selander, 1990) + - - 
MSA2020 Human SSS 121 France (Musser & Selander, 1990) + - + 
MSA2120 Human 126 Denmark, 1983 (Musser & Selander, 1990) + - + 
MSA1601 Human MRSA ET53 USA, 1980s (Musser & Kapur, 1992) + - - 
MSA3418 Human MRSA ET89 Australia, 1980s (Musser & Kapur, 1992) + - - 
Table 3.1: S. aureus strains investigated by PCR to determine distribution of selx, sely and selz 
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Strain Host ST/ET Geographic origin Reference/ Source selx sely selz 
MSA3400 Human MRSA ET91 Ireland, 1990 (Musser & Kapur, 1992) + - - 
MSA1695 Human SSS ET93 Japan (Musser & Selander, 1990) + + - 
MSA890 Human ET93 USA (Musser & Kapur, 1992) + - - 
MSA820 Human MRSA ET93 USA (Musser & Kapur, 1992) + - - 
MSA2965 Human Sepsis ET191 Canada, 1983 (Musser & Selander, 1990) + - + 
B40 Swine 9 Hong Kong (Guardabassi et al., 2009) + - + 
DS95 Ovine 9slv Denmark (Mork et al., 2005) + - + 
MSA535 Ovine ET66 Germany (Musser & Selander, 1990) + - - 
DS13 (St7) Ovine 133 Italy (Foschino et al., 2002) + - - 
DS83 (891-1) Ovine 133 Norway (Mork et al., 2005) + - - 
ED133 Ovine 133 France, 1997 (Ben Zakour et al., 2008) + - - 
DS102 (6659-2) Ovine 151slv Sweden (Mork et al., 2005) + + + 
VET-BZ30 Ovine 750 Brazil, 2003 (Aires-de-Sousa et al., 2007) + - - 
DS30 (St153) Caprine 22 Italy (Foschino et al., 2002) + - - 
DS27 (St125) Caprine 25 Italy (Foschino et al., 2002) + - - 
VI50895 Caprine 130 Norway (Jorgensen et al., 2005) + - - 
DS74 (1563-4) Caprine 133 Norway (Mork et al., 2005) + - - 
VI50896 Caprine 481 Norway (Jorgensen et al., 2005) + - - 
DS28 (St152) Caprine 133 Italy (Foschino et al., 2002) + - - 
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Strain Host ST/ET Geographic origin Reference/ Source selx sely selz 
RF103 Bovine 71 Ireland (Fitzgerald et al., 1997) + + - 
CTH108 Bovine 115 USA (Smith et al., 2005) + - - 
951 Bovine 126 USA (Sischo et al., 1993) + - - 
MSA948 Bovine 126 USA Musser J.M + - - 
MSA961 Bovine 126 USA (Musser & Kapur, 1992) + - - 
VI50905 Bovine 130 Norway (Jorgensen et al., 2005) + - - 
DS36 (V329) Bovine 133 Sweden (Cucarella et al., 2001) + - - 
RF287 Bovine 133 Ireland, 1986 Fitzgerald, J.R + - - 
VI50901 Bovine 133 Norway (Jorgensen et al., 2005) + - - 
38963 Bovine 151 UK (Sung et al., 2008) + + + 
RF113 Bovine 151 Ireland Fitzgerald, J.R + + + 
C123/5/005 Bovine 151 UK, 2003 (Sung et al., 2008) + - + 
T2 (2521) Bovine NK Ireland Symth, C. + - + 
T6 (2242) Bovine NK Ireland Symth, C. + - - 
T7 (2242) Bovine NK Ireland Symth, C. + - - 
T12 (2242) Bovine NK Ireland Symth, C. + + - 
T21 (2487) Bovine NK Ireland Symth, C. + + + 
T22 (2487) Bovine NK Ireland Symth, C. + - - 
   + or – indicates presence or absence of putative SAg genes. 













MSSA476 NC_002953.3 UK, 1997 1 (Holden et al., 2004) 
MW2 NC_003923.1 USA, 1998 1 (Baba et al., 2002) 
N315 NC_002745.2 Japan, 1982 5 (Kuroda et al., 2001) 
Mu50 NC_002758.2 Japan, 1997 5 (Kuroda et al., 2001) 
Mu3 NC_009782 Japan 5 (Neoh et al., 2008) 
ED98 NC_013450.1 UK, 96 5 (Lowder et al., 2009) 
FPR3757 NC_007793.1 USA, 2003 8 (Diep et al., 2006) 
TCH1516 NC_010079.1 USA 8 (Highlander et al., 
2007) 
Newman NC_009641.1 UK, 1950 8 (Baba et al., 2008) 
NCTC8325 NC_007795.1 UK, 1960 8 (Gillaspy, 2006) 
MRSA252 NC_002952.2 UK, 1997 36 (Holden et al., 2004) 
JH1 NC_009632.1 USA, 2000 105 (Mwangi et al., 2007) 
JH9 NC_009487.1 USA, 2000 105 (Mwangi et al., 2007) 
ED133 CP001996 France 133 (Guinane et al., 2010) 
RF122 NC_007622 Ireland, 1993 151 (Herron-Olson et al., 
2007) 











Primer  Forward sequence (5´-3´) 
a
 Reverse sequence (5´-3´) 
a
 
PCR   
selx                GGAATTGGGTTTATTCAGAGAGACC ACTTGTTCAATGTCATTAACACTTTTCAC 
sely                 TGGTTACAGTAGCTATTCTTTGTTGG TTAGTTAAGTGCACTTCTATTTCCGTT 
selz                 AGCGAAACTATGGTTTTTATTGAC CTTGTGAGTCACTCAATATGTCGC 
RT-PCR   
egcA                 TCTTGATACGTATTTGACACTTGC TGCGAATGCCCTACCTGATCCTAA 
egcB TCCTCTTCCTTCAACAGGTGGAGA CATCGTGCTTAAACGGAGAGT 
egcC ACCTTCTTGTTGGACACACCATCT AGTTCGCCTTATGAGACTGGCT 
egcD TCACCAGATTTCAGATTCAGGCATCA GCGCAAGGAGATTGGTGTAGGT 
egcE GATCAAATCATTGGGACCGGTTG TCGTCTGTTGATGTATACGGCCT 
egcF ACCCGCTAAAGTAACTCCTCCGTA TTGTCATGGTGAGCATCAAGTGAAA 
egcG GCTACTCCTATTTCTTTAGGTTCGT AGAGTTGTTACAGTCGCTACACC 
qRT-PCR   
16srRNA                       TATGGAGGAACACCAGTGGCGAAG TCATCGTTTACGGCGTGGACTACC 
selxq                          AGCAGACGCGTCAACACACAAA     GGTCTCTCTGAATAAACCCAATTCC 
selyq GTTGGAAGCTAGAGCAAGACA    GCCAAGAACCCGTATTGACT 
selzq CCTACAATGTACGGACAGTGCTCTAC  GGATCATACTTAACTACTGTGCCACG 
tstq TGGTATAGTAGTGGGTCTGACGCT AGGCTGATGTGCCATCTGTGTTT 
secq AACAGTTCACCATATGAAACAGGT AGATTGGTCAAACTTATCTCCTGGT 
sellq ATCTAACGGCGCGATGTAGGTCCA   CTAAGCGGTGTGATTCTGGTGA 
segq TGCGAATGCCCTACCTGATCCTAA    TCCTCTTCCTTCAACAGGTGGAGA 
selnq CATCGTGCTTAAACGGAGAGT    ACCTTCTTGTTGGACACACCATCT 
seluq AGTTCGCCTTATGAGACTGGCT TCACCAGATTTCAGATTCAGGCATCA 
seiq GCGCAAGGAGATTGGTGTAGGT GATCAAATCATTGGGACCGGTTG 
selmq TCGTCTGTTGATGTATACGGCCT   ACCCGCTAAAGTAACTCCTCCGTA 
seloq TTGTCATGGTGAGCATCAAGTGAAA   GCTACTCCTATTTCTTTAGGTTCGT 
se26q AACGCAATGTAGTTATGGTGGTGT TCTGTTTGATGTCCGTCAATCCAT 
Cloning   
selxpET TAGCCATATGTCAACACAAAATTCCTCAA GCGCGGATCCTCAAACTTGTTCAATGTC 
selypET TAGCCTCGAGAGACACAAAATGATCCAAA GCGCCTCGAGCTACTTTTTAGTTAAGT 
Table 3.3 Primers used in this study 
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Primer  Forward sequence (5´-3´) 
a
 Reverse sequence (5´-3´) 
a
 
selzpET GCGCCATATGAAAACAACTGGATTGATTA GCGCGGATCCCTATTTCATATAAATATC 
segpET GCGCCATATGCTACCTGATCCTAA GCGCGGATCCTTATATATTCAGATTC 
seipET GCGCCTCGAGGATATTGGTGTAGGTA GCGCCTCGAGTTAGTTACTATCTACATA 
selopET GCGCCATATGAATGAAGAAAATCCTA GCGCGGATCCTTATGTAAATAAATAAAC 
selupET GCGCCATATGAATAAAGCGAGTGAAT GCGCGGATCCCTTATTTTTTGGTTAA 
T7 AAATTAATACGACTCACTATAGG GCTAGTTATTGCTCAGCGGT 
a  



























3.2.4 Transcriptional analysis of SAg genes  
 
3.2.4.1 RNA extraction from S. aureus 
Total RNA was extracted from S. aureus RF122 exponential (OD600 = 0.6) and 
stationary phase (12 h) cultures using the RNeasy miniprep kit (QIAgen, West 
Sussex, UK) as described in the manufacturer’s instructions except for re-
suspension in Tris-EDTA with 100 µg/ml lysostaphin and incubation at 37 °C for 
20 min. RNA was treated with Turbo DNase (Ambion Inc, Applied Biosystems 
(AB) Warrington UK) as described in the manufacturer’s protocol. Agarose gel 
electrophoresis of RNA samples in 2% (w/v) agarose gels was carried out to verify 
the integrity of the RNA. 
 
3.2.4.2 Reverse transcriptase - PCR (RT-PCR) 
0.5 µg mRNA from at least 3 separate total-RNA extractions were reverse-
transcribed to cDNA with Superscript III reverse transcriptase (Invitrogen), 
according to the manufacturer’s instructions. RT-PCR reactions were carried out to 
amplify transcripts A to G in a Biorad thermal cycler using PFU DNA polymerase 
(Stratagene, Agilent,  UK) with 100 ng cDNA and forward and reverse primers 
spanning adjacent genes of the egc, listed in Table 3.3. No template (NTC), no 
Reverse Transcriptase (no RT) and positive genomic DNA controls were included. 
The thermal programme was 1 cycle at 95 °C for 3 min, followed by 40 cycles at 95 
°C for 1 min, 50 °C for 1 min and 72 °C for 1 min 30 s. 
 
3.2.4.3 Quantitative Reverse Transcriptase - PCR (qRT-PCR) 
qRT-PCR reactions were performed using Superscript III Platinum qRT-PCR kit 
with SYBR Green Supermix-UDG (Invitrogen) using a Mx3000P light cycler 
(Strategene, Agilent Technologies UK Ltd. Cheshire). qRT-PCR primers were 
designed to amplify 150 to 200 bp fragments of each target gene and were 
optimised by absolute quantification with a titration of primer concentrations 
ranging from 300 nM to 600 nM in 25 µl reactions containing 1 ng  RF122 gDNA 
(Table 3.3). The thermocycling conditions were 10 min at 95 °C for 1 cycle, 20 s at 
95 °C, 20 s at 60 °C and 20 s at 72 °C for 40 cycles. The optimal primer 
concentration chosen to amplify each SAg gene transcript produced the lowest CT 
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value and highest flourescence value, with primer concentration reduced where 
possible. In each case a standard curve was generated from serial 10-fold dilutions 
of gDNA. The reaction efficiency was calculated based on the slope of the standard 
curve and expected exponential increase in the amount of template. Optimal values 
were between 90 to 110%.  
Relative values of transcription of SAg genes were obtained using gene-
specific qRT-PCR primers listed in Table 3.3 by comparative quantification to the 
internal control 16SrRNA. 16S rRNA primers have been described elsewhere (Ster 
et al., 2005). RNA samples were processed in triplicate with no template (NTC), no 
Reverse Transcriptase (no RT) and gDNA controls. Fluorescence was measured at 
the end of the annealing phase of each cycle and a threshold value for the 
fluorescence set by the MxPro qPCR software version 4.1. The reaction cycle at 
which fluorescence exceeds this threshold was identified as the threshold cycle (CT) 
and converted to relative quantity of mRNA. qRT-PCR data was analyzed using 
MxPro software version 4.1. 
 
3.2.5 Cloning and purification of recombinant SAg proteins 
Primers, plasmids and restriction enzymes used in the cloning of SAg genes from 
RF122 into the pET15b plasmid (Novagen, California, USA) are listed in Table 3.3.  
Forward primers were designed to amplify within the coding sequence of the gene, 
immediately after the signal peptide, as predicted by Signal P 3.0 Server 
(http://www.cbs.dtu.dk/services/SignalP/). Reverse primers were designed to 
overlap the stop codon of the gene. Appropriate restriction enzymes were 
incorporated to facilitate cloning. PCR reactions were carried out with forward and 
reverse primers listed in Table 3.3, using Vent polymerase (New England Biolabs, 
Herts, UK). DNA fragments were cloned into Strataclone vector pSC-B 
(Stratagene, Agilent, UK) as described in the manufacturer’s instructions. pSC-B 
plasmid DNA containing insert was isolated by miniprep (Qiagen, UK) and 
digested with the appropriate restriction enzymes (New England Biolabs, Herts, 
UK), purified using QIAquick gel extraction or PCR purification kits from QIAgen 
(West Sussex, UK), ligated with T4 DNA ligase as described in the manufacturers’ 
instructions (New England Biolabs, Herts, UK), and transformed into E.coli DH5α.  
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The resulting pET constructs were isolated from DH5α using the QIAprep 
Spin Miniprep kit (QIAgen, West Sussex, UK)  as described in the manufacturers 
instructions, and transformed into BL21 for induction. BL21 cells containing 
recombinant plasmids were induced when the cultures reached mid-exponential 
phase of growth, with 0.05 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) 
(ForMedium Ltd., Norfolk, UK) and grown for 4 h. Cells were recovered by 
centrifugation at 8000 x g, disrupted by French Press, and His-tagged recombinant 
proteins were purified by affinity chromatography on a Ni-NTA nickel affinity 
column (Invitrogen, Paisley, UK) as described in the Novagen manual. Protein 
purity was assessed by SDS-PAGE as described in General Methods.  
 
3.2.6 Western immunoblot analysis 
Recombinant proteins were resolved by SDS-PAGE and either stained overnight at 
room temperature with Coomassie Blue (Severn Biotech) or transferred to 
nitrocellulose membranes (Amersham Hybond™ ECL™, GE Healthcare, Slough, 
UK) for Western analysis as described in General Methods. The membrane was 
incubated for 1 h with primary antibody, either a 1:2500 or 1:5000 dilution of 
bovine and ovine or human patient serum respectively. The membrane was then 
incubated with secondary antibodies for 1 h at dilutions of 1:2500 goat anti-bovine 
IgG/HRP and rabbit anti-sheep IgG/HRP (horseradish perixodase conjugated), 
(Santa Cruz Biotechnology, Heidelberg, Germany), or 1:5000 polyclonal rabbit 
anti-human IgG/HRP, Dako, Cambridgeshire, UK. Human sera samples were 
obtained from infectious endocarditis patients at the New Royal Infirmary, 
Edinburgh between 2006 and 2009. Sera samples from experimental infection of 
sheep were provided by E. Vautor (Le Maréchal C, 2009). Sera samples obtained 
from cows with bovine mastitis were provided by C. Smyth, and were originally 









3.3.1 Bovine S. aureus strain RF122 encodes an array of SAg genes 
Bioinformatic interrogation of the genome of the sequenced bovine isolate of S. 
aureus, RF122 (Genbank accession number AJ938182) revealed a total of 11 SAg 
or putative SAg genes and 2 SAg pseudogenes (Table 3.4). The relative location of 
SAg genes within the genome is indicated in Figure 3.1. There are three bovine-
specific allelic variants of characterised SAg genes, tstbov, sellbov and secbov 
located on the bovine staphylococcal pathogenicity island (SaPIbov), and an egc 
encoding a further 5 bovine specific allelic variants of SAg genes seg, sei, selo, 
seln, selu and a pseudogene of selm, located on vSaβ. A further 3 genes were 
identified, SAB0321, SAB0026 and SAB2421c which display significant homology 
with the nucleotide sequence of previously characterised SAgs (Table 3.4).  
SAB0026 shares 98% nucleotide identity with a putative SAg identified in 
the capsule type 1- associated cassette chromosome element SCCcap1 of S. aureus 
strain M (Luong et al., 2002). Of note, in RF122, SAB0026 is located beside orfx 
(SAB0024), the integration site of staphylococcal cassette chromosome elements, 
but there is no SCCcap1 element present (Herron-Olson et al., 2007).  SAB2421c 
shares 58% nucleotide homology with set which encodes the newly described 
enterotoxin SET (Ono et al., 2008), and 53% nucleotide identity with pyrogenic 
exotoxin G (SPEG) of S. pyogenes. SAB0321 encodes a protein annotated as 
hypothetical in the RF122 genome, which shares 45% nucleotide homology with 
both tst and ssl7, and SAB1473c is a pseudogene of a putative SAg gene found in 
strain Newman (NWMN_1503). The predicted amino acid sequence of SAB1473c 
reveals the derived protein is truncated after 125 amino acids whereas the full 
length protein in strain Newman is 235 amino acids long. These putative novel SAg 
genes have been provisionally named selxbov (SAB0321), selybov (SAB0026), 
selzbov (SAB2421c) and se26 (NWMN_1503) according to the standard 















SAg gene (%) 
tstbov Toxic shock syndrome toxin-1 (TSST-1bov) SAB0360c 98% (tst) 
secbov Staphylococcal enterotoxin C-bovine 
(SECbov) 
SAB0363 99% (sec1) 
sellbov Staphylococcal enterotoxin like toxin L-
bovine (SElLbov) 
SAB0364 99% (sel1) 
segbov Staphylococcal enterotoxin G-bovine 
(SEGbov) 
SAB1696c 77% (seg1) 
seibov Staphylococcal enterotoxin I-bovine (SEIbov) SAB1699c 97% (sei1) 
selnbov Staphylococcal enterotoxin like toxin N-
bovine (SElNbov) 
SAB1697c 95% (sen1) 
selubov Staphylococcal enterotoxin like toxin U-
bovine (SElUbov) 
SAB1698c 97% (selu1) 
selmbov Staphylococcal enterotoxin like toxin M-
bovine (SElMbov) 
SAB1700c 87% (selm1) 
selobov Staphylococcal enterotoxin like toxin O-
bovine (SElObov) 
SAB1701c 98% (selo2) 
selxbov Staphylococcal enterotoxin like toxin X-
bovine (SElXbov) 
SAB0321 45% (tst) 
selybov Staphylococcal enterotoxin like toxin Y-
bovine (SElY) 
SAB0026 57% (seg1) 
selzbov Staphylococcal enterotoxin like toxin Z-
bovine (SElZ) 
SAB2421 58% (set) 
se26  Staphylococcal enterotoxin like toxin 26 
(SE26) 






















Figure 3.1: Relative positions of SAg genes in the S. aureus RF122 genome. 
Dark green arrows indicate bovine variants of characterised SAg genes, light green 
arrows denote putative SAg genes, and red arrows represent SAg pseudogenes. 





3.3.2 Phylogenetic analysis of SAg genes  
Staphylococcal SAg genes are known to display significant sequence homology and 
can be divided into 4 distinct groups according to their phylogenetic relatedness 
(Thomas et al., 2007, Orwin et al., 2002). Sequences of all characterised and 
putative SAg genes including allelic variants from sequenced S. aureus strains 
available in Genbank (Table 3.2), were identified by BLAST. Phylogenetic analysis 
revealed that selx belongs to Group IV, sely to group I, and selz to group II (Figure 
3.2).   
 
3.3.3 Distribution of putative SAg genes in S. aureus strains from 
humans and animals   
Investigation into the distribution of novel SAg genes selx, sely and selz was carried 
out by PCR analysis of 57 isolates from a wide range of hosts and geographical 
origins (Table 3.1). selx was found in an unusually high number of strains 
investigated, including all animal associated strains, 20 bovine, 7 ovine, 6 caprine 
and 1 swine strain (Table 3.1). selx was also present in 21 human isolates and 
absent in 2 which belong to CC30. Overall 55 of 57 (96.5%) S. aureus strains 
investigated possessed the selx gene. In contrast, sely was found in only 9 of 57 
(15.7%) strains including 3 human, 1 ovine and 5 bovine isolates. Similarly selzbov 
was detected in 11 (19.2%) strains, including 4 human, 2 ovine and 5 bovine 
isolates (Table 3.1).  
 
3.3.4 SAg genes are expressed at different levels in a growth phase 
dependent manner  
Expression levels of the putative and characterised SAg genes and pseudogenes of 
S. aureus RF122 in mid-exponential and stationary phase cultures were determined 
by qRT-PCR. Relative quantification of the level of transcription of all 11 genes 
and 2 pseudogenes, compared to an internal control, 16S rRNA was carried out. The 
results indicate that all 11 genes and 2 pseudogenes are transcribed in stationary and 
mid-exponential phase, with the highest level of transcription detected for the 
secbov gene (Figure 3.3). Overall, SAg genes located on SaPIbov were found to be 






































































































Figure 3.2: Phylogenetic analysis of all characterised staphylococcal SAg genes, 
including allelic variants from all fully sequenced genomes of S. aureus. Circles 
indicate SAgs encoded by RF122: dark green circles represent bovine variants of 
characterised SAg genes, light green circles denote putative SAgs and red circles 
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Figure 3.3: Transcription levels of RF122-encoded SAg genes from exponential 
and stationary cultures, relative to 16S rRNA. Relative quantities of RF122 
reverse-transcribed mRNA normalized to the internal control 16SrRNA, determined 
by qRT-PCR. Results shown are the means of triplicate experiments and error bars 





pseudogenes. The results also indicate that SaPIbov SAg genes and putative SAg 
gene, selxbov are upregulated in stationary phase, consistent with regulatory control 
by agr. In contrast, putative SAg genes sely and selz are transcribed maximally in 
mid-exponential phase implying a distinct regulatory control. Low level 
transcription of egc genes was detected which was independent of growth phase.  
 
3.3.5 Transcription of egc genes 
The egc genes of human S. aureus strain A900322 were previously demonstrated to 
belong to an operon by RT-PCR analysis (Jarraud et al., 2001). To determine 
whether the egc genes of RF122 are co-transcribed in a similar way, RNA was 
extracted from RF122 stationary and exponential phase cultures, converted to 
cDNA by reverse transcription, and amplified by PCR using primer pairs spanning 
adjacent genes as outlined in Figure 3.4. RT-PCR products of the expected size 
were obtained for transcripts B (seg and seln), D (selu and sei) and F (selm and 
selo) in mid-exponential phase and C (seln and selu) in both mid-exponential and 
stationary phase indicating co-transcription of these genes (Figure 3.4). In contrast, 
no RT-PCR products were obtained for the regions A and G from either phase of 
growth or B, D, E and F in stationary phase. The results indicate that in mid-
exponential phase there are two major transcripts, specific for seg, seln, selu and 
sei, and selm and selo, respectively. No transcript was obtained for the region 
spanning sei and the truncated form of selm. Northern blot experiments would be 
useful to further confirm the size of the transcripts. 
 
3.3.6 Recombinant expression of SAgs encoded by RF122 
In this study, putative novel SAg genes have been tentatively designated as selxbov, 
selybov, and selzbov. However to fulfil the standardised toxin nomenclature criteria, 
expression of the genes must be confirmed, and characterisation of the proteins 
carried out (Lina., 2004). To confirm that selxbov, selybov, selzbov encode an intact 
protein, they were cloned into pET15b, and recombinant proteins rSElXbov, 
rSElYbov, rSElZbov, proteins were expressed in E. coli and purified with the His-tag 
by Ni
2+
chelation chromatography. To further investigate the expression of SAg 
genes encoded by the egc which are transcribed by RF122 at low  
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Figure 3.4: Transcriptional architecture of egc genes a) Schematic diagram of 
the order and complement of genes within the egc of S. aureus RF122. White 
arrows indicate SAg genes and black arrows indicate pseudogenes. Analysis of egc 
transcripts was carried out by RT-PCR using cDNA prepared from S. aureus RF122 
total RNA and subjected to PCR using the schematically represented primer 
pairs A to G. + and – symbols indicate whether or not a transcript was obtained.  b) 
RT-PCR analysis of egc transcription was carried out using primer pairs A to G. 
Lane 1, non-template control (NTC); Lane 2, gDNA; Lane 3, noRT stationary 
phase; Lane 4, stationary phase cDNA; Lane 5, noRT mid-exponential phase; Lane 
6,  mid-exponential phase cDNA.  
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levels in vitro (Figure 3.3), segbov, selubov, seibov and seobov were also cloned 
into pET15b and recombinant proteins rSEGbov, rSEIbov, rSElObov and rSElUbov were 
purified. Each of the recombinant proteins resolved at their predicted molecular 
weight on a 10% SDS-PAGE gel, except for rSEGbov, which has a predicted 
molecular weight of 20.635 kDa but has been shown to resolve at around 23kDa, 
and rSEIbov which is approximately 27 kDa, larger than the predicted size of 24.6 
kDa (Figure 3.5).  
 
3.3.7 Immunogenicity of recombinant SAg proteins with sera from 
bovine, ovine and human S. aureus infections. 
To determine whether SElXbov, SElYbov, SElZbov, SEGbov, SEIbov, SElObov and 
SElUbov are expressed in vivo, Western immunoblot analysis with convalescent sera 
was carried out (Table 3.5). Sera sample 2211 obtained from a cow without a 
history of S. aureus mastitis, was included as a negative control and did not contain 
antibody reactive for any of the SAgs tested (Table 3.5). rSElXbov was reactive with 
all convalescent sera samples tested, including 5 of ovine, 4 of bovine and 5 of 
human origin, respectively indicating that an IgG response was generated against 
SElX during human, bovine and ovine S. aureus infections, consistent with an 
important role in pathogenesis. An IgG response was detected against rSElYbov with 
all 4 bovine, 2 of 5 human and 1 of 5 ovine sera samples, and rSElZ was reactive 
with 2 of 5 bovine, 2 of 5 human and 1 of 5 ovine sera samples. IgG responses 
against egc-encoded SAgs were detected in a smaller number of samples, rSElUbov 
reacted with 2 of 5 bovine and 1 of 5 ovine samples. rSEIbov was reactive with only 
one human sera sample, and rSEGbov and rSElObov were not reactive with any of the 
samples tested. For bovine sera samples 2480 and 2487, the matching S. aureus 
isolates were obtained and screened for the presence of putative SAgs selx, sely and 
selz (Table 3.1). Serum from cow 2480 contained antibodies against rSElXbov and 
rSElYbov and was obtained from a cow infected with strain T12 which harbours the 
encoding genes selx and sely. Serum sample 2487 contained antibodies specific for 
rSElXbov, rSElYbov and rSElZbov and was obtained from a cow infected with strain 



























Figure 3.5: Recombinant expression and immunogenicity of SAgs encoded by 
RF122 with sera from bovine, ovine and human S. aureus infections. 
Recombinant SAg proteins were resolved on an SDS-PAGE gel and either stained 
with Coomassie a) or detected by Western blot analysis of the immunogenicity of 
recombinant SAgs with representative b) human, c) ovine and d) bovine 
convalescent sera samples. 
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Table 3.5: Immunogenicity of recombinant SAg proteins with sera from 



















Human         
IE19 + + + - - - - 
IE37 + + + - + - - 
IE41 + - - - - - - 
IE51 + - - - - - - 
IE54 + - - - - - - 
Ovine        
011 + + + - - - + 
040 + - - - - - - 
046 + - - - - - - 
0112 + - - - - - - 
0348 + - - - - - - 
Bovine        
2480 + + - - - - - 
2487 + + + - - - - 
2521 + + + - - - + 
4227 + + - - - - + 
2211 - - - - - - - 
+ or – indicate whether or not serum samples are reactive with SAg proteins.  
a
 Human serum samples were obtained from infective endocarditis patients between 
2006-2009, New Royal Infirmary of Edinburgh. Serum samples from experimental 
infection of sheep were provided by E. Vautor (Le Maréchal C, 2009); samples 
obtained from bovine mastitis, and from Cow 2211 without a history of S. aureus 
infection were provided by C. Smyth, originally obtained from Teagasc Dairy 






Our understanding of the role of SAgs in the pathogenesis of bovine mastitis is very 
limited. However it has been proposed that they contribute to evasion of the 
immune response and enhanced persistence within the host (Ferens & Bohach, 
2000). We have identified genes encoding 8 previously characterised, 3 novel 
putative SAgs, and 2 SAg pseudogenes in the sequenced genome of the bovine S. 
aureus strain, RF122. These genes include those located on SaPIbov; secbov, sell 
and tst, and the egc genes; sei, selo, seln, selu and truncated forms of seg and selm. 
In addition 3 further ORFs displaying significant homology to known SAgs have 
been identified, SAB0321, SAB0026 and SAB2421c which have provisionally been 
designated selxbov, selybov and selzbov. The novel SAgs have been named 
alphabetically in the order of discovery, which is in accordance with the regulations 
proposed by the International Nomenclature Committee for Staphylococcal 
Superantigens (Lina et al., 2004). Previously, selw which is encoded by the egc has 
been described, but to our knowledge SElW has not yet been characterised as a 
distinct SAg (Collery & Smyth, 2007). Our data indicate that RF122 has the 
capacity to produce a larger number and wider range of SAgs than was previously 
appreciated (Fitzgerald et al., 2001a).  
All SAgs identified to date are encoded by mobile genetic elements (MGE) 
(Fitzgerald et al., 2001a, Jarraud et al., 2001, Johns & Khan, 1988, Ono et al., 2008, 
Lindsay & Holden, 2006, Ben Zakour et al., 2008). Therefore, the distribution of 
SAg genes among S. aureus strains is highly variable. Omoe et al, showed that 80% 
of human nasal isolates contain at least one SAg gene, including 50% which contain 
the egc locus and Smyth et al demonstrated that 57% of animal associated strains 
screened contained at least one SAg gene with the egc found in 30% of isolates 
(Smyth et al., 2005, Omoe et al., 2005a). These studies suggest that no single SAg 
is encoded by more than 50% of strains and that about a fifth of all strains may not 
have the capacity to produce SAgs at all. In this study the distribution of putative 
novel SAgs selx, sely and selz in a diverse range of S. aureus strains from a wide 
range of hosts was investigated (Table 3.1). selx is the most prevalent SAg gene, 
found in all isolates examined except for isolates belonging to the CC30 lineage 
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(96.5% of all S. aureus strains investigated). In contrast sely and selz were 
identified in a much lower percentage of strains, 15.5% and 18.6% respectively. 
Allelic variation of staphylococcal SAgs genes including tst, sec, seg and sei 
has been reported previously (Fernandez et al., 2006a, Jarraud et al., 2001, Thomas 
et al., 2006, Ho et al., 1989).  In this study, phylogenetic comparison of novel SAgs 
to previously identified SAg genes revealed that sely belongs to group I, selz to 
group II and selx to Group IV (Figure 3.2). Previously the only member of the most 
phylogenetically distinct group IV was tst (Thomas et al., 2007). It is noteworthy 
that RF122 has the potential to encode SAgs belonging to each of the phylogenetic 
groups, which could potentially lead to the activation of a wide array of Vβ 
subfamilies (Figure 3.2). Additionally, individual members of SAg gene clusters 
such as SaPIbov and egc SAgs belong to 3 distinct phylogenetic groups, which 
suggests an advantage for the bacteria to encode phylogenetically distinct SAgs.  
 Relative expression levels of RF122-encoded SAg genes in stationary and 
mid-exponential phase were determined by qRT-PCR, and revealed that all 
characterised and putative SAg genes and pseudogenes are transcribed in both 
phases of growth. High levels of expression of SaPIbov genes, and in particular 
secbov were detected. The egc genes were transcribed at very low levels in vitro. 
The growth phase-dependent upregulation of genes encoding SaPIbov SAgs and the 
putative SAg, SElXbov in stationary phase cultures is consistent with agr control. 
agr control of expression has previously been determined for SEB, SEC and SED 
(Gaskill & Khan, 1988, Tseng et al., 2004, Regassa et al., 1991, Derzelle et al., 
2009). In the current study, transcription of putative SAg genes sely and selz was 
also shown to be growth phase-dependent with upregulation in mid-exponential 
phase. In this study transcription of egc genes has not been shown to be growth 
phase-dependent; in contrast to a previous study which described upregulation of 
egc genes in exponential phase (Grumann et al., 2008). Our results are consistent 
with those of Derzelle et al, who have described a low abundance of egc transcripts 
produced by S. aureus strains and only a slight decrease in SAg gene transcription 
in post-exponential phase (Derzelle et al., 2009).  These results imply that SAgs 
encoded by the egc may be less important than other SAgs in S. aureus 
pathogenesis. However, these in vitro results may not reflect the situation in vivo. 
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Previously, Northern blot analysis revealed seg1 and sei1 were located on an 
unusually large transcript which suggested egc genes could be transcribed on a 
polycistronic locus (Munson et al., 1998a). egc genes of human isolate A900322 
were demonstrated to belong to an operon, by RT-PCR analysis (Jarraud et al., 
2001, Munson et al., 1998a). RT-PCR analysis of the egc region of RF122 in the 
current study indicates that egc genes segbov, selnbov, selubov and seibov are co-
transcribed, as are selm and selobov in mid-exponential phase. selnbov and selubov 
which are in close proximity are co-transcribed in both mid-exponential and 
stationary phase of growth. There is no transcript detected between seibov and the 
truncated form of selm in either phase of growth. These results indicate 
transcription of the egc in RF122 is distinct from that determined for the human 
strain, A900322 in the initial study (Jarraud et al., 2001). Sequence variation in the 
egc is commonly observed between strains (Letertre et al., 2003). The archetypal 
egc cluster identified in A900322 contains 5 SAg genes segL29P, seln1, sei1, selm1 
selo1 and 2 pseudogenes φent1 and φent2. In contrast, the egc of RF122 encodes 
selnbov, selubov, seibov, selobov, and truncated forms of selm and seg (Figure 3.4). 
Strain-dependent sequence variation of the egc between strains is likely to be 
responsible for variable transcription. Putative -35 and -10 promoter sequences, 
TTGTCT and TAATTT respectively were identified by Jarraud et al, upstream of 
the selo1 gene (Jarraud et al., 2001). At the same genomic location in RF122 the  
-35 sequence is conserved, but the -10 sequence is unique, TAGTTT. However this 
region has been predicted as a putative promoter site, using NNPP / Prokaryotic, a 
prokaryotic promoter prediction tool (Bayer College of Medicine). In addition there 
were a number of other putative -35 and -10 promoter sequences identified in the 
RF122 egc locus (data not shown), which are consistent with the transcriptional 
architecture predicted in the current study (Figure 3.4). 
Most human adults have antibodies specific for S. aureus SAgs including 
SEA, SEB, SEC, SED, SEE and TSST-1, presumably as a result of exposure to S. 
aureus during colonisation or infection (Takei et al., 1993, Ulrich, 2000). Despite 
the relatively high prevalence of the egc cluster in clinical isolates of S. aureus, 
neutralising antibodies are rare (Holtfreter et al., 2004). Importantly in this study we 
have shown that SElX, SElY, SElZ, and to a lesser extent SElU and SEI are 
expressed by S. aureus in vivo. Antibodies against each of the putative SAgs SElX, 
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SElY and SElZ have been detected in at least one serum sample of bovine, ovine 
and human origin, which suggests they are important in a range of hosts. In 
particular, an IgG response against SElX was detected in all sera samples examined. 
Taken together with the unusually high prevalence of the encoding gene, these data 
suggest an important role in staphylococcal disease pathogenesis. The results of this 
study further confirm that antibodies against egc genes are not frequently detected, 
implying a limited role for egc-encoded SAgs in human and animal infections. 

























Functional evolutionary characterisation 














In this study we have described the discovery of a putative novel SAg gene selxbov 
in the genome of the bovine S. aureus strain, RF122, and have demonstrated 
expression of the putative novel SAg in vitro and in vivo. Remarkably, we have 
discovered that the selx gene was present in 96.5% of diverse S. aureus strains 
examined, including human and ruminant strains, implying a broad role in 
pathogenesis in multiple host species. However designation as a SAg requires 
further experiments to fulfil the criteria of the International Nomenclature 
Committee for Staphylococcal Superantigens, including Vβ specific T-cell 
activation, pyrogenicity, lethality to rabbits in miniosmotic pumps and endotoxin 
enhancement (Lina et al., 2004).  
 
In this study the aim was to further investigate the function and molecular origin of 
this novel SAg, by: 
 
• Examining the molecular evolution of selx  
 
• Functional characterisation of SElX by examination of bovine T-cell 















4.2 Materials and Methods 
 
4.2.1 Bacterial strains and plasmids 
 S. aureus strains used in this study are described in Table 4.1. E. coli strains BL21 
and DH5α were used as cloning hosts. Media supplemented where appropriate with 
50 µg/ml ampicillin, and 150 µg/ml X-gal (5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside). 
 
4.2.2 DNA sequencing of selx  
gDNA was extracted from strains indicated in Table 4.1 as described in General 
Methods. PCR amplification of selx was carried out with PfuUltra II Fusion DNA 
Polymerase (Agilent, UK), using 100 nM forward and reverse primers; selxseq-F: 
TGGTAGCAAATTAAAGTTAATCAAGAG and selxseq-R: 
TGCTAATCATAACAAAGAAAGCTAGG, as described in General Methods. PCR 
products were purified using a QIAquick purification kit and sequenced by 
Genepool Sequencing Service (King’s Buildings, University of Edinburgh, UK). 
PCR amplification of selx for DNA sequencing was carried out by R. Cartwright, 
University of Edinburgh, UK. 
 
4.2.3 Phylogenetic analysis 
The sequences of selx alleles were obtained from DNA sequencing and genome 
sequence files deposited in GenBank (Table 4.2). Nucleotide and translated amino 
acid sequences were aligned by ClustalW using MEGA 4.0.1 software as described 
in General Methods. Recombination detection program RDP v3.39 was used to 
identify putative end points of recombination in selx alleles (Heath et al., 2006). 
Recombination events predicted were detected by at least 3 of 6 RDP programs 









Table 4.1: S. aureus strains used in this study 







 Human UK 8 (Duthie, 1952) 
LAC
 Ψ
 Human USA 8 (Voyich et al., 2006) 
88008
 Ψ
 Human USA 8 (Kennedy et al., 2008) 
88010
 Ψ
 Human USA 8 (Kennedy et al., 2008) 
126* Human UK 12 (Enright et al., 2000) 
MSA2389* Human Sweden 45 (Musser & Selander, 1990) 
MSA2020*
Ψ
 Human France 121 (Musser & Selander, 1990) 
MSA2965
 Ψ
 Human Canada, ET191 (Musser & Selander, 1990) 
RF103* Bovine Ireland 71 (Fitzgerald et al., 1997) 
RF31* Bovine Ireland 97 Fitzgerald J.R 
951* Bovine USA 126 (Sischo et al., 1993) 
RF287
 Ψ
 Bovine Ireland, 133 Fitzgerald J.R 
VI50901
 Ψ
 Bovine Norway 133 (Jorgensen et al., 2005) 
RF122
 Ψ
 Bovine Ireland, 151 (Fitzgerald et al., 1997) 
RF122-8 Bovine Ireland 151 Section 6.3.4 
RF113
 Ψ
 Bovine Ireland 151 Fitzgerald J.R 
ED98
 Ф
 Avian N. Ireland 5 (Rodgers et al., 1999) 
DS27 * Caprine Italy 25 (Foschino et al., 2002) 
VI50895
 Ψ
 Caprine Norway 130 (Jorgensen et al., 2005) 
ED133
 Ψ
 Ovine France, 133 (Ben Zakour et al., 2008) 
DS83 
Ψ
 Ovine Norway 133 (Mork et al., 2005) 
DS95 (1)
 Ψ
 Ovine Denmark 706 (Mork et al., 2005) 
VET-BZ30
 Ф
 Ovine Brazil, 750 (Aires-de-Sousa et al., 2007) 
B40* Swine Hong Kong 9 (Guardabassi et al., 2009) 



















MSSA476 NC_002953.3 1 + SAS0347 
MW2 NC_003923.1 1 + MW0345 
TCH70 ACHH01000007.1 1 + 12962-12351 
N315 NC_002745.2 5 + SA0357 
Mu50 NC_002758.2 5 + SAV0370 
Mu50_omega BABM01000001.1 5 + 415121-415732 
Mu3 NC_009782   5 + SAHV_0367 
CF marsielle CABA01000104.1 5 + 34300-33689 
MR1 ACZQ01000042.1 5 + 21763-21152 
ED98 NC_013450.1 5 + 377804-378415 
A10102 ACSO01000006.1 5 + 79351-79962 
A5937 ACKC01000031.1 5 + 354030-354641 
A6224 ACKE01000012.1 5 + 48160-48771 
A9781 ACKL01000029.1 5 + 9191-9802 
A6300 ACKF01000002.1 5 + 53512-54123 
A9299 ACKH01000031.1 5 + 89178-88567 
A9719 ACKJ01000043 5 + 261259-261870 
A8155 ACKG01000031.1 5 + 261394-262005 
A9763 ACKK01000029.1 5 + 89367-88756 
A5948 ACKD01000059.1 8 + 35867-35256 
TCHFPR3757 NC_007793.1 8 + SAUSA300_0370 
USA300 
TCH1516 
NC_010079.1 8 + USA300HOU_039
2 
Newman NC_009641.1 8 + NWMN_0362 
NCTC8325 NC_007795.1 8 + SAOUHSC_00354 
132 ACOT01000013.1 8 + 85792-86403 
D30 ABFB01000008.1 8 + 27371-26760 
930918-3 ABFA01000030.1 8 + 34590-33979 
Table 4.2: Distribution and coordinates of selx in sequenced S. aureus genomes.  
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D139 ACSR01000010.1 10 + 3446-4057 
NOH4 Sanger 22 slv + NK 
EMRSA-15 Sanger 22 + NK 
A9635 ACKI01000032.1 45slv + 90134-90562 
TCH60 ACHC01000008.1 30 - N/A 
MRSA252 NC_002952.2 36 - N/A 
M876 ACJV01000012.1 30 - N/A 
MN8 ACJA01000076.1 30 - N/A 
TCH130 ACHD01000271.1 72 + 27060-27671 
JH1 NC_009632.1 105 + SaurJH1_0429 
JH9 NC_009487.1 105 + SaurJH9_0419 
RF122 NC_007622 151 + SAB0321 
058                                                     
2/TW20 
FN433596.1 239 + 467388- 467999 
 
JKD6008 ABRZ01000012.1 239 + 5328-5939 
JKD6009 ABSA01000060.1 239 + 5327-5938 
COL NC_002951.2 250 + SACOL0442 















4.2.4 Transcriptional analysis of selx.  
Total RNA was extracted from S. aureus strains RF122, LAC and ED133 
exponential (OD600 = 0.6) and stationary phase (12 h) cultures using the RNeasy 
miniprep kit (QIAgen, West Sussex, UK) as described in the manufacturer’s 
instructions except for re-suspension in TE buffer with 100 µg/ml Lysostaphin and 
incubation at 37 °C for 20 min. RNA was treated with Turbo DNase (Ambion Inc, 
Applied Biosystems (AB) Warrington UK) as described in the manufacturer’s 
protocol. 0.5 µg mRNA from at least 3 separate total-RNA extractions were 
reverse-transcribed to cDNA with the Power SYBR® Green RNA-to-CT 2-Step Kit 
(AB, Warrington, UK) as described in the manufacturer’s protocol.  
To quantify cDNA generated by reverse transcription from target RNA, 
qRT-PCR reactions were carried out in 25 µl reactions containing 50 ng of cDNA, 
300 nM selxq and 16S rRNA primers (Table 3.3), and SYBR Green I dye master 
mix (AB, Warrington, UK), in a Stratagene Mx3000P light cycler (Strategene, 
Agilent Technologies UK Ltd. Cheshire). Relative values of transcription of selx 
was determined by comparative quantification to the internal control 16SrRNA. The 
thermal conditions were: 10 min at 95 °C for 1 cycle, 20 s at 95 °C, 20 s at 60 °C 
and 20 s at 72 °C for 40 cycles. RNA samples were processed in triplicate with no 
template (NTC), no Reverse Transcriptase (no RT) and positive genomic DNA 
controls. Fluorescence was measured at the end of the annealing phase of each 
cycle and a threshold value for the fluorescence set by the MxPro qPCR software 
version 4.1. The reaction cycle at which fluorescence exceeds this threshold was 
identified as the threshold cycle (CT) and converted to relative quantity of mRNA.  
 
4.2.5 Cloning and purification of recombinant SElX variants.  
selx alleles, selxov and selx2 from strains ED133 and Newman respectively, were 
cloned into the pET15b plasmid as described for selxbov in Section 3.2.5, using 
selxpET primers listed in Table 3.3. Protein purity was assessed by SDS-PAGE. 
Samples were dialysed using Spectra/Por
®
Float-A-Lyzer tubing with 8 to 10 kDa 
MWCO (Spectrum Laboratories, Fischer Scientific, Leicestershire, UK) 
Lipopolysaccharide (LPS) was removed by affinity chromatography with Detoxi 
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Gel endotoxin removal gel as described in the manufacturer’s instructions (Pierce, 
Thermo Fisher Scientific, Northumberland, UK).  
 
4.2.6 Concentration of secreted S. aureus proteins 
S. aureus strains selected to represent a diverse host range (Table 4.1) were grown 
in 10 ml TSB until stationary phase. Cultures were centrifuged at 4000 x g for 20 
min and supernatant fractions were concentrated with Amicon Ultra-15 Centrifugal 
Filter units (10 kDa MWCO) as described in the manufacturers instructions 
(Millipore, Watford, UK). 
 
4.2.7 Western immunoblot analysis.  
Recombinant proteins and concentrated secreted proteins were seperated by SDS-
PAGE and transferred to nitrocellulose membranes (Amersham Hybond™ ECL™, 
GE Healthcare, Slough, UK) as described in General Methods. The membrane was 
then incubated for 1 h with sera samples diluted 1:2500 (bovine and ovine), or  
1:5000 (human) in washing buffer, or 2 h with 1:1500 dilution of rat antisera raised 
against rSElXbov. Membrane was washed and incubated with secondary antibodies 
for 1 h at dilutions; 1:2500 (Goat anti-bovine IgG/HRP, and rabbit anti-sheep 
IgG/HRP, Santa Cruz Biotechnology, Heidelberg, Germany), 1:5000 (Polyclonal 
rabbit anti-human IgG/HRP, Dako, Cambridgeshire, UK), or 1:1500 (Goat 
polyclonal antibody to rat IgG/HRP, Abcam, Cambridge, UK). Membrane was 
washed as before and visualised by enhanced chemiluminescene (ECL). Sera 
samples were obtained as described in Section 3.2.6. Semiquantitative spot 
densitometry was carried out with the ChemiImager 4000i.V4 program, by use of a 
MultiImager light cabinet (Alpha Innotech). 
 
4.2.8 Bovine T-cell proliferation assays  
Blood was obtained from Holstein–Friesian cattle, animals 1683 and 1693, aged 18 
to 36 months via jugular vein venupuncture. Animals were reared indoors and 
maintained on a ration of hay and concentrates. PBMC were isolated from blood by 
density gradient centrifugation as described in General Methods, and stimulated 
with ten-fold dilutions (10 µg/ml to 1 fg/ml) at least in triplicate of rSElX variants. 
Culture media and 50 µg/ml Concanavalin A were used as negative and positive 
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controls respectively. Proliferation of Bovine PBMC was assessed by a [
3
H]-
thymidine incorporation assay as described in General Methods. Total RNA was 
extracted from bovine PBMC (4 × 106 cells) prior to stimulation or after stimulation 
with rSElX proteins (1 µg/ml) for 96 h, using Tri-reagent (Sigma–Aldrich, Dorset, 
UK) as described in the suppliers instructions. Vβ-dependent T-cell activation in 
response to rSElX variants was determined using the qRT-PCR bovVβ assay 
described in Section 5.2.5. 
 
4.2.9 Protein structural modelling 
Translated nucleotide sequences of selx2, selxbov and selxov were modelled using 
Phyre (Kelley & Sternberg, 2009). Predicted 3D structures were were generated for 
SElX2, SElXbov and SElXov using the crystal structure of TSST-1 as a template, 

























4.3.1 selx is encoded by the majority of S. aureus strains 
Bioinformatic interrogation of 45 publicly available S. aureus genomes for the 
presence of selx was carried out by BLASTx analysis. In addition to the 57 isolates 
previously examined by PCR (Table 3.1), the strains (n = 102) represent the full 
breadth of species diversity and include the most important human and animal 
pathogenic clones. Remarkably, of the 102 isolates, 96 (94%) contained the selx 
gene which included all strains examined except isolates of the CC30 clonal 
complex (Table 3.1 and Table 4.2). BLASTx analysis also revealed the absence of 
selx in other staphylococcal species. The high prevalence of selx in S. aureus strains 
is unique, and indicative of core-genome location.  
Analysis of the genomic location of selx amongst sequenced strains representing 
diverse STs (ST1, 5, 8, 10, 45slv, 72, 105, 133, 151, 239, 250 and 1159) (Table 4.2) 
revealed that selx is located at an identical chromosomal site in all strains 
examined. Specifically, it is located about ~400 kb from the origin of replication in 
the oriC environ among a cluster of 4 genes specific for S. aureus including a 
predicted integrase pseudogene and 2 genes encoding hypothetical proteins of 
unknown function (Figure 4.1). The cluster is flanked by conserved genes encoding 
ribosomal proteins and a DNA-binding protein involved in DNA replication 
(Figure 4.1) which are located at the same genomic location in other staphylococcal 
species such as Staphylococcus epidermidis (Figure 4.1). The genetic linkage of 
selx with an integrase pseudogene, its wide distribution across the full breadth of S. 
aureus species diversity, and its absence in the genome of other staphylococcal 
species indicates an ancient horizontal acquisition which may have occurred during 
S. aureus speciation.  The existence of a single S. aureus clonal complex (CC30) 
which does not contain selx but contains the adjacent integrase pseudogene at the 
same chromosomal site, is consistent with a deletion event in a progenitor of the 

















Figure 4.1. Genomic location of selx in S. aureus. selx is depicted by a red arrow, 
the integrase pseudogene is depicted with a blue arrow, conserved staphylococcal 
genes conserved genes encoding ribosomal proteins and a DNA-binding protein 
involved in DNA replication are indicated by black arrows, and white arrows 






4.3.2 selx exhibits species-wide allelic variation and evidence for 
assortive recombination 
 To examine the allelic variation of selx among S. aureus strains representing the 
breadth of species diversity, DNA sequencing of selx was carried out for 9 S. 
aureus strains of ST 9, 12, 25, 45 slv, 97, 121 and 126, indicated in Table 4.1 and 
compared to the sequence of selx for 41 strains available in Genbank (Table 4.2). 
selx contained a total of 8.27% variable nucleotide sites and was represented by 14 
distinct allelic variants encoded by human and animal strains, designated selx1-11, 
selxbov1, selxbov2 and selxov, respectively.  
In general, strains belonging to each clonal complex encode a unique selx 
allele (Figure 4.1b) consistent with point mutation being the major driving force for 
evolution within individual lineages. However, 2 alleles, selx2 and selx5 were 
associated with multiple clonal complexes indicating that assortive recombination 
of the selx gene has contributed to the distribution of the selx locus in some strains. 
Specifically, selx2 was identified in ST12 and CC8 strains, and selx5 was encoded 
by ST1 and ST72 strains, respectively. In addition, examination of the role of 
recombination in selx diversity employing the RDP3 suite of detection programs 
(Heath et al., 2006) revealed evidence for at least 2 distinct recombination events 
leading to hybrid alleles of selx (Figure 4.3). Furthermore, a phylogenetic tree 
based on selx gene sequences has a topology which was very distinct from the 
phylogenetic tree derived from concatentated MLST loci (Figure 4.2). Taken 
together, these data suggest that recombination has contributed to the species-wide 
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Figure 4.2: Phylogenetic analysis of selx and its species-wide distribution. a) 
Neighbour-joining tree based on all known staphylococcal SAgs and SAg-like 
protein ssl7 showing their relatedness to selx. b) Neighbour-joining tree of 
concatenated MLST sequences of representative S. aureus STs representing the 
breadth of species diversity. Coloured circles denote the presence of specific selx 
alleles. c) Neighbour-joining tree of all selx alleles identified in this study. 
























Figure 4.3 Predicted recombination sites identified in selx alleles. 
Recombination events and their breakpoints were detected by RDP v3.39 software 
and those with significant P value, P<0.05 in at least three of seven recombination 






4.3.3 SElX is expressed by clinical isolates in vitro and during human, 
bovine and ovine infection 
In Section 3.3.4 we described growth-phase dependent transcription of selx by 
bovine S. aureus strain RF122. To investigate whether the transcription of 
representative clinical isolates of human and ovine origin, LAC and ED133 was 
similar to RF122, qRT-PCR was carried out. selx was transcribed by each strain in 
a growth-phase dependent manner with highest expression during stationary phase 
(Figure 4.4). To further investigate the in vitro expression of SElX we carried out 
Western blot analysis with stationary phase culture supernatants of 15 clinical 
isolates of human, bovine, and ovine origin using rat anti-sera specific for rSElXbov 
which was generated by Keun Seok Seo at the University of Idaho.  Expression of 
SElX was detected in 14 of 15 isolates in total including 6 of 6 human strains 
isolated from sepsis, Scalded Skin Syndrome and infective endocarditis patients, 4 
of 4 bovine mastitis, 3 of 4 ovine mastitis and 1 caprine mastitis isolate, indicating 
that SElX is made by most clinical isolates at detectable levels in vitro (Figure 4.4 
and Table 4.1).   
To determine whether SElX is expressed during human and animal 
colonization or infection, Western immunoblot analysis was carried out with 
recombinant SElX human, bovine and ovine variants and sera from humans, cows 
and sheep recovering from S. aureus infections. All 5 human, 4 bovine and 5 ovine 
sera samples contained antibody which cross-reacted with the SElX recombinant 
proteins but not with recombinant SElO SAg suggesting that SElX is made during 
S. aureus colonization or infection of humans and animals and stimulates a humoral 
immune response. Of note, densitometric analysis of SElX immunoreactive bands 
indicated a approximate 2-fold lower affinity of human and bovine IgG for SElXov 
in comparison to ovine IgG suggesting that SElXov has structural differences 
leading to distinct epitopes which are less reactive with human and bovine IgG 
(Figure 4.4). The expression of SElX during infection of humans and animals 












Figure 4.4. SElX is expressed by clinical isolates in vitro and during infection. 
a) Growth-phase dependent transcription of selx. Relative quantities of RF122 
reverse-transcribed mRNA normalized to the internal control 16SrRNA, determined 
by qRT-PCR. Results shown are the means of triplicate experiments and error bars 
indicate ± S.D. b) Western blot analysis of concentrated S. aureus supernatants of 
strains ED133, RF122 and LAC separated by SDS-PAGE with antibody specific for 
SElXbov. c) Immunogenicity of rSElX proteins with human infective endocarditis 
convalescent sera. Lane 1, rSElXh; lane 2, rSElXov; and lane 3, rSElXbov.  
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4.3.4 SElX demonstrates Vβ-dependent mitogenicity  
In addition to the recombinant bovine variant of SElX (rSElXbov) purified in 
Section 3.3.6, human (rSElX2) and ovine (rSElXov), variants of SElX were purified 
and used to stimulate bovine PBMCs in a thymidine incorporation assay. rSElXbov 
and rSElXov were mitogenic for bovine T-cells at concentrations as low as 0.01 
pg/µl, whereas  rSElX2 required a 10-fold higher dose of 0.1 pg/µl to induce 
proliferation of bovine T-cells (Figure 4.5). The bovVβ activation profile of each 
SElX variant was determined using the qRT-PCR assay described in Section 5.3.4 
(Table 4.3).  All SElX variants stimulated bovVβ subfamilies 3, 11, 17, 24 and X. 
In addition SElXov activated bovVβ 16, SElXbov activated bovVβ 5 and 16, and 
SElX2 activated bovVβ 5 and 6. Importantly, theses results demonstrate differences 
in mitogenic activity and distinct Vβ activation profiles for different SElX variants 
made by S. aureus strains associated with different host species. 
 
4.3.5 SElX has a unique predicted SAg structure 
SElX shares 30% and 27% amino acid identity with its closest homologs, SSL7 and 
TSST-1, respectively. To investigate the predicted structure of the novel SAg, 
SElX, we carried out structural modelling using the program Phyre (Kelley & 
Sternberg, 2009) with crystal structures of the most closely-related proteins in the 
database (TSST-1 or SSL7) as a template. The predicted structures of SElX variants 
indicate their potential to form a characteristic 2 domain SAg structure comprising 
a long central α-helical domain A with a C terminal β grasp motif, and a B domain. 
However the B domain of SElX is considerably smaller than the B domain for 
previously characterised SAgs, and lacks an N-terminal OB fold (Figure 4.6). The 
OB fold is involved in TSST-1 binding to the α-chain of the MHC class II complex 
on APC (Dinges et al., 2000, McCormick et al., 2003). The functional implications 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure: 4.5. Vβ-dependent T-cell activation of bovine PBMC cultures.  
a) Proliferation of PBMCs in response to stimulation with SElXbov, SElX2, or 
SElXov after [3H]-thymidine incorporation.  Relative fold-change in Vβ expression 
(mean ± S.E.M.) after stimulation with a final concentration of 1 µg/ml, b) SElX2,  
c) SElXbov and d) SElXov for 4 d. Results shown are the means ± S.E.M. of three 























Table 4.3: Activation of bovVβ subfamilies in response to rSElX variants.  
 
SElX variant Bovine Vβ
a, b
 
SElX2 3, 5, 6, 11, 17, 24, X 
SElXbov 3, 5, 11, 16, 17, 24, X 
SElXov 3, 11, 16, 17, 24, X 
a
 bovVβ subfamilies were named according to the nomenclature system described 
by Arden et al (Arden et al., 1995).  
b
 bovVβ subfamilies activated in response to the all SElX variants are highlighted 
















Figure 4.6: Schematic diagram of the solved structures of TSST-1, SSL7 and 
modelled structures of human, bovine and ovine variants of SElX. Structural 
domains A and B are indicated. SElX composite structure was obtained by 


























4.4 Discussion  
We have identified the first SAg encoded by the great majority of S. aureus strains. 
The distribution of selx across the full breadth of S. aureus diversity, its absence 
among other staphylococcal species and its genetic association with a gene 
encoding an integrase indicates an ancient horizontal acquisition event which 
happened prior to the most recent common ancestor of the S. aureus species. The 
gene is absent from only a single clone examined (CC30) but the associated 
integrase gene is retained suggesting that a deletion event has resulted in the loss of 
selx from a progenitor of the CC30 clone. Of note, previous studies have discovered 
that the majority of CC30 isolates contain a SaPI which encodes TSST-1, the most 
closely-related SAg to SElX and the only other member of the phylogenetic group 
IV of staphylococcal SAgs (Lindsay et al., 2006, Holden et al., 2004). These data 
imply that virtually all S. aureus isolates have the capacity to produce a 
phylogenetic group IV SAg suggesting an important role in disease pathogenesis. 
The gene appears to have undergone lineage-specific diversification leading to at 
least 14 different allelic variants identified among the strains examined (Figure 
4.2).     
 Although SElX is the first S. aureus SAg identified in the core genome, the 
streptococcal SAg, SMEZ is found in the great majority of Group A Streptococci 
isolates, and exhibits extensive allelic variation leading to antigenic variation. 
However, SMEZ allelic variation does not influence Vβ-specificity or mitogenicity 
(Proft et al., 2000). Whereas GAS is specific for human hosts, S. aureus is 
represented by both human, and animal clones which are most likely the result of 
human to animal host jumps followed by adaptive genome diversification (Lowder 
et al., 2009). In contrast to SMEZ, SElX bovine- and ovine-specific variants 
displayed increased mitogenicity and a distinct Vβ profile for bovine lymphocytes 
in comparison to a human SElX variant suggesting that they have undergone 
adaptive diversification leading to enhanced activity in ruminants.   
 The response of human Vβ activation in response to stimulation with SElX 
variants was also determined in collaboration with Dr Keun Seok Seo and Prof. 
Greg Bohach of the University of Idaho (Table 4.4). HumVβ subfamilies 1, 6, 18 
and 21 are activated by rSElXbov and rSElX2; however rSElXov activates HumVβ 1, 
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6 and 18 only (data not shown). These data indicate a unique pattern of Vβ gene 
activation for SElX in comparison to other previously characterised SAgs (Seo et 
al., 2010, Thomas et al., 2009). The activation profiles of human and bovine Vβ 
subfamilies in response to activation with SElX are distinct. This is in part due to 
the activation of humVβ subfamilies 18 and 21, for which there are no bovine 
orthologs, and bovVβ X which has no human ortholog. However, the orthologous 
HumVβ 6 and bovVβ 6 are both activated by SElX2.  In addition the activated 
bovVβ subfamilies 8 and 16 are phylogenetically similar to HumVβ 6. Of note, 
humVβ 1 and the closely related bovVβ 5 were activated but not the orthologous 
bovVβ 1. However, it cannot be ruled out that other SElX variants made by human 
strains would have a similar functional activity for bovine lymphocytes. Previously, 
it was shown that the proliferation of human and bovine lymphocytes varied in 
response to stimulation with allelic variants of the SAg SEC. SECbov requires 
between 10 and 100-fold more toxin than SEC1 and SECov to induce proliferation 
of human or bovine PBMCs, and different Vβ-dependent T-cell activation profiles 
were observed (Deringer et al., 1997, Marr et al., 1993). 
 In addition to mitogenicity, in collaboration with Prof. Pat Schlievert of the 
University of Minnesota, Minneapolis, we have tested the pyrogenicity, lethality, and 
enhancement of endotoxic shock in rabbits of a representative variant rSElX2 (data 
not shown). Pyrogenicity of rSElX2 was examined in 5 rabbits after 24 h at a dose of 
0.2 mg/kg. Of the 5 rabbits, 4 died within 7 d (P=0.047). In addition rSElX2 
stimulated enhancement of endotoxic shock. Taken together, rSElX2 demonstrated 
functional characteristics required for classification as a SAg including mitogenicity, 
pyrogenicity and endotoxic shock enhancement. Additionally it would be desirable 
to confirm that SElX binds to MHC class II and activates T-cells without antigen 
processing. 
Although most allelic variation in selx is clonal and due to point mutations, 
we found evidence of a role for recombination in the diversification of SElX 
including whole gene transfer of the selx allele between 2 different pathogenic 
clones. Although recombination rates are predicted to be low in S. aureus in general 
(Feil et al., 2003), evidence for recombination, particularly among genes involved 
in virulence has been observed previously (Robinson et al., 2005, Watanabe et al., 
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2009). Such rapid evolution may facilitate antigenic or functional diversification of 
proteins which are critical for pathogenesis.  
                    Analysis of selx transcription levels revealed a growth phase-
dependent expression by each strain analogous to numerous other staphylococcal 
virulence proteins which are under the control of the agr. Of note, the human CA-
MRSA USA300 strain LAC had very high levels of expression of SElX which 
correlates with the previously reported up-regulation of RNAIII and secreted 
virulence proteins by the USA300 epidemic clone (Li et al., 2009). The USA300 
epidemic clone is a major cause of mortality and morbidity in the USA and unlike 
most strains of hospital-acquired MRSA can cause disease in otherwise healthy 
individuals (DeLeo et al., 2010). The molecular basis for the increased virulence of 
USA300 strains is the subject of intensive research efforts. Several reports have 
highlighted the high levels of expression of secreted proteins such as PVL, α-toxin, 
and phenol-soluble modulins as a possible cause of the increased severity of 
infection associated with USA300 strains (Li et al., 2009, Montgomery et al., 
2008). Our data reveal a novel putative virulence factor made at high levels by 
USA300 strains which may contribute to its characteristic enhanced virulence.  
In addition to demonstrating the in vitro expression of SElX by most S. 
aureus strains, we also identified SElX-specific antibodies in convalescent sera 
samples from humans, and ruminants. Due to the lack of pre-infection sera samples 
we cannot rule out the possibility that antibodies were induced during 
asymptomatic colonization of human or animal hosts rather than during disease 
pathogenesis. Nonetheless, our data indicate a broad role for SElX in S. aureus 
colonization or infection of multiple host species.  
Structural modelling revealed SElX has the potential to form the characteristic 2 
domain SAg structure. However domain B of SElX is predicted to be much smaller 
than that of other SAgs identified to date (Figure 4.6). Ongoing crystallography 
analyses should result in important insights into the molecular interaction of the 
uniquely structured SElX with its ligands which may facilitate the design of 
molecules to inhibit its function. Because of their importance in the pathogenesis of 
severe infection and their potential as an agent of biological warfare, therapeutic 
strategies which target SAgs have been the focus of considerable research efforts 









Table 4.4: Activation of human and bovine Vβ subfamilies in response to 
rSElX variants.  
 





SElX2 1, 6, 18, 21 3, 5, 6, 11, 17, 24, X 
SElXbov 1, 6, 18, 21 3, 5, 11, 16, 17, 24, X 
SElXov 1, 6, 18 3, 11, 16, 17, 24, X 
a
 Vβ subfamilies were named according to the nomenclature system described by 
Arden et al (Arden et al., 1995).  
b

















vaccination, passive immunization, peptide antagonists and receptor mimics have 
been developed with limited success (Fraser & Proft, 2008). Importantly, the 
diversity of SAgs made by different strains and their distinct Vβ-dependent binding 
activities has complicated efforts to design broadly effective therapeutics.  
In summary, we have discovered a novel SAg made by the great majority of 
S. aureus clinical isolates which is involved in immune modulation during human 
and animal infections. The discovery may have important implications for our 




























Comprehensive analysis of bovine T-cell 















Vβ specific activation of human T-cells in response to staphylococcal SAgs has 
been well characterised (Seo et al., 2010, Thomas et al., 2009, Ono et al., 2008), 
but the bovine T-cell response to SAgs is poorly understood. Previously, SEC and 
TSST-1 have been shown to induce Vβ specific proliferation of bovine T-cells 
(Deringer et al., 1997, Deringer et al., 1996, Fitzgerald et al., 2001a). However 
these studies were limited by the number of TRBV gene sequences available, and 
only 5 subfamilies VB1, 2, 4, 13, and 28 were included. The recent bovine genome 
sequencing project and cDNA analyses led to the identification of the full 
complement of bovine Vβ subfamilies and almost the entire repertoire of bovine 
TRBV genes (Connelley et al., 2009, Elsik et al., 2009). This has facilitated the 
development of qRT-PCR assay to study the bovVβ response to stimulation with 
staphylococcal SAgs. 
 
The aim of this study was to investigate the effect of SAgs on the bovine T-cell 
response by: 
 
• Examining mitogenic potential of RF122-encoded SAgs for bovine T-cells. 
 












5.2 Materials and Methods 
 
5.2.1 Bacterial strains and plasmids  
Bacterial strains and plasmids used are shown in Table 5.1. Media were 
supplemented where appropriate with chloramphenicol at 10 µg/ml (S. aureus) or 
200 µg/ml (Escherichia coli), 50 µg/ml ampicillin, and 150 µg/ml X-gal. 
 
5.2.2 Cloning of SAg genes into expression plasmid pALC2073 
Primers were designed to amplify RF122-encoded SAg genes for cloning into the 
expression plasmid pALC2073. Each 5´ oligo was designed to prime upstream of 
the predicted ribosome binding site (RBS) with a KpnI site incorporated to facilitate 
cloning. The 3´ primer was designed to include the stop codon of the gene with a 
SacI site incorporated. A schematic diagram of the cloning procedure is presented 
in Figure 5.1. PCR reactions were carried out as described in General Methods with 
100 nmol forward and reverse primers, as listed in Table 5.2, using 1 U Vent 
polymerase (New England Biolabs, Herts, UK). PCR products were cloned into the 
pSC-B blunt cloning vector as described in the manufacturer’s instructions 
(Stratagene, Agilent, UK). SAg gene inserts were released from the pSC-B 
plasmids by digestion with SacI and KpnI for 3 h at 37 °C, purified by gel 
extraction, ligated with digested pALC2073 plasmid DNA using T4 DNA ligase, 
and transformed into E.coli DH5α. The resulting pALC2073::SAg plasmids were 
isolated from DH5α and transformed by electroporation into an intermediate 
electrocompetent strain of S. aureus, RN4220. Subsequently the plasmids were re-
isolated and transformed into the SAg and α toxin-deficient strain RF122-8α, the 
construction of which is described in Section 6.3.1. 
 
5.2.3 Expression of SAg proteins in RF122-8α 
 RF122-8-α strains containing each of the pALC2073::SAg constructs were induced 
with 50 ng/ml, a sub-inhibitory concentration of tetracrycline (Sigma-Aldrich, 




Table 5.1: Bacterial strains and plasmids used in this study 
Strain or plasmid Description  Source/Reference 
S. aureus   
RN4220 Restriction/modification
- 
(Kreiswirth et al., 1983) 
RF122 Bovine mastitis (Fitzgerald et al., 2000) 



































































RF122-8α-Z RF122-8α containing 
pALC2073::SElZbov 
This study 
          E. coli   




 lacZ∆M15 mutation, endA, 
recA deficient 
Stratagene 




pSK236 containing the 
tetR gene and the xyl/tetO 
promoter 








pALC2073::SElLbov sellbov cloned into 
pALC2073 
This study 
































Strain or plasmid Description Source/Reference 
pALC2073::SElYbov 
 












































Table 5.2: Primers used to clone SAg genes encoded by RF122 into the SacI 
and KpnI sites of pALC2073.  
Primer 
a




























  F, forward primer, R, reverse primer. 
 
b
































Figure 5.1: Schematic diagram of the procedure used to clone SAg genes 






4 h (Bateman B.T et al, 2001). Cells were centrifuged at 4000 x g and supernatant 
fractions containing secreted proteins were removed and concentrated with Amicon 
Ultra-15 Centrifugal Filter units with a 10 kDa MWCO as described in the 
manufacturers instructions (Millipore, Watford, UK). RF122-8α containing 
pALC2073 was used as a negative control for induction. Concentrated secreted 
proteins were separated on 10% SDS-PAGE gels, stained overnight at room 
temperature with Coomassie Blue (Severn Biotech), or transferred to Nitrocellulose 
membranes (Amersham Hybond™ ECL™, GE Healthcare, Slough, UK) for 
Western blot analysis. The membrane was incubated with primary antibody for 1 h 
with 1:2500 dilution of anti-SEC (Santa Cruz Biotechnology, Heidelberg, 
Germany), or 2 h with a 1:2000 dilution of rat antisera specific for rTSST-1, rSElL, 
or rSElXbov (provided by K.S Seo, University of Idaho). Membrane was incubated 
with secondary antibody for 1 h at dilutions; 1:2500 (Rabbit anti-mouse IgG, 
Zymed, Invitrogen, UK), or 1:1500 Goat polyclonal antibody to rat IgG/HRP, 
(Abcam, Cambridge, UK), and visualised by ECL.  
 
5.2.4 T-cell proliferation assays 
Blood was obtained from Holstein–Friesian cattle, animals, 851, 1683 and 1693 
aged 18 to 36 months via jugular vein puncture, and PBMC were isolated by 
density gradient centrifugation as described in General Methods. PBMC adjusted to 
a concentration of 1 × 106 cells/ml in complete cell culture medium, were 
stimulated in triplicate at least with 10-fold dilutions (0.01 ng/ml to 100 ng/ml) of 
concentrated S. aureus supernatant fractions. Culture media and 50 µg/ml 
Concanavalin A were used as negative and positive controls respectively. 
Proliferation of Bovine PBMC was assessed by [
3
H]-thymidine incorporation assay 
or FACS analysis of CFSE stained cells as described in General Methods.  
 
5.2.5 Analysis of Vβ T-cell activation 
Total RNA was extracted from bovine PBMC (4× 106 cells) using Tri-reagent 
(Sigma–Aldrich, Dorset, UK) as described in the suppliers instructions. First-strand 
cDNA was generated from 0.5 µg of RNA using Power SYBR® Green RNA-to-CT 
2-Step Kit (Applied Biosystems, Warrington, UK). The reverse transcription 
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reaction was performed in a 20 µl volume according to the manufacturer’s 
specifications.  Bovine Vβ subfamily specific qRT-PCR primers were designed 
with Primer3 (Rozen, 2000), based on an alignment of bovine Vβ sequences. cDNA 
sequences for bovine TRBV genes were derived from the bovine genome and 
cDNA analyses described by Connelley et al (Connelley et al., 2009). To quantify 
cDNA generated by reverse transcription from target RNA, qRT-PCR reactions 
were carried out in 25 µl reactions containing 100 ng cDNA, 100 nM primers 
(Table 5.3), and SYBR Green I dye master mix (AB) as per the manufacturers 
instuctions, using a Stratagene Mx3000P light cycler. The thermal conditions were: 
1 cycle at 50 °C for 10 min, 1 cycle at 95 °C for 10 min, 15 s at 95 °C and 1 min at 
60 °C for 40 cycles. RNA samples were processed in triplicate with NTC and no 
RT controls.  
qRT-PCR data were analyzed using MxPro software version 4.1 
(Strategene, Agilent Technologies UK Ltd. Cheshire). The threshold cycle (CT) was 
determined and normalized to internal controls, β-actin and Constant β (Cβ), by 
calculating ∆CT [CT target - CT β-actin- CT (β-actin – Cβ)). Specificity of the qRT-PCR 
products was determined by melt curve analysis. Normalized ∆CT data were then 
compared by calculating ∆∆CT =  -(∆CT stimulated - ∆CT of unstimulated). Values 
>0 reveal expansion of particular subset, whereas values equal to or < 0 reveal non 
expansion of particular subset by stimulation with concentrated RF122-8α 
















Vβ subfamily     Forward Sequence (5’-3’) Reverse Sequence (3’-5’) 
Vβ 1 (9) CTGATCAAATCAAGAAAASCAGCAAG CTGAGTCTGYCAGCTCCAAG 
Vβ 2 (20) CGCTCTCGTCTCTCAGCAG TAACCTTGTTCGTATGTGGCATC 
Vβ 3 (28) GCTGCTCCATTTCTCAATCGA GGCACATCCCCTTCCTCAA 
Vβ 4 (29) CTCCTGGGACTGGGTTCTG AGCCCTGATTGGCAGTAGC 
Vβ 5 (5) CCTATGTCTGGACACAGCAGTG TCGAAAAGTTTCCTTTAGCTCTTTG 
Vβ 6 (7) GGGAGGGGCCAGACTGTAA TTTAGGCATYCCTGATTTGTC 
Vβ 7 (4) CTCAGATACCAAAATACCTAGTCATG GAACACTCTCATTTCCAGTGAGTTTC 
Vβ 8 (12) GTCACTCTGAGTTGTGAGCYGA CCGACTCATCAATAGGAGCTTG 
Vβ 9 (3) CCTCACACAGATGGGAACTAAGAC GCACCGTTTCATTTCCAACG 
Vβ 10 (21) AGCAAAGATGGATTGTGTCCC GGTGGAGTTGATTTCCAGGCT 
Vβ 11 (25) TCAAACTATGGGCCTTGACAAC GCTCTCCTTTCTCCGTGGTATTAAC 
Vβ 13 (6) CCAKGTCGTGAGGASAGGA CTGAGTAATGGATYAGCCTCAG 
  Vβ 15 (24)   CACAGGAAAGAGCACTGTACTGG CATCTCCTTTGTTAATATCATCGATACC
Vβ 16 (14) GACCCTATTTCTGGACATGAATCT CCTTTGGGCATCCCTGAGT 
Vβ 17 (19) GTGACCCTGGARTGTRAACAG TCWCGAGAGRCRCTGTAGC 
Vβ 24 (15) TACCGGGCTGGGAAAACC TGTTTTTTTCCTTGGTGATTTGTTTA 
Vβ 28 (26) CGCAGGATCTTGGAGACTGA TCTTAAAGGAGTCAGGGCCAGTT 
Vβ X (X) CTACAGGTGCTGGCCAGTCTG GGTTTATGACTTCCTTATCCCCGG 
 Constant β CCTGGTGGGTGAACAGGAAG CCTCCCACTGGTCCTGGTC 
 β-actin GGCCGAGCGGAAATCG GCCATCTCCTGCTCGAAGTC 
a
 Vβ subfamily nomenclature followed the classification of Arden et al (Arden et 










5.3.1 Expression of individual RF122-encoded SAgs in the SAg-
deficient strain RF122-8α 
To investigate the effect of individual RF122-encoded SAgs on bovine T-cells in 
vitro, SAg genes were cloned into the expression plasmid pALC2073, which has an 
inducible promoter, to allow controlled expression in a SAg-deficient strain, 
RF122-8α, the construction of which is described in Chapter 6. RF122 SAg genes; 
secbov, sellbov, tstbov, segbov, seibov, selobov, selnbov,  selubov, selxbov, selybov, 
and selzbov encoded by RF122 were cloned into the SacI and KpnI sites of 
pALC2073 resulting in constructs; pALC2073::SECbov, pALC2073::SElLbov, 
pALC2073::TSST-1bov, pALC2073::SEGbov, pALC2073::SEIbov, 
pALC2073::SElObov, pALC2073::SElNbov, pALC2073::SElUbov, 
pALC2073::SElXbov, pALC2073::SElYbov, and pALC2073::SElZbov, respectively 
(Table 5.1). Constructs were verified by restriction digestion with SacI and KpnI, 
which revealed inserts of the expected size (Figure 5.2). DNA sequencing reactions 
were also carried out with MCS primers (Table 5.2).  
 pALC2073::SAg constructs and pALC2073 were transformed into RF122-
8α, and cultures were induced with a sub-inhibitory concentration of tetracycline. 
To determine whether SAg proteins are expressed under the control of the 
pALC2073 plasmid promoter, pALC2073::SAg supernatant fractions were 
compared with supernatant from a culture of pALC2073 only (Figure 5.3). Proteins 
of the predicted molecular weight were expressed in supernatants of induced 
RF122-8α cultures containing, pALC2073::SECbov (27.6 kDa) pALC2073::SElLbov 
(24.7 kDa), pALC2073::TSST-1bov (22 kDa), pALC2073::SElUbov (27.2 kDa), 


















Figure 5.2: Verification of pALC2073 constructs containing RF122-encoded 
SAg genes by digestion with SacI and KpnI. Lane 1, 1 kb+ ladder; lane 2, 
undigested pALC2073; lane 3, digested pALC2073; lane 4, pALC2073::TSST-1bov; 
lane 5, pALC2073::SECbov; lane 6, pALC2073::SElLbov; lane 7, 
pALC2073::SElUbov; lane 8, pALC2073::SElNbov; lane 9, pALC2073::SElObov, lane 
10, pALC2073::SEIbov; lane 11, pALC2073::SEGbov; lane 12, pALC2073::SElYbov; 













Figure 5.3: Expression of SAg genes in RF122-8α. RF122-8α supernatants 
expressing individual RF122-encoded SAgs, concentrated approx. 100-fold and 
resolved on SDS-PAGE gels and stained with Coomassie. Lane 1, Full range 
Rainbow ladder; lane 2, RF122-8α containing pALC2073; lane 3, RF122-8α-C, 
lane 4, RF122-8α-L; lane 5 RF122-8α-T; lane 6, RF122-8α-G; lane 7, RF122-8α-N; 
lane 8, RF122-8α-U; lane 9, RF122-8α-Y; lane 10, RF122-8α-I; lane 11, RF122-8α-
Z; lane 13, RF122-8α; lane 14,  RF122-8α-X; lane 15, RF122-8α-O. Black arrows 





However it was not possible to visually detect expression of SEGbov, SElNbov, 
SEIbov, SElObov or SElXbov. SElXbov which is 19.5 kDa in size was not detectable on 
the Coomassie stained gel, but was detected by western blot analysis with rat anti-
sera specific for rSElXbov (Figure 5.4).  In addition western blot analysis was used to 
confirm expression of SaPIbov SAgs; SECbov, SElLbov and TSST-1bov (Figure 5.4). 
Primary antibodies specific for SEGbov, SElNbov, SEIbov, and SElObov were not 
available to confirm expression. 
 
5.3.2 RF122-encoded SAgs are mitogenic for bovine T-cells  
To examine if RF122-encoded SAgs are mitogenic for bovine T-cells, culture 
supernatants of RF122-8α containing pALC2073::SAg constructs were used to 
stimulate bovine PBMC and proliferation was measured using a thymidine 
incorporation assay (Figure 5.5). Previously, superantigenic activity of SECbov, 
TSST-1 bov had been described (Fitzgerald et al., 2001a, Deringer et al., 1997, 
Deringer et al., 1996). Here, we have shown that in addition to SECbov and TSST-
1bov, bovine variants of characterised SAgs, SElLbov SEIbov, SElNbov, and novel 
SAgs, SElXbov and SElYbov are mitogenic for bovine T-cells. RF122 and RF122-8α 
supernatants containing SECbov, TSST-1bov, SElLbov SElNbov, SElXbov and SElYbov 
induced proliferation at concentrations ranging from 10 pg/µl to 0.01µg/ml (Figure 
5.5). SEIbov induced proliferation at concentrations ranging from 100 pg/µl to 
0.01µg/ml. However proliferation was not induced by 10 pg/µl to 0.01µg/ml 
RF122-8α supernatants containing SElObov, SEGbov , SElUbov or SElZbov.  FACS 
analysis of CFSE stained PBMC stimulated with 10 ng/ml culture supernatants was 
also carried out, where proliferation was assessed by measuring loss of fluorescence 
in dividing cells. SECbov, TSST-1bov, SElLbov, SEIbov, SElNbov, SElXbov and SElYbov 
induced proliferation of bovine T-cells, which confirmed the results of the 
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Figure 5.4: Western blot analysis of SECbov, TSST-1bov, SElLbov and SElXbov 
expression in RF122-8α. Western blot analysis of concentrated RF122-8α 
supernatants containing SAgs separated by SDS-PAGE, with antibody specific for 

















Figure 5.5: Proliferation of bovine T-cell populations in response to 
stimulation with RF122-encoded SAgs. PBMC proliferation after 4 d exposure to 
RF122-8α supernatants containing SAgs, as indicated by the incorporation of [
3
H] 
thymidine. Results shown are the means of triplicate measurements from 2 animals 








Figure 5.6: T-cell proliferation in response to stimulation with RF122-encoded 
SAgs assessed by CFSE staining. Bovine PBMC were labelled with CFSE prior to 
culture and stimulated for 4 d with 10 ng/ml culture supernatants of; a) RF122-8α 
containing; pALC2073, b) RF122-8α-T, c) RF122-8α-L, d) RF122-8α-C, e) RF122-
8α-Y, f)  RF122-8α-X, g) RF122-8α-Z, h) RF122-8α-N, i) RF122-8α-I, j) RF122-
8α-G, k) RF122-8α-O and l) RF122-8α-U. Broken lines indicate the data obtained 




RF122-8α supernatant was toxic for bovine PBMC at concentrations over 
0.1 µg/ml, meaning that proliferation could not be measured. Consequently, it is 
possible that SElObov, SEGbov, SElUbov and SElZbov require a higher concentration 
than was tested to induce proliferation. Our data indicate that SElUbov and SElZbov 
are not mitogenic at the concentrations examined, but expression of SElObov and 
SEGbov in RF122-8α has not been confirmed and it is therefore not possible to 
conclude a lack of mitogenic activity. Of note, SElU is mitogenic for human T-cells 
(Thomas et al., 2006, Thomas et al., 2009), but SElUbov, which is encoded by an 
allelic variant is not mitogenic for bovine T-cells. In contrast to the lack of T-cell 
proliferation observed during stimulation with RF122-8α supernatant containing 
SElZbov, data obtained for isogenic mutant RF122-8 deficient in SElZbov expression 
compared with RF122-7 (construction of which is described in Section 6.3.1), 
indicates that SElZbov is mitogenic (Figure 5.7). This discrepancy may be explained 
by the fact that culture supernatants were obtained from different phases of growth. 
RF122-7 supernatant was obtained from post-exponential phase whereas RF122-8α-
Z supernatant was harvested from stationary phase. This implies that SElZbov 
superantigenic activity may require the presence of another factor expressed in 
stationary phase.  
 
5.3.3 RF122-encoded SAgs activate unique bovVβ profiles  
Previous studies of the bovine Vβ-dependent expansion capacity of staphylococcal 
SAgs have been restricted by the number of identified bovine Vβ subfamilies 
(Fitzgerald et al., 2001a, Deringer et al., 1997). The recent bovine genome 
sequencing project has facilitated identification of almost the entire TRBV 
repertoire (Elsik et al., 2009, Connelley et al., 2009). Connelley et al recently 
established an RT-PCR assay to identify clonal expansion within the full 
complement of bovVβ subfamilies (Connelley et al., 2008). However this assay is 
not quantitative, so to quantify the expansion of bovine Vβ subfamilies in response 
to stimulation with RF122-encoded SAgs, we have developed a novel qRT-PCR 
assay which includes the complement of bovine Vβ subfamilies. We have used the 
Vβ nomenclature scheme proposed by Arden et al, to allow comparison with 
previous studies which have determined humVβ activation in response to SAgs 












Figure 5.7: SElZbov has mitogenic activity for bovine T-cells, Bovine PBMC 
were labelled with CFSE prior to culture and stimulated for 4 d with a) medium 
only, or 10 ng/ml culture supernatants of b) RF122, c) RF122-7 (SAg-deficient 
except for selzbov, and d) RF122-8 (SAg-deficient). Results shown are from a 
single representative experiment that was performed at least twice.  
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subfamily specific primer pairs were designed within the bovVβ genes, with 
degenerate nucleotides used where sequence variation exists between subfamily 
members. In this study we have not confirmed the amplification of each individual 
subfamily member, but this could be achieved by cloning and sequencing of 
amplified qRT-PCR products. To increase specificity both primers were designed 
within the gene, rather than one primer within the gene and another within the β 
constant region as has been described for previous humVβ qRT-PCR studies 
(Ochsenreither et al., 2008).  In addition to β-actin, primers within the β constant 
region gene (Cβ) were used as an internal control for the number of T-cells.  
 Accordingly, for the first time we were able to comprehensively evaluate the 
response of 18 bovVβ subfamilies to stimulation with staphylococcal SAgs by qRT-
PCR (Figure 5.8). SECbov, SElLbov, TSST-1bov, SEIbov, SElNbov, SElXbov and SElYbov 
were shown to induce Vβ-specific activation of bovine T-cells (Figure 5.8). Each of 
the RF122-encoded SAgs has a unique BovVβ activation profile which is 
summarised in Table 5.4, which is consistent with the effect of SAgs on humVβ 
cells (Choi et al., 1989).  
 Importantly, this study reveals that each of the bovVβ subfamilies are 
activated in response to at least one RF122-encoded SAg, such that RF122 has the 
potential to stimulate the entire bovVβ repertoire. BovVβ subfamilies activated by 
RF122-encoded SAgs are indicated on a phylogenetic tree of all functional TRBV 
gene sequences (Figure 5.9). It is also important to note that SaPIbov SAgs alone 
are able to activate 15 of 18 subfamilies. In comparison, egc SAgs activate only 8 of 
18 subfamilies. Extensive duplication within the bovVβ repertoire has resulted in 9 
multimember subgroups, the largest of which (bovVβ 1, 10 and 13) contain 23, 9 
and 20 functional TRBV genes, respectively (Connelley et al., 2009, Elsik et al., 
2009). Each of the SaPIbov encoded SAgs, SECbov, SElLbov and TSST-1bov and egc 
encoded SEIbov can activate at least one of these large subfamilies (Figure 5.8). 
SElLbov activates both bovVβ 1 and 10 which is consistent with the large proportion 















































































































































































































































































































Figure 5.8: Vβ-dependent activation of bovine T-cell populations in response to 
stimulation with RF122-envoded SAgs. Relative fold change in bovVβ expression 
after 4 d stimulation with a) SElNbov, b) SEIbov, c) TSST-1bov, d) SECbov, e) SElLbov, 
b) SElXbov and b) SElYbov. Results shown are the means of triplicate measurements 


















Table 5.4: Activation of Vβ subfamilies in response to RF122-encoded SAgs. 
SAg Bovine Vβ 
a, b, c
 SAg Human Vβ 
a, b, d, e
 
TSST-1bov 1, 2, 4, 11, 16, 24, X TSST-1 2 
SElLbov 1, 5, 6, 7, 10, 16, 24, X SElL 1, 5, 7, 16, 22, 23 
SECbov 11, 13, 15, 17, 28 SECbov, 12, 13, 14, 15, 17, 20 
SElNbov 8, 9, 11, 16, 17, 24, X SElN 7, 8, 9, 17 
SEIbov 1, 8, 16 SEI 1, 5, 6, 23 
SElXbov 3, 5, 11, 16, 17, 24, X SElXbov 1, 6, 18, 21 
SElYbov 3, 8, 11, 16, 17, 24, X SElYbov NK 
SElObov N/A SElObov 5, 7, 22 
SElUbov N/A SElUbov 13, 14 
SEGbov N/A SEGbov 3, 12, 13, 14, 15 
a 
 Vβ subfamilies were named according to the classification of Arden et al (Arden et 
al., 1995). 
b 
Bovine and human Vβ subfamilies activated in response to the same SAg are 
highlighted in bold type.  
c 
N/A, not applicable. 
d 
NK, not known. 
e
 HumVβ activation data has been compiled from Section 4.4 and the references 



































































































































































































Figure 5.9: Phylogenetic analysis of bovine TCR Vβ gene sequences. Neighbour-
joining tree based on all known TRBV gene sequences, constructed using MEGA 
from a ClustalW alignment of translated amino acid sequences. Coloured circles 
indicate activation of bovVβ subfamily in response to stimulation with RF122-
encoded SAgs. At least 500 bootstrap trees were generated to examine the stability 




In this study we have investigated bovine T-cell activation in response to all SAgs 
encoded by a single bovine S. aureus strain, RF122. All 11 SAg genes encoded by 
RF122 were cloned into the pALC2073 plasmid facilitating controlled SAg gene 
expression in the SAg-deficient strain RF122-8α. Expression of SAgs in their 
natural S. aureus host should result in their native confirmation and avoids LPS 
contamination issues. Furthermore, functional activity may require the presence of 
co-factors made only by the native host. 
  Previously, only SECbov and TSST-1bov had been shown to be mitogenic for 
bovine T-cells (Deringer et al., 1997, Marr et al., 1993, Fitzgerald et al., 2001a). In 
addition, in this work, we have previously described mitogenicity of rSElX (Figure 
4.5). Here we have shown that in addition to SElXbov, SECbov and TSST-1bov, 
SElLbov, SElNbov, SEIbov and SElYbov induced proliferation of bovine T-cells. SElU 
encoded by the egc is known to be mitogenic for human T-cells (Thomas et al., 
2009, Thomas et al., 2006). In this study we have shown that RF122-8α 
supernatants containing the bovine variant SElUbov, are not mitogenic for bovine T-
cells at total protein concentrations ranging from 10 pg/µl to 10 ng/ml after 4 d in 
culture. Thomas et al reported that proliferation of humVβ 13 and 14 was observed 
for SElU after 6 d at concentrations ranging from 1 µg/ml to 10 ng/ml. Previous 
studies have demonstrated maximal levels of Vβ specific T-cell proliferation in 
response to SAg are reached between 72 and 96 h after stimulation (Seo et al., 
2007, Sriskandan et al., 1996). Seo et al demonstrated that SEC1 induced non 
specific bovVβ specific T-cell proliferation after 96 h (Seo et al., 2007). 
Accordingly in this study we have measured T-cell activation after 96 h. We could 
not test concentrations above 10 ng/ml, as RF122-8α supernatants were toxic for 
bovine PBMC, which taken together with the shorter culture incubation time, could 
explain the lack of mitogenicity observed in response to stimulation with SElUbov. 
Alternatively, it is possible that allelic variation between selu1 and selubov is 
responsible for the functional difference observed. We were not able to confirm 
expression of egc SAgs SElObov and SEGbov in RF122-8α. Therefore further 
experiments will be required to investigate whether rSEG and rSElO are able to 
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activate bovine T-cells. It is noteworthy that SEGbov is a truncated form of the 
characterised human SEG protein which implies the protein may not be functional.  
 Previously, we have carried out functional analysis of the novel SAg, SElX. 
Here we have demonstrated the mitogenic activity of novel SAgs SElYbov and 
SElZbov for bovine T-cells. As a result these proteins can be described as SAgs and 
have been named in accordance with standard nomenclature (Lina et al., 2004). In 
addition to mitogenicity, for full functional characterisation of a SAg, further 
experiments to determine pyrogenicity and endotoxin enhancement will be required 
(Lina et al., 2004). Experiments with rSElZ and RF122-8α-Z induced in stationary 
phase will be required to confirm mitogenicity of SElZ. Of note, selz is 
phylogenetically related to set (Figure 3.2), a recently identified SAg which 
activates T-cells but is not Vβ specific (Ono et al., 2008), suggesting a T-cell 
activation mechanism which is distinct from that observed for previously 
characterised staphylococcal SAgs. 
Vβ specific activation of human T-cells in response to staphylococcal SAgs 
has been well characterised (Seo et al., 2010, Thomas et al., 2009, Ono et al., 
2008). This has largely been achieved by FACS analysis using a commercial kit, 
IOtest® Beta Mark (Immunotech Beckman Coulter) containing a panel of 
monoclonal antibodies (mAbs) against almost all human Vβ subfamilies, or using a 
recently developed qRT-PCR assay (Seo et al., 2010, Thomas et al., 2009, Ono et 
al., 2008). Unfortunately, no Vβ-specific monoclonal antibodies are available for 
cattle, and until recently TRBV gene information was limited. For the first time we 
have determined the unique bovVβ activation profile of bovine variants of 
previously characterised SAgs, SECbov, TSST-1bov, SElLbov, SElNbov, SEIbov, and 2 
novel SAgs SElXbov and SElYbov (Table 5.4). The bovVβ activation profiles 
determined for SECbov and TSST-1bov in this study are consistent with previous 
studies carried out with limited bovVβ subfamilies. Previously, Deringer et al 
examined the response of 5 bovVβ subfamilies to stimulation with SECbov  by semi-
quantitative PCR (Deringer et al., 1997). SECbov stimulated bovVβ 28 but not 1, 3, 
4 or 7, which is consistent with our results. In addition, Fitzgerald et al investigated 
the response of the same 5 bovVβ subfamilies to stimulation with stationary phase 
culture supernatants of RF122 and sequential mutants RF122-1 (∆tstbov) and 
RF122-2 (∆tstbov∆secbov). RF122 supernatant activated bovVβ 1, 4, 7, and 28 but 
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not VB3 (Fitzgerald et al., 2001a). RF122-1 was unable to activate bovVβ 4, which 
was attributed to the deletion of tstbov in this strain. Similarly, RF122-2 was unable 
to activate bovVβ 28, due to the deletion of secbov (Fitzgerald et al., 2001a). Here 
we have demonstrated that TSST-1bov is the only RF122-encoded SAg which can 
activate bovVβ 4, and SECbov is the only SAg that can activate bovVβ 28 (Figure 
5.8). Previously, RF122-3 was able to activate bovVβ 1 and 7, here we have shown 
that SElLbov activates both of these subfamilies, and is transcribed at high levels in 
stationary phase (Figure 3.3) (Fitzgerald et al., 2001a). 
We have demonstrated that RF122 has the potential to stimulate the entire 
bovVβ repertoire by expression of SAgs (Figure 5.9). It has been shown previously 
that all humVβ subfamilies are activated by at least one SAg (Thomas et al., 2009). 
However activation of all humVβ by the SAgs encoded by a single strain has not 
been reported. Our data also indicates that some bovVβ subfamilies can be activated 
by multiple SAgs, for example, Vβ 24 is activated by 6 SAgs, and Vβ  6, 11 and X 
are activated by 5 SAgs (Figure 5.9). This apparent functional redundancy implies 
an important role in pathogenesis for activation of these subgroups. A similar 
redundancy has been observed in the humVβ response to SAgs, Vβ  5 and 14, and 
Vβ 18 and 21 were targeted by 5 and 6 different SAgs respectively (Thomas et al., 
2009). It has been proposed that humVβ profiles could be used diagnostically to 
indicate SAg exposure during some staphylococcal  diseases, such as TSS (Ferry et 
al., 2008). However the observed redundancy in SAg activation of specific bovVβ 
subfamilies suggests this would not be feasible as a diagnostic test for bovine 
mastitis infections.  
For the first time we have been able to compare the human and bovine Vβ 
activation in response to staphylococcal SAgs, which has revealed that bovVβ 
activation is distinct from humVβ activation. Our data reveals some similarities, but 
also marked differences in activation which suggests host species adaptation. (Table 
5.4) (Seo et al., 2010, Thomas et al., 2009). There are a number of human and 
bovine subfamilies activated in common, by each SAg (Table 5.4). The differences 
observed are in part due to activation of a bovine or human Vβ subgroup for which 
there is no orthologous subgroup, such as the activation of humVβ 12, 14, 20, 22, 
and 23, and bovVβ 10, 28 and X (Connelley et al., 2009). However there are a 
number of subfamilies from one host which have been activated, but the 
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orthologous subgroup from the other is not. Of note, SECbov activates bovVβ 11 but 
not humVβ 11. Similarly, SElLbov activates bovVβ 6 and 24, TSST-1bov activates 
bovVβ 1, 4, 11, 16, 24, SEIbov activates bovVβ 8 and 16 and humVβ 5 and 6, and 
SElNbov activates bovVβ 11, 16, 24 and humVβ 7, but not the equivalent human or 
bovine subgroups. It is important to note that with the exception of SEC bov, human 
Vβ profiles described here are in response to stimulation with SAgs encoded by 
human S. aureus strains (Seo et al., 2010, Thomas et al., 2009). Allelic variants of 
sell differ by one synonymous nucleotide, therefore it can be inferred that SElLbov 
and SElL are identical. Translated amino acid sequences of TSST-1bov, SElNbov and 
SEIbov, have 97, 94 and 95% identity with human variants respectively. Host 
specific SAgs variants have been shown to activate distinct Vβ profiles, SEC1 and 
SECov induced proliferation of bovVβ 26 and bovVβ 28 whereas SECbov  induced 
bovVβ 28 only (Deringer et al., 1997), therefore this must be considered when 
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Bovine mastitis caused by S. aureus infection is typically chronic in nature with the 
host often unable to eliminate the organism (Ferens & Bohach, 2000, Sol et al., 
2000). The factors responsible for this persistence in the host are not well 
understood. It has been proposed that SAgs may contribute to persistence by 
modulation of the bovine immune response. In the current study, analysis of the 
genome sequence of bovine clinical isolate RF122 revealed an array of SAg genes. 
Here we have demonstrated that RF122-encoded SAgs are expressed in vitro and 
have superantigenic activity for bovine T-cells. To investigate the effect of SAgs 
expressed during S. aureus disease pathogenesis in vivo, targeted disruption of 
genes leading to loss of function will be carried out to allow the contribution of 
individual loci to be determined.  
 
The aim of this component of the study was to investigate the role of SAgs in S. 
aureus pathogenesis and persistence of disease by: 
  
• Constructing a SAg-deficient derivative of RF122 by allele 
replacement. 
 
• Experimental infection of dairy cattle with wild type and SAg-















6.2 Materials and Methods 
 
6.2.1 Bacterial strains and plasmids  
Bacterial strains and plasmids used in this study are indicated in Table 6.1. Media 
was supplemented where appropriate with erythromycin (Fisher Scientific, UK) at 
10 µg/ml (S. aureus) or 200 µg/ml (Escherichia coli), 50 µg/ml ampicillin (Sigma-
Aldrich, UK) and 150 µg/ml X-gal (Melford, UK). 
 
6.2.2 Construction of allele replacement plasmids 
pMAD gene deletion constructs were generated by overlapping PCR as outlined in 
Figure 6.1.  PCR products of approximately 500 bp flanking the left (A and B) and 
right (C and D) region of the gene of interest were amplified with primers listed in 
Table 6.2. PCR amplification with primers A and D was carried out with 
approximately 100 ng of purified AB and CD template DNA to produce a single 
spliced amplicon. Sequence complementary to primer B was incorporated into the 
CD fragment by Primer C, which allows the products of the first PCR to anneal. AD 
products were then purified and cloned into the Strataclone pSC-B plasmid 
(Stratagene) according to the manufacturer’s instructions. Expected sizes of AB, 
CD and AD amplicons and the regions to be deleted associated with each plasmid 
constructed in this study are shown in Table 6.2. pSC-B plasmid containing the AD 
insert was restriction digested with EcoR1 for 2 h at 37 °C, or digested sequentially 
with SmaI at 25 °C overnight and SalI at 37 °C for 6 h. The AD fragment was then 
purified, ligated into the dephosphorylated gene replacement plasmid, pMAD, and 
transformed into E. coli strain DH5α. The resulting pMAD deletion construct was 









Table 6.1: Bacterial strains and plasmids used in this study 
Strain or plasmid Description Source/ Reference 
S. aureus   
RF122 Wild type bovine mastitis (JR Fitzgerald, 1997) 
RF122t  
 
Transducable variant of RF122 
 












 ∆sec This study 
RF122-4  tst::Tc
r
 ∆sec∆sell This study 
RF122-5 tst::Tc
r
 ∆sec∆sell∆egc This study 
RF122-6 tst::Tc
r
∆sec∆sell∆egc∆selx This study 
RF122-7 tst::Tc
r


















derivative of NTCC8325 
(Kreiswirth et al., 1983) 
Newman Human isolate (Duthie, 1952) 
E. coli   


















pMAD Thermosensitive gene replacement 
plasmid, pE194 derivative 
(Arnaud et al., 2004) 
 
pMAD:secbov secbov deletion construct This study 
pMAD:sellbov   sellbov deletion construct This study 
pMAD:egc egc deletion construct This study 
pMAD:selxbov      selxbov deletion construct This study 
pMAD:selybov     selybov deletion construct This study 
pMAD:selzbov   selzbov deletion construct This study 























Table 6.2: Primers used to obtain and verify pMAD gene deletion constructs.  
Primer Sequence (5´ - 3´) 
a 
 
secbovA    ATGAATTCCTGTGGATTTAGAAATAAGG 
secbovB    CCAACATTCCCAAGAAGTATC 
secbovC     GATACTTCTTCTTGGGAATGTTGGAAGAATGGATAATGTTAAT
CC   
secbovD                                           TTATCCATGGCAAGCATCAAAC 
secbovE                               GTCATGTTTCGGTTGATAGG                       
secbovZ                                                         ATGGCGGTGTTACTAAAGC 
UpsecF                               GCAGGTACTTCGGTACTTGCCTAT 
UpsecR GGAGAAACAGAGGATTTCTAAGCATC 
secprobe-F                                TGAAGGAAACCACTTTGATAATGGG 
secprobe-R AGATTGGTCAAACTTATCTCCTGGT 
sellbovA       GATATATTTGAAAGGTAAGTACTTCG              
sellbovB                                           AGTGTAGTATTCCATATGAATGATGGT         
sellbovC         ACCATCATTCATATGGAATACTACACTATACAAAAGGTTATA
GGAAGAGTT   
sellbovD                       CAATTTCTACAGATATGACTCCC 
sellbovZ      TGTACAAATGGACTTAAGATATAGCG   
egcA       TCTTGATACGTATTTGACACTTGC          
egcB    AGCTATACGAGTTTGATGGTTCTG     
egcC        CAGAACCATCAAACTCGTATAGCTAACTAAGCGACTCAGATA
ATAGAC 





selxbovA                                              TGTCGATGCTATGGATAGTGAGG    
selxbovB                 TAATTACCTCCTTGATGTAAAGC                                   
 126 
Primer Sequence (5´ - 3´) 
a
 
selxbovC                                            GCTTTACATCAAGGAGGTAATTATATCGCTAATACTTTGAAAG
TTAGG 
selxbovD TCAAATGTAGCAGTATACATTAATTGCG      
selxbovE ATCTCAGTTGTCTCTTTGATAGTGC 
selxbovZ TTACTCTTCATGTGTCACTTCATTTCG 




selybovA   ACTTGAAGGTATGTATGTTACACG      
selybovB                                              TCTAGCTTCCAACAAAGAATAGC    
selybovC         GCTATTCTTTGTTGGAAGCTAGAGGTAATGAAACAGTTGAAT
CAGC    
selybovD   AAGAACCACGCGAACACACAAGC                     
selybovE AGATTATTAGGTAAGGCATAAATAGC 
selybovZ TCAGCTTACAATAATGTGCAAGTTGG 




selzbovA   AAGGTGACAATCCTGAAATCAC 
selzbovB                                              CAGATCATCCTTTCTCATTTAAGATT 
selzbovC         AATCTTAAATGAGAAAGGATGATCTGGTTCCAACATAAATGCG














pMAD-2m              AAGCGAGAATCATAATGGG 
pMAD-3c     CTTGCTCCAACTGAAAATCCC 
a


































Table 6.3: Generation of pMAD gene deletion constructs. Size of AB and CD 
products, spliced AD fragments and deletion obtained.   
Deletion target AB (bps) CD (bps) AD (bps) Deletion 
(bps) 
secbov 512 506 1018 825 
sellbov 285 320 605 685 
egc 614 641 1255 5319 
selxbov 532 478 1010 674 
selybov 555 564 1119 668 
selzbov 546 480 1026 673 

















6.2.3 Allelle replacement mutagenesis by temperature shifting with 
enrichment 
S. aureus containing the pMAD deletion construct of interest was shaken overnight 
at 30 °C in 2 ml TSB containing erythromycin. To select for integration of the 
plasmid into the chromosome through homologous recombination (Figure 6.1), 




 were incubated on TSA containing 
erythromycin at a non-permissive temperature for plasmid replication, 45 °C. 
Colonies which grew at this temperature were sub-cultured to single colonies on 
TSA containing erythromycin at 45 °C to ensure a pure culture, and checked by 
PCR for single cross over integration. To generate double cross-over excisants, 
integrants were then grown in TSB without antibiotic at 30 °C for 24 h. 10-fold 
serial dilutions were plated onto TSA containing X-gal and incubated on TSA at 30 
°C overnight. Colonies were then screened for sensitivity on erythromycin plates 
(inferring loss of the plasmid) and screened for WT or mutated forms of the genes 
by colony PCR with primers upstream (E) and downstream (Z) of the gene of 
interest (GOI). The resulting mutant strain which has lost the GOI was further 
verified by PCR analysis for no amplification with primers within the deleted 
region or with pMAD MCS primers. The mutant strains were also sequenced using 
primers upstream (E) and downstream (Z) of the GOI to confirm the predicted 
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Figure 6.1: Schematic diagram of the procedure used to obtain gene 
replacement by recombination using the pMAD plasmid. a) PCR products of 
approximately 500 bp flanking the left (A and B) and right (C and D) of the gene of 
interest were amplified. Primer B is complementary to primer C which allows the 
products of the first PCR to anneal at the region of overlap during a second PCR 
with primers A and D. The AD product is then cloned into the pMAD plasmid.  
b) Areas labelled AB and CD represent DNA sequences located upstream and 
downstream of the gene of interest. The crossed lines indicate a crossover event. 
Single crossover integration via homologous recombination can occur at either 
region. The co-integrate then undergoes a second recombination event with excision 
of the pMAD plasmid, resulting in either recreation of the wild type or a gene 























6.2.4 Southern Hybridisation  
2 µg genomic DNA was digested with HindIII restriction endonuclease overnight at 
37 °C and analysed by agarose gel electrophoresis in a 0.8% (w/v) agarose gel. The 
gel was depurinated in 0.25 M HCl (Fisher Scientific, UK) for 10 min, immersed in 
denaturation solution containing 0.5 M NaOH (Fisher Scientific, UK) and 1.5 M 
NaCl (Melford, UK) for 1 h, followed by neutralisation solution (0.5 M TrisHCL, 
1.5 M NaCl, pH 7.5) for 1 h. DNA fragments were transferred by alkaline capillary 
blotting onto a nylon membrane (Amersham, GE Healthcare).  Labelling of the 
probes and DNA hybridisation was performed according to the protocol supplied 
with the ECL Direct nucleic acid labelling and detection system (Amersham, GE 
Healthcare).  
 
6.2.5 Extraction of S. aureus secreted and CWA proteins  
Secreted and CWA proteins were extracted from S. aureus mid-exponential (3 h) 
and stationary phase (12 h) cultures grown in BHI. Cells were centrifuged at 4000 x 
g and supernatant fractions containing secreted proteins were removed and 
concentrated with Amicon Ultra-15 Centrifugal Filter units with a 10 kDa MWCO 
as described in the manufacturers instructions (Millipore, Watford, UK). Cell-wall 
associated proteins were extracted from pelleted cells by washing with 1 ml  PBS 
(Oxoid, Cambridge, UK), resuspension in 1 ml lysis buffer (50 mM TrisHCl, 20 
mM MgCl2, 30% Raffinose (Fluka, UK), adjusted to pH 7.5) containing 200 µg/ml 
Lysostaphin (AMBI products LLC, NY, USA) and protease inhibitors (Sigma-
Aldrich, UK) and incubation at 37 °C for 20 min. Samples were centrifuged at 6000 
x g for 20 min and the CWA proteins were recovered from the supernatant fraction. 
Proteins were seperated by SDS-PAGE as described in General Methods, and 
stained overnight at room temperature with Coomassie Blue (Severn Biotech). 
 
6.2.6 Haemolytic activity of S. aureus 
Overnight cultures of S. aureus strains grown in TSB were centrifuged at 4000 x g 
and supernatants obtained to assess the haemolytic activity of S. aureus cuture 
supernatants by titration. Doubling dilutions of the supernatants were mixed with 
equal volumes rabbit erythrocytes. Erythrocytes were obtained from blood by 
washing 3 times with 2 x PBS for 10 min at 1500 x g and 4 °C and re-suspended as 
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2% (w/v) packed cell volume in PBS in round bottomed microtitre plates (Corning 
incorporated). End points were assessed after incubation at 37 °C for 30 min and 
overnight incubation at 4 °C. The reciprocal of the dilution in the last well showing 
50% lysis is the haemolytic titre for each strain.  
 
6.2.7 Growth curve of S. aureus strains 
S. aureus strains were cultured overnight in 5 ml Brain–Heart Infusion (BHI) broth 
(Oxoid Ltd., Basingstoke, UK) in triplicate. After 12 h strains were sub-cultured at 
a dilution of 1/100 into 30 ml fresh BHI broth in 250 ml Erlenmeyer flasks and 
placed in a shaking incubator at 37 °C and 200 rpm. Absorbance readings were 
measured at 600 nm (OD600) using a spectrophotometer (Cecil Aurius CE2021, 
Thistle Scientific Ltd., Glasgow, UK) over a period of 12 h and a growth curve was 
determined.  
 
6.2.8 Experimental infection of dairy cattle 
Lactating Holstein cows from the University of Idaho dairy herd were assigned to 2 
experimental groups, positive control and experimental. Positive control group 
received intramammary instillations of the wild type strain S. aureus RF122t to one 
udder quarter, and the experimental group received the SAg-deficient mutant 
RF122-8 (Figure 6.2). PBS was instilled into an udder quarter of the other udder 
half as a negative control of infection. Bacterial suspensions for intramammary 
instillations were prepared in 10 ml PBS and contained 2, 5 or 10 CFU (colony 
forming units). Inocula were prepared by serial dilution and verified by viable 
counts. Milk samples were obtained daily from each mammary quarter using a 
specially adapted quarter milking apparatus (Figure 6.2). Somatic cell count (SCC) 
of milk was determined by measuring DNA content, using the membrane filter 
technique developed by Bremel et al (Bremel, 1980). In brief, 2.5 ml of milk was 
mixed with 20 ml of a warm diluent (40 °C) containing 0.1% vol/vol of Triton X-
100 (Sigma, St. Louis, MO) and 4.5 g/L trisodium EDTA in PBS, and filtered 
through a cellulose acetate membrane filter of 3 to 5 µm pore size to retain somatic 
cells.  The membrane was rinsed with 2 ml of PBS to remove detergent and 
individual filters were placed in glass tubes containing 5 ml of colour reagent (1:2:1 
parts of 5 M HCl, water, and 0.06 % indole).  Filters were incubated at 90 °C for 25 
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min, and colour development was quenched by immersion in cold water.  The OD 
of the samples was measured at 490 nm using a spectrophotometer. A cell-free milk 
sample was processed to obtain a blank sample (Ward & Schultz, 1973). 
                Bacterial counts were determined by inoculating serially-diluted squirt 
milks directly onto blood agar plate. Intramammary infection (IMI) was considered 
established when 2 daily cultures were positive for S. aureus. Elevation of body 
temperature >105 °F  indicated a high risk for loss of the animals (University of 
Idaho animal use guidelines), therefore experiments were stopped by treatment with 
anti-inflammatory drug (Benamin), aspirin, and penicillin G. Intramammary 
instillation of cattle and SCC measurements were performed by Brent Hatch and 

































Figure 6.2: Experimental infection of dairy cows. a) Direct intra-mammary 











6.3.1 Construction of a SAg-deficient derivative of RF122 
S. aureus RF122-1, a tstbov-deficient derivative of the bovine clinical isolate RF122 
had been constructed previously by disruption of the tst gene with a tetracycline 
resistance cassette (Fitzgerald et al., 2001a). To delete all the remaining SAg genes 
encoded by RF122-1 by sequential allelic replacement, pMAD constructs, 
pMAD:secbov, pMAD:sellbov, pMAD:egc, pMAD:selxbov, pMAD:selybov and 
pMAD:selzbov were generated. Spliced AD fragments of regions flanking secbov, 
sellbov, egc, selxbov, and selybov were cloned into the EcoRI site of pMAD. There 
is an EcoRI site in the sequence downstream of selz (CD fragment). Accordingly 
the spliced AD fragment for selzbov was cloned between the SalI and SmaI sites of 
pMAD. pMAD:secbov, pMAD:sellbov, pMAD:egc, pMAD:selxbov and 
pMAD:selybov were digested with EcoRI to confirm the correct size of the cloned 
AD fragments (Figure 6.3), and PCR analysis was used to confirm the correct size 
of the cloned AD fragment of pMAD:selzbov, 1026 bp (Figure 6.3).  
Initially the pMAD:secbov plasmid was transformed into RF122-1. 
Integration of the plasmid into the RF122-1 chromosome was selected for on TSA 
containing erythromycin at a non-permissive temperature for plasmid replication, 
45 °C. Colonies which grew at this temperature were checked for single cross over 
integration by PCR with a chromosomal primer downstream of the AD region, 
secbovZ and either pMAD MCS primer pMAD-2m or pMAD-3c. To generate 
double cross over excisants, integrants were then grown in TSB without antibiotic 
at 30 °C for 24 h. Colonies obtained after incubation on TSA at 30 °C overnight 
were then checked for sensitivity on erythromycin plates (loss of the plasmid) and 
screened for wild type or mutated forms of the genes by colony PCR. 
To confirm that allelic exchange had been successful, and a mutated form of the 
secbov gene was inherited, PCR amplication with primers secbovE and sellbovZ 
across the deleted gene revealed that the size of the product was consistent with the 
presence of the mutant allele. The EZ region amplified from strain RF122-1 was 
3070 bp, whereas a region of 2245 bp was amplified from the final RF122-3  
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Figure 6.3: Verification of pMAD deletion plasmids. a) EcoR1 restriction digests 
of pMAD deletion constructs to confirm the size of the AD inserts. Lane 1, 1kb+ 
ladder; lane 2, uncut pMAD; lane 3, EcoRI digested pMAD; lane 4, pMAD:egc; 
lane 5, pMAD:selybov; lane 6, pMAD:selxbov; lane 7, pMAD:secbov; lane 8, 
pMAD:sellbov. b) PCR analysis of pMAD:selzbov with pMAD multiple cloning 
site primers 2m and 3c. Lane 1, 1kb+ ladder; lane 2, pMAD; and lane 3, 
pMAD:selz. c) EcoR1 restriction digests of pMAD:hla deletion constructs. Lane 1, 
1kb+ ladder; lane 2, uncut pMAD; lane 3, EcoRI digested pMAD; lane 4, 
pMAD:hla. 
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 (∆tst∆secbov) mutant strain indicating a deletion of 825 bp from the secbov gene 
(Figure 6.4).  
In the same way, each SAg gene was deleted sequentially in this strain 
resulting in the final SAg-deficient derivative RF122-8 (Figure 6.5). Allelic 
replacement of sellbov was carried out in RF122-3 using pMAD:sellbov, generating 
RF122-4 which is deficient in all SaPIbov SAg genes, tst, secbov and sellbov 
(Figure 6.4). Allele replacement of the entire 5.3 kb egc region in RF122-4 was then 
carried out using pMAD:egc resulting in RF122-5, which is deficient in SaPIbov 
and egc SAg genes. PCR amplification with egcE and egcZ revealed the region in 
RF122 to be the expected size of 6898 bp and RF122-5 was 1579 bp, consistent 
with a 5319 bp deletion of the egc region (Figure 6.4). Similarly pMAD:selxbov 
was used to delete putative SAg gene selxbov in RF122-5, producing RF122-6. 
PCR amplification with selxbovE and selxbovZ revealed bands of the expected 
sizes, 2108 bp for RF122 and 1440 bp for RF122-6, representing a 668 bp deletion 
of selx (Figure 6.4). In turn, selybov was deleted in RF122-6 using pMAD:selybov, 
creating RF122-7. PCR amplification using selybovE and selybovZ showed the 
region spanning the gene to be 2043 bp in RF122 and 1369 bp in RF122-7, 
demonstrating that a 674 bp deletion of selybov has been introduced (Figure 6.4). 
Finally, allele replacement of selz was carried out in RF122-7 with pMAD:selz. 
PCR analysis with selzbovE and selzbovZ across the gene produced bands of the 
expected sizes, 1966 bp for RF122 and 1296 bp for RF122-8, indicating a deletion 
of 670 bp has occurred (Figure 6.4). The resulting SAg-deficient strain RF122-8 
contained deletions in each of the SaPIbov, egc and putative SAg genes (Figure 
6.5).  
Further confirmation of each deletion event was provided by no 
amplification with primers outside and within the deleted regions (results not 
shown), sequencing across the deleted regions, and Southern blot analysis of the 
wild type and mutant strains with probes specific for regions of DNA upstream or 
downstream of the deleted regions (Figure 6.6). The size differences between 
hybridising HindIII-digested fragments of genomic DNA from each strain with the 
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Figure 6.4: PCR verification of deleted SAg genes. a) PCR amplification of the 
SaPIbov region in RF122 and derivatives using primers secbovE and sellbovZ. PCR 
analysis with primers (E and Z) spanning the deleted region of each gene, b) egc, c) 













































Figure 6.5: Schematic of sequential allele replacement events in S. aureus 
RF122-1 resulting in the generation of RF122-8. Dark green arrows indicate 
bovine variants of characterised SAg genes, light green arrows denote putative SAg 
genes, and red arrows represent SAg pseudogenes. Unfilled arrows indicate genes 
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Figure 6.6: Southern blot analysis to confirm deletion of SAg genes. a) secbov 
b) sellbov c) egc d) selxbov e) selybov f) selzbov hybridised with gene-specific 
probes.  Lanes 1-8 contain S. aureus strains RF122, RF122t, RF122-1, RF122-3, 








mutant strain was the expected size in relation to the wild type, indicating that the 
predicted deletion event had taken place (Figure 6.6). 
 
6.3.2 Phenotypic analysis of the RF122 and SAg-deficient derivative 
RF122-8  
To investigate the possibility that deletion of SAg genes could have pleiotropic 
effects, the phenotype of WT and mutant strains was compared. It was also 
important to rule out the possibility that any undesired mutations had occurred 
during passage, such as in the agr locus (Somerville et al., 2002). Firstly, a growth 
curve was determined for RF122, RF122t and RF122-8 grown in BHI liquid culture 
for 10 h at 37 °C, which revealed growth rates and yields were similar for each 
strain (Figure 6.7). In addition, the haemolysis of rabbit erythrocytes incubated with 
culture supernatants of RF122 and SAg-deficient derivative strains was 
investigated. In each case the haemolytic titre of RF122 and SAg-deficient 
derivatives was 1022, indicating that the deletion of SAg genes had no effect on 
haemolytic activity and that the agr locus was functional (Figure 6.7). Furthermore, 
analysis of the profile of secreted and CWA proteins of WT and mutant strains 
revealed no unexpected differences (Figure 6.7). The only observed difference is 
the expected absence of SECbov, a secreted protein of approximately 26 kDa, in 
strains RF122-3, RF122-4, RF122-5, RF122-6, RF122-7 and RF122-8, indicated by 
a red arrow in Figure 6.7. 
Stationary and mid-exponential phase culture supernatants (10 ng/ml) of 
RF122 and RF122-8 were used to stimulate CFSE stained bovine PBMC to 
investigate their mitogenic activity. RF122-8 does not induce proliferation of 
bovine T-cells in either phase of growth, confirming loss of mitogenicity due to the 
deletion of all SAgs (Figure 6.8). RF122 induces higher level of T-cell proliferation 
in stationary than mid-exponential phase, which is consistent with the high level of 
transcription of SAg genes in stationary phase observed in this project. The level of 
T-cell proliferation of CFSE stained cultures in response to stimulation with RF122 
appears to be lower than was measured by thymidine incorporation (Figure 6.11), 
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Figure 6.7: Phenotypic analysis of the RF122 and SAg-deficient derivative 
RF122-8 a) Growth curve of S. aureus strains RF122t, RF122 and RF122-8 grown 
in BHI at 37 °C. b) Haemolytic activity of S. aureus strains Newman, RF122 and 
mutant strains. Experiments were performed at least in triplicate. End points of 
haemolysis have been circled in red. c) SDS-PAGE analysis of secreted and CWA 
proteins extracted from stationary phase cultures of S. aureus. SECbov protein is 
indicated by a red arrow. Lane 1, RF122; lane 2, RF122t; lane 3, RF122-1; lane 4, 
RF122-3; lane 5, RF122-4; lane 6, RF122-5; lane 7, RF122-6; lane 8, RF122-7; lane 
9, RF122-8; lane 10, RF122; lane 11, RF122t; lane 12, RF122-1; lane 13, RF122-3; 
lane 14, RF122-4; lane 15, RF122- 5; lane16, RF122-6; lane 17, RF122-7; lane 18, 
RF122-8; lane 19, RN4220.   












































Figure 6.8: FACS analysis of CFSE stained bovine PBLs after stimulation with 
a) medium only, b) RF122 and c) RF122-8 stationary and mid-exponential 
phase culture supernatants for 4 d. Red broken lines indicate the data obtained 
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Figure 6.9: Experimental IMI of dairy cattle. Infectious dose of RF122 and 
RF122-8 was determined by instillation of a) 2 CFU, b) 5 CFU and c) 10 CFU of 
RF122 and RF122-8 directly into the udder of each cow. Body temperature, SCC, 
and bacterial counts obtained from the animals were measured daily throughout the 
course of infection.  
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6.3.3 SAg-deficient strain RF122-8 requires a higher infectious dose 
than wild type RF122 to establish experimental infection of dairy cattle 
Preliminary experiments were carried out to determine the infectious dose of each 
strain, for IMI of cows. An initial inoculum of 2 CFU of either RF122 or RF122-8 
was introduced directly into the udder. Infection was established with RF122 after 3 
d, however RF122-8 was not infectious at this dose (Figure 6.9). Similarly, 
instillation of 5 CFU resulted in an infection with RF122 after 3 d, but not with 
RF122-8 (Figure 6.9). Symptoms of acute clinical mastitis were observed during 
infection including swelling of the udder, high body temperature and high SCC 
which indicates a strong inflammatory response caused by bacterial infection. 
Elevation of body temperature above 41 °C (105 °F) indicated a high risk for loss of 
the animals (University of Idaho animal use guidelines). Therefore experiments 
were stopped by treatment with anti-inflammatory drug (Benamin), aspirin, and 
penicilin G.  Establishment of infection with strain RF122-8 required an inoculum 
of 10 CFU, and once established the clinical symptoms associated with each strain 
were similar including high SCC of 6 Log
SCC
 and elevation of body temperature 
above 41 °C (105 °F) (Figure 6.9). These studies have shown that despite evidence 
of some attenuation of the SAg-deficient derivative of RF122 reflected in differing 
infectious doses, both strains are infectious at extremely low doses and are highly 
virulent in their natural host.  
 
6.3.4 Construction of α-toxin-deficient derivatives of RF122 and RF122-
8  
The University of Idaho guidelines associated with large animal experimentation 
require animals to be treated with antibiotics when there is high risk of death, which 
has proven problematic for studying pathogenesis of highly virulent strains RF122 
and RF122-8. To allow the experimental infections to be carried out over the full 
course of infection, it is necessary to attempt to reduce the virulence of the strains. 
In this study we have demonstrated that the culture supernatant of RF122 exhibits a 
high level of haemolytic activity when incubated with rabbit erythrocytes (Figure 
6.10), due at least in part to high levels of α-toxin production. Animal infection 
studies have shown that strains containing the toxin are more virulent than their 
isogenic derivatives in a murine model of mastitis (Bramley et al., 1989). Deletion 
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of hla was carried out in strains RF122 and RF122-8 with the aim to reduce 
virulence and allow the effect of both hla and SAg gene deletions in mastitis to be 
elucidated.  pMAD:hla was constructed by cloning the spliced fragments flanking 
the hla gene between the SalI and SmaI sites of pMAD. Digestion of pMAD:hla 
with EcoRI confirmed the expected restriction pattern of the insert, 814 bp and 428 
bp (Figure 6.3). pMAD:hla was transformed into RF122 and RF122-8 and hla-
deficient derivatives were obtained by allelic replacement. The region spanning the 
hla gene amplified from strains RF122t and RF122-8 is 2229 bp, and 1241 bp in 
RF122t-α and RF122-8α, indicating a deletion of 988 bp from the hla gene (Figure 
6.4). In addition, sequencing across the region in RF122t-α and RF122-8α was 
carried out to verify an in frame deletion has occurred at the appropriate site.  
 
6.3.5 Phenotypic verification of α toxin deficient derivatives of RF122 
and RF122-8 
Phenotypic tests were carried out to investigate the effect of the hla deletion on the 
strains RF122t-α and RF122-8α. Firstly, a growth curve was determined for RF122, 
RF122t, RF122t-α, RF122-8 and RF122-8α  grown in BHI liquid culture for 10 h at 
37 °C, which revealed growth rates are unchanged by deletion of the hla gene 
(Figure 6.10). Similarly analysis of the secreted and CWA protein profiles produced 
by strains RF122t, RF122t-α, RF122-8 and RF122-8α by SDS-PAGE revealed no 
unexpected changes (Figure 6.10). The 33 kDa α-toxin could not be visualised on 
the SDS-PAGE gel, but is thought to be masked by a highly abundant 31 kDa 
protein.  
Stationary phase culture supernatants of RF122t, RF122t-α, RF122-8 and 
RF122-8α were used to stimulate bovine PBMC to investigate their mitogenic 
activity. As expected, RF122-8 and RF122-8α do not induce proliferation of bovine 
T-cells confirming loss of mitogenicity due to the deletion of all SAgs in both 
strains (Figure 6.10). RF122t and RF122t-α induce high levels of T-cell 
proliferation, however it is noteworthy that there is a slight decrease in proliferation 
associated with RF122t-α. The haemolysis of rabbit erythrocytes incubated with 
culture supernatants was investigated and confirmed a drastically reduced 
haemolytic titre of 4 associated with hla-deficient strains RF122t-α and RF122-8α, 
compared to a haemolytic titre of 2044 for WT and SAg-deficient derivatives 
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(Figure 6.10). Experimental infection of dairy cattle with RF122t-α and RF122-8α 





































































































































Figure 6.10: Phenotypic verification of α toxin-deficient derivatives of RF122 
and RF122-8. a) Growth curve of S. aureus strains RF122t, RF122t-α, RF122-8 
and RF122-8α grown in BHI at 37 °C. b) Haemolytic activity of S. aureus RF122 
and mutant strains. End points of haemolysis have been circled in red. c) Coomassie 
stained SDS-PAGE analysis of and stationary phase. Lanes 1 to 4 contain secreted 
proteins from exponential phase cultures of RF122t, RF122t∆α, RF122-8 and 
RF122-8 ∆α, Lanes 5 to 8, secreted proteins from stationary phase cultures of 
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Figure 6.11: Bovine T-cell activation by RF122t, RF122t-α, RF122-8 and 
RF122-8α. PBMC proliferation after 4 d exposure to S. aureus supernatants, as 
indicated by the incorporation of [
3
H] thymidine. Experiments were performed in 









A small number of pathogenic clones of S. aureus are responsible for the majority 
of bovine mastitis infections (Smyth et al., 2009). In this study, analysis of the 
genome of S. aureus RF122, a representative isolate of the common bovine clone 
ST151, revealed the full complement of SAg genes encoded by this strain. Targeted 
disruption of staphylococcal genes leading to loss of function is an important tool in 
the study of S. aureus disease pathogenesis, allowing the contribution of individual 
genes to be determined. Antibiotic resistance cassettes are often used as markers for 
mutated alleles however this limits the number of genes that can be inactivated in a 
single strain. Gene disruption using the pMAD plasmid overcomes this limitation 
by the incorporation of a constitutively expressed β-galactosidase gene to allow 
blue/white colony screening for double crossover events (Arnaud et al., 2004). 
SaPIbov was originally characterised in RF122, and tstbov-deficient RF122-
1 and tstbov and secbov-deficient RF122-2 isolates were obtained by disruption 
with tetracycline and erythromycin resistance cassettes respectively (Fitzgerald et 
al., 2001a). In the study by Fitzgerald et al, residual SAg activity was observed in 
the absence of secbov and tstbov, which indicated that RF122 expressed additional 
SAgs. This is consistent with our finding that RF122 has the potential to express a 
further 9 SAgs. In the current study we have deleted all remaining SAg genes in 
RF122-1 by sequential allele replacement with pMAD gene deletion constructs, 
leaving no additional antibiotic resistance markers. Many strains of S. aureus are 
not transformable and require transformation into an intermediate restriction-
modification negative host such as RN4220 before phage transduction into the 
strain of interest (Kreiswirth et al., 1983). In this study we have been able to 
introduce deletion plasmids directly into the strains of interest. The reason for the 
unusually high transformation efficiency of RF122t and derivative strains is 
currently unknown, but could be the result of a mutation in a restriction-
modification pathway which has occurred during passage.  
The resulting strain RF122-8 is deficient in SAg genes, and represents a 
valuable tool which can be used in wide range of both in vitro and in vivo studies. 
For example, we have described expression of individual SAg genes in this strain, 
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which has allowed Vβ specific lymphocyte expansion in response to specific SAg 
proteins to be investigated. The deletion of all SAgs in RF122-8 had the expected 
effect of abrogating mitogenicity of culture supernatants. Importantly, comparable 
levels of haemolysis and similar protein profiles obtained for WT and mutant 
strains suggests there have been no unexpected mutations affecting agr function 
during passage of the strains. Previously, in vitro passage of S. aureus has resulted 
in mutations within the agr operon (Somerville et al., 2002). Vojtov et al, reported 
the ability of some SAgs to act as global repressors of exotoxin synthesis, where 
SDS-PAGE analysis revealed a significant reduction in levels of exoprotein 
production when tst was inactivated (Vojtov et al., 2002a). In contrast, we have 
demonstrated that the deletion of all SAg genes in RF122, including tstbov had no 
effect on protein synthesis. tstbov is an allelic variant of tst with 98% nucleotide 
identity, which may explain the lack of exoprotein repression associated with 
TSST-1bov, alternatively it could be due to the RF122 strain background.   
SAgs play a direct role in food poisoning and toxic shock syndrome (TSS) 
however their role in other diseases such as mastitis is less well understood. In this 
study SAg-deficient strain RF122-8 was constructed to determine the effect of SAgs 
produced during staphylococcal IMI on cytokine release, leukocyte sub-population 
changes, progression of disease severity and persistence. The infectious dose of 
each strain was determined by direct instillation of bacteria into the udder of the 
cows. Remarkably, infection was established with only 2 CFU of RF122, indicating 
the highly virulent nature of the strain.  
RF122-8 required a higher inoculum of 10 CFU to establish infection. 
However once infection was established the clinical symptoms associated with each 
strain were similar and typical of acute clinical mastitis including; swelling of the 
udder, high SCC (6 Log
SCC
) and elevation of body temperature above 41 °C (105 
°F). These studies have shown that despite an evident attenuation in infectious dose 
of the SAg-deficient derivative of RF122, both strains are infectious at very low 
doses and are highly virulent in their natural host. Previous experimental intra-
mammary infection studies have described infectious doses ranging from as low as 
50 CFU for strains M60 and 409 (Tollersrud et al., 2006) to 10
3
 CFU for strain 
RC108 and 10
4
 CFU of strains 510, 571, and 581 (Pellegrino et al., 2008). 50 CFU 
of strain 409 was an optimal dose to establish a subclinical mastitis model 
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(Tollersrud et al., 2006). It is remarkable that an infectious dose of only 2 CFU of 
RF122 causes symptoms of acute clinical mastitis. In contrast, an infectious dose of 
10
8 
CFU is necessary to establish infection of mice with ST151 isolates which are 
clonally related to RF122 (Guinane et al., 2008). This is consistent with the intrinsic 
sensitivity of natural hosts when exposed to host-specialised S. aureus strains. The 
mouse model is a useful tool for studying mastitis but such large variations in 
infectivity highlight the importance of studying the pathogenesis of bacterial strains 
in their natural host.   
The progression of disease during staphylococcal mastitis often begins with 
an acute clinical episode as observed during infection with RF122 and RF122-8, 
which then develops into a persistent chronic infection (Anderson, 1982). 
Unfortunately due to high risk of animal loss, experiments were stopped 
prematurely and we were unable to monitor the animals throughout the full course 
of intra-mammary infection (IMI). The guidelines associated with large animal 
experimentation which require animals to be treated with antibiotics when there is 
high risk of death, have proven problematic for studying pathogenesis of these 
strains. To allow the experimental infections to be carried out over the full course of 
infection, it is necessary to reduce the virulence of the wild type and SAg-deficient 
strains. Analysis of the genome sequence of RF122 revealed that in addition to 
SAgs, RF122 has the potential to produce many toxins which could potentially be 
responsible for the increased virulence of the strain, including SSLs, α- and β-toxin, 
exfoliative toxins, streptolysin homologs, leukocidins and leukotoxins (Herron-
Olson et al., 2007). α-haemolysin is a pore forming toxin which promotes cell lysis 
and release of internalised bacteria, and is produced by almost all bovine isolates of 
S. aureus (Kenny et al., 1992). Animal infection studies have shown that strains 
producing the toxin are more virulent than their isogenic derivatives in a murine 
model of mastitis (Bramley et al., 1989). Previously, it has been demonstrated that 
strain RF122 produces high levels of α-toxin (Guinane, 2008). Therefore we have 
constructed α-toxin-deficient derivatives of RF122 and RF122-8 to allow future 
experiments to be carried out to determine the role of SAgs produced during 
staphylococcal IMI. RF122t and hla-deficient RF122t-α induce high levels of T-cell 
proliferation, however it is noteworthy that we have observed a slight decrease in 
proliferation associated with RF122t-α which could be due to a potential 
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synergestic mode of action of SAg and α-toxin. α-toxin has recently been shown to 
augment penetratation of TSST-1 through porcine vaginal tissue in an ex vivo 
model (Brosnahan et al., 2009), but it is unknown whether a similar phenomenon is 
observed in the bovine udder. Future experiments utilizing the hla and SAg-
deficient strains constructed in this study would allow investigation into this 
hypothesis. 
In this study, preliminary experimental IMI has been carried out and 
revealed attenuation of the infectious dose of a SAg-deficient derivative of RF122 
compared with WT. We have also constructed hla-deficient derivatives of RF122 


















































SAgs are known to play a direct role in the pathogenesis of diseases such as food 
poisoning and TSS (Dinges et al., 2000), but SAg genes are harboured by strains 
isolated from a wide range of hosts and disease manifestations (Holtfreter et al., 
2007). Although SAgs are known to contribute to immunomodulation, the 
consequences of this activity for disease progression are not well understood. In 
particular, the role of SAgs in bovine mastitis has not been investigated in detail. In 
recent years, there has been an exponential increase in the number of S. aureus 
genome sequences submitted to public databases such as NCBI. This information 
has been valuable in the identification of genes encoding novel virulence factors. 
Most of the sequenced strains are of human origin, but genomes of isolates from 
bovine, ovine and avian hosts have recently been included, facilitating comparative 
genomic analysis of staphylococcal adaptation to different host species (Guinane et 
al., Lowder et al., 2009, Herron-Olson et al., 2007). In the current study, the 
genome sequence for bovine strain RF122 allowed us to perform a genome scale 
analysis of the presence of characterised or novel SAg genes.  
Previously, SaPIbov which contains genes encoding SECbov, SElLbov and 
TSST-1bov was discovered in strain RF122 (Fitzgerald et al., 2001a). In addition, we 
have identified bovine variants of characterised SAgs encoded by the egc including 
SEG, SEI, SElO, SElN and SElU, and 3 novel putative SAg genes. The novel SAgs 
genes were found in a number of human and ovine lineages, in addition to bovine 
strains. It is likely that as additional genome sequences are released, more SAgs will 
be discovered. S. aureus is now known to encode 25 distinct SAgs, SEA through to 
E, SEG to J, SER to SET, SElK to Q, SElU, SElV, and SElX to SElZ and TSST-1. 
In addition there are a further 2 putative SAg genes selw and se26 which have not 
been characterised.  
Regulation of a number of SAgs including SEC and TSST-1 has been 
shown to be agr dependent (Novick, 2003). We investigated the transcription of all 
RF122-encoded SAg genes and found that secbov, sellbov, tstbov and selxbov are 
upregulated in stationary phase, consistent with regulatory control by agr. Of note, 
ST151 strains were previously demonstrated to have higher levels of RNAIII 
transcription in comparison with other ruminant clones (Guinane et al., 2008). 
Further, although ST151 strains contain an Agr group II operon, AgrC is encoded 
by a novel allele and sarU and sarT genes are absent (Herron-Olson et al., 2007). 
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There is also a novel transcriptional regulator within a gene cluster previously 
shown to affect agr expression (Shaw et al., 2006) which may contribute to the 
elevated RNAIII levels (Guinane et al., 2008). Taken together, these data suggest 
that ST151 strains have a unique agr expression phenotype which may influence 
SAg production. We have also observed upregulation of some SAgs including 
SElYbov and SElZbov in mid-exponential phase. The distinct regulation among SAg 
genes encoded by strain RF122 implies specific SAgs may be expressed at different 
stages of infection.  
Our observation that egc genes are transcribed at very low levels in both 
mid-exponential and stationary phase of growth, is consistent with Derzelle et al 
who reported low egc transcript levels among 28 human strains (Derzelle et al., 
2009). It is possible that the egc genes may be expressed at higher levels in vivo, as 
has been observed for the streptococcal SAgs SPEA and SPEC (Kazmi et al., 2001, 
Broudy et al., 2001). SPEA was produced in small quantities in vitro, but in the 
BALB/c mouse, SPEA production was significantly increased (Kazmi et al., 2001), 
and SPEC production has been shown to increase in co-culture with human 
pharyngeal cells (Broudy et al., 2001). However, despite the relatively high 
prevalence of the egc cluster among clinical isolates of S. aureus, neutralising 
antibodies are rare (Holtfreter et al., 2004). It has been demonstrated that less than 
10% of normal human serum samples contain neutralising antibody specific for egc 
SAgs, in comparison with between 32% and 86% of individuals which have 
antibody against selected non-egc encoded SAgs (Holtfreter et al., 2004). Similarly, 
in this study we have observed lower levels of antibody against egc-encoded SAgs, 
SEGbov, SElObov, SElUbov and SEIbov in comparison with the novel SAgs, SElXbov, 
SElYbov and SElZbov, in sera obtained from humans and animals. The low 
transcription levels of egc genes, taken together with the low levels of antibodies 
detected, leads us to speculate that the egc-encoded SAgs may be less important 
than other SAgs in S. aureus disease pathogenesis, including bovine mastitis. 
Furthermore in the RF122 genome, selmbov and segbov are predicted to encode 
truncated proteins, which may not be functional, consistent with a limited role for 
the egc locus in the pathogenesis of bovine pathogenesis. 
 Prior to this study all identified SAgs produced by S. aureus were known to 
be encoded by MGEs or highly variable chromosomal regions (Fitzgerald et al., 
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2001a, Jarraud et al., 2001, Johns & Khan, 1988, Ono et al., 2008, Ben Zakour et 
al., 2008). Here we have identified and characterised SElX, which is the first SAg 
encoded by the core genome of S. aureus and found in the great majority of strains. 
SElX is most closely related to TSST-1 and belongs to phylogenetic group IV of 
staphylococcal SAgs. Fraser et al proposed that TSST-1 was the sole survivor of an 
early divergence between the related toxin families, SAgs and SSLs (Fraser & 
Proft, 2008). TSST-1 is phylogenetically most closely related to the SSLs, but has 
the biological function of a SAg. It is likely that SElX is a second example of an 
intermediate survivor between these two groups. Structural modelling of SElX 
revealed it has a unique predicted structure with a much smaller B domain than that 
of other SAgs identified to date and the OB fold is absent. The well conserved and 
successful 2-domain structure common to SAgs and SSLs, is thought to have 
evolved through recombination of 2 small ancestral β-strand motifs, predicted to be 
Ig-binding motifs of streptococcal proteins G and L, and the OB fold of the heat 
labile enterotoxin family which resemble domains A and B respectively, where 
conserved amino acids in the central alpha helix brought 2 domains together 
(Mitchell et al., 2000). Previously, it was shown that Bordetella pertussis cytolysin, 
which has both adenylate cyclase and haemolytic activity evolved through a similar 
mechanism (Glaser et al., 1988). SElX therefore represents an intermediate that 
lacks the OB fold, which could have important implications for our understanding 
of the structural evolution of the SAg family. Ongoing crystallography analyses 
should result in important insights into the molecular interaction of SElX with its 
ligands which may facilitate the design of molecules to inhibit its function. The 
predicted structure of SElX is most closely related to TSST-1 and SSL7. SSL7 has 
two functional sites, the OB-fold which binds to the FcαR1 portion of the IgA Fc 
region is missing in SElX, however the C-terminal A domain which binds to the C5 
component of complement is similar (Fraser & Proft, 2008). It would therefore be 
important to investigate the possibility that SElX is a hybrid molecule which has 
both SSL and SAg activity by investigating its capacity to inhibit complement.  
In this study we have demonstrated that bovine- and ovine-specific SElX 
variants have increased mitogenicity and a distinct bovVβ T-cell activation profile 
in comparison with a human SElX variant suggesting that SElX has undergone 
adaptive diversification leading to enhanced activity in ruminants. This indicates 
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that S. aureus is able to produce highly adapted SAg variants with optimal 
efficiency in their natural hosts, but which are functional across a diverse range of 
hosts. We have identified 11 distinct selx alleles from divergent human lineages, 
and further investigation of human-specific allelic variants may reveal similar 
functional diversification or antigenic variation. Importantly, we have described 
high levels of expression of SElX by the CA-MRSA strain USA300 LAC, which 
may contribute to the characteristic enhanced virulence of this strain. Ongoing 
experiments with LAC and an isogenic SElX-deficient derivative in a rabbit model 
of necrotising pneumonia will allow us to determine the importance of this novel 
SAg in virulence.   
For the first time in this study we have comprehensively evaluated bovVβ-
specific T-cell activation in response to stimulation with all SAgs encoded by a 
single successful mastitis isolate. We have established that RF122 has the potential 
to stimulate the entire bovVβ repertoire by expression of SAgs. It is possible that 
this capacity allows the bacteria to contend with host genetic variation in the 
expressed TCR Vβ repertoire among the cattle population. It is also feasible that 
SAgs with distinct bovVβ activation profiles are expressed at different stages of 
infection, potentially indicating a role for SAgs in persistence. In future 
experiments, it will be important to address whether the proportion of T-cells 
expressing Vβ genes varies between animals, and the effect particular frequencies 
have on susceptibility to mastitis caused by S. aureus. In addition, it will be 
important to examine the Vβ specificity of T cells activated during future 
experimental mammary gland infections with S. aureus. 
To determine the role of SAgs in bovine mastitis, we have constructed a 
SAg-deficient derivative of RF122 by sequential allele replacement, which provides 
a unique tool to investigate SAg function in in vitro and in vivo studies. Previous 
studies have monitored the effects of intra-mammary instillation of purified SEC1 
or a laboratory strain RN4220 with a plasmid containing the sec1 gene (Ebling et 
al., 2001, Kuroishi et al., 2003). Kuroishi et al described migration of neutrophils 
into milk within 24 h after intramammary instillation of SEC1 (Kuroishi et al., 
2003). Ebling et al were unable to detect any alteration in the CD4 or CD8 T-cell 
populations in response to plasmid-encoded SEC1 during infection (Ebling et al., 
2001). However isogenic mutants of clinical isolates deficient in SAg production 
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have not been previously examined in experimental IMI. In this study we carried 
out experimental intra-mammary infection of dairy cattle with RF122 and the SAg-
deficient strain RF122-8 with the aim to determine the effect of SAg expression 
during persistent infection. Unfortunately, we were unable to establish a subclinical 
mastitis infection, due to the hyper-virulence of strain RF122 in its natural host. 
ST151 strains are often isolated from subclinical infections (Fitzgerald et al., 1997, 
Fitzgerald et al., 2000), which suggests the route of delivery used in the current 
study may contribute to the hyper-virulence observed during experimental infection 
with RF122. It is feasible that damage to the teat canal at the injection site during 
direct intra-mammary inoculation may have contributed to the acute clinical 
outcome of infection. In addition, the bacteria used to inoculate the cows have been 
grown in vitro in TSB, a nutrient-rich growth medium which may lead to the 
expression of higher levels of toxins than would be associated with natural 
infection. 
In spite of these limitations, our data suggest that SAgs play a role in early 
infection due to the observed attenuation of infectivity with the SAg-deficient 
mutant. RF122 was able to establish infection at a dose as low as 2 CFU, whereas 
RF122-8 required a dose of 10 CFU. Classically, SAgs have been implicated with 
modulation of the adaptive immune response, however there is mounting evidence 
that they also play a role in the early stages of infection. For example, SEC1 was 
shown to induce early migration of neutrophils to the mammary gland (Kuroishi et 
al., 2003) and Dauwalder et al have also described early induction of leukocytes by 
SEA in vitro (Dauwalder et al., 2009). Furthermore expression of SPEA2, SPEJ and 
SMEZ is upregulated during early infection of cynomolgus macacques in 
experimental pharyngitis (Virtaneva et al., 2005).   
 The extremely low inoculum required to establish infection of dairy cattle 
in this study is in stark contrast with the 10
8 
CFU dose necessary to establish 
infection of mice with ST151 isolates (Guinane et al., 2008). To our knowledge, 2 
CFU is by far the lowest inoculum that has been described to establish intra-
mammary infection by bacteria. The mouse model is a useful tool for studying S. 
aureus pathogenesis but the large discrepancy in doseage required highlights the 
importance of studying the pathogenesis of bacterial strains in an appropriate 
animal host. This is particularly important when studying the effect of SAgs as the 
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murine and bovine immune T-cell repertoires are very different (Connelley et al., 
2009, Bosc & Lefranc, 2000). In addition, it is well established that mice are much 
less sensitive to the effect of SAgs than humans due to a much lower binding 
affinity for murine than human MHC class II molecules (Sriskandan et al., 2001, 
DaSilva et al., 2002, Yeung et al., 1996, Faulkner et al., 2005, Peavy et al., 1970).  
In this study we have comprehensively evaluated bovine T-cell activation in 
response to SAg stimulation. Further experiments are necessary to characterise the 
interaction of SAgs with bovine MHC class II molecules, particularly as 
comparison between mastitis resistant and susceptible cows reveals an association 
with DH24A (DRB3.2*24 and DQA*1A, DQB*1 (Park et al., 2004, Kelm et al., 
1997). Most SAgs including SEA, SEB, SED, SEH and TSST-1 are known to bind 
preferentially to human MHC class II HLA-DR molecules with the exception of 
SEC which binds preferentially to HLA-DQ (Herrmann, 1989). The cattle MHC is 
distinct from the human MHC in a number of ways including a chromosomal 
inversion, ruminant specific DYA and DYB genes (Ballingall et al., 2004, Ellis, 
2004), and a variable number of DQ genes. It would be interesting to investigate if 
the bovVβ profile is dependent on the HLA-DR allelic polymorphism or differences 
in SAg concentrations, as has been observed with the human Vβ response 
(Llewelyn et al., 2006). Additionally, the bovine genome has recently been 
sequenced which leading to the identification of a large number of novel cytokines, 
attributed to extensive colonisation of the gut rumen (Elsik et al., 2009). 
Accordingly, further investigation into bovine cytokine release in response to SAgs 
is warranted.  
SAgs are produced by a diverse range of microbial species. In addition to 
well characterised bacterial SAgs, a number of viral SAgs have been identified, 
such as the nucleocapsid produced by the Rabies virus (Astoul et al., 1996). 
Furthermore, the fungal species Candida albicans and the parasite Toxoplasma 
gondii have been shown to produce proteins with SAg like activity (Devore-Carter 
et al., 2008, Vallochi et al., 2001). This suggests that Vβ-specific T-cell activation 
is important in the pathogenesis of diverse microbial infections. Because of their 
importance in pathogenesis, therapeutic strategies which target SAgs have been the 
focus of considerable research efforts (Fraser & Proft, 2008). Strategies employing 
vaccination, passive immunization, peptide antagonists and receptor mimics have 
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been developed with limited success (Fraser & Proft, 2008). In addition, future 
therapeutic interventions which target an alternative SAg-specific Lck-independent 
T-cell signalling pathway have been proposed (Bueno et al., 2006). Importantly, the 
diversity of SAgs made by different strains and their distinct Vβ dependent binding 
activities has complicated efforts to design broadly effective therapeutics. Affinity 
matured forms of Vβ domain derived SAg antagonists, of SEC, TSST-1, and SEB 
are in development (Buonpane et al., 2005, Buonpane et al., 2007, Kieke et al., 
2001). Here we have described the capacity of a single bovine isolate to produce 
SAgs which activate the entire bovVβ T-cell repertoire, which suggests that a 
successful Vβ receptor analog would need to be effective against all bovVβ 
subfamilies. A number of bovine mastitis vaccines currently in development such as 
MastaVac
TM 
are based on SEC (Chang et al., 2008), however the efficacy of this 
vaccine may be limited as only 19% of bovine strains examined harbour the secbov 
gene (Smyth et al., 2005). In this study, we have identified a novel toxin SElX 
which is encoded by the great majority of S. aureus strains and may represent a 
novel therapeutic target. 
Despite the large number of strains which can produce SAgs, toxinoses such 
as TSS and food poisoning are a relatively rare outcome, suggesting that such 
disease symptoms are not the primary role of SAgs in pathogenesis. It has often 
been proposed that the role of SAgs in pathogenesis is to subvert the normal 
immune response to the SAg-producing bacteria. The production of SAgs by S. 
aureus may be advantageous in particular niche environments, where competing 
bacteria are unable to evade the activated immune response (Sriskandan et al., 
2007). It is feasible that very low concentrations of SAgs may produce local T-cell 
activation to suppress local inflammation and allow bacterial survival. SAgs have 
been shown to induce the development of Tregs which control the immune response 
to both self and foreign antigens (Sakaguchi, 2004). Recently, long term exposure 
to SEC was demonstrated to induce immunosuppressive Treg development at 
physiologically relevant low concentrations in the bovine immune system (Seo et 
al., 2007, Seo et al., 2009). In our future planned experimental IMI it will be 
important to examine the effect of WT and SAg-deficient strains on the 
development of CD4+ CD25+ Tregs and their role in the persistence of infection. 
Most humans are exposed to SAgs during their lifetime as has been demonstrated 
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by the widespread presence of neutralising antibodies (Holtfreter et al., 2006). It has 
been suggested that inhibition of SAgs by α- and β-globin chains produced in blood 
prevents TSS (Schlievert et al., 2007). In addition, Chau et al have recently 
proposed that the response to SAg activity is controlled by the bacteria through 
downregulation of the T-cell response by Toll-like receptor 2 activation (TLR2). 
This signal initiates the apopotosis pathway for APCs, leads to activation of NF-kβ 
within the APC, which in turn leads to production of IL-10 inhibiting the response 
to SAgs (Chau et al., 2009).  
In conclusion, the role of SAgs during pathogenesis is very complex. The 
array of staphylococcal SAgs which have been identified is expanding, and has 
been expedited with the recent advances in genomics. This diversity is potentially 
driven by the need to activate a large number of T-cells, and bind to MHC class II 
molecules in multiple ways, contributing to immune evasion. In this work, we have 
employed a genome scale approach to investigate SAgs encoded by the bovine 
isolate RF122. The results of this study contribute to our understanding of 
staphylococcal SAg diversity and provide a comprehensive analysis of the bovine 
T-cell response to SAgs. In addition, preliminary experimental infections of dairy 
cattle with WT and SAg-deficient strains have revealed a potential role for SAgs in 
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